Page last updated: 2024-08-25

voriconazole and Mycoses

voriconazole has been researched along with Mycoses in 622 studies

Research

Studies (622)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (0.96)18.2507
2000's237 (38.10)29.6817
2010's321 (51.61)24.3611
2020's58 (9.32)2.80

Authors

AuthorsStudies
Guarro, J; Mariné, M; Pastor, FJ; Rodríguez, MM; Serena, C1
Dannaoui, E; Datry, A; Dromer, F; Hoinard, D; Lacroix, C; Lortholary, O; Paugam, A; Poirot, JL; Raoux, D1
Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Gutierrez, MO; Rodriguez-Tudela, JL1
Bouza, E; Guinea, J; Peláez, T; Recio, S; Torres-Narbona, M1
Hashimoto, K; Kaeriyama, M; Kimura, A; Mitsuyama, J; Narita, H; Nishikawa, H; Nomura, N; Todo, Y; Yamada, E1
Azor, M; Cano, J; Fothergill, AW; Gené, J; Guarro, J; Rinaldi, MG; Sutton, DA1
Dho, G; Esposto, MC; Gianni, C; Grancini, A; Ossi, C; Prigitano, A; Tortorano, AM; Viviani, MA1
Fille, M; Hausdorfer, J; Hinterberger, G; Lass-Flörl, C; Mayr, A; Perkhofer, S; Speth, C1
Guarro, J; Mariné, M; Rodríguez, MM; Ruíz-Cendoya, M1
Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL2
Mehta, J; Pennick, G; Pi, J; Scheetz, MH; Trifilio, SM; Yarnold, PR1
Bartley, R; Biswas, C; Chen, SC; Djordjevic, JT; Ellis, DH; Jolliffe, KA; Obando, D; Pantarat, N; Sorrell, TC; Widmer, F1
Chai, X; Guan, Z; Hu, H; Sun, Q; Wu, Q; Yan, Y; Yu, S; Zou, Y1
Esterly, JS; Fotis, M; Gorski, E; Postelnick, M; Scheetz, MH; Trifilio, S1
Cao, Y; Chai, X; Jiang, Y; Sun, Q; Wu, Q; Zhang, D; Zhang, J; Zou, Y1
Garneau-Tsodikova, S; Garzan, A; Shrestha, SK1
Wang, SQ; Wang, YF; Xu, Z1
Aragona, P; Biondo, C; Inferrera, L; Postorino, EI; Roszkowska, AM; Severo, AA1
D'agostino, M; Debourgogne, A; Frippiat, JP; Lavergne, RA; Le Pape, P; Machouart, M; Tesse, N1
Hou, JY; Huang, HM; Huang, TH; Liu, HC; Lu, CH; Sun, FJ; Yeh, TC1
Amiri, S; Borjian Boroujeni, Z; Getso, MI; Hashemi, SJ; Raiesi, O; Raissi, V; Yarahmadi, M1
Deng, S; Hu, Q; Li, Y; Sun, S; Tang, M1
Al-Hatmi, AMS; Blechert, O; Hu, F; Jiang, Q; Wang, C; Wang, P; Zhan, P; Zhang, L1
Cornely, O; Janssen, S; Mehler, K; Oberthuer, A; Seifert, H; Zweigner, J1
Arunga, S; Burton, MJ; Chaudhary, P; Hoffman, JJ; Hu, VH; Leck, A; Macleod, D; Mishra, SK; Roshan, A; Sanyam, SD; Singh, SK; Yadav, R1
Allameen, NA; Cho, J1
Acharya, NR; Das, M; Devi, L; Krishnan, T; Lalitha, P; Lietman, TM; Liu, Z; Porco, TC; Prajna, NV; Radnakrishnan, N; Rajaraman, R; Rose-Nussbaumer, J; Srinivasan, M; Zegans, ME1
Aykaç, K; Başaran, E; Büyükköroğlu, G; Demirel, M; Tunali, Y; Yenilmez, E1
Aram, JA; Cao, G; Cornely, OA; Desai, A; Fayyad, R; Guo, X; Hamed, K; Wu, D; Zhang, J; Zhang, Y1
Chelnokova, IA; Karachrysafi, S; Karampatakis, V; Kavvadas, D; Komnenou, A; Papadopoulou, K; Papaliagkas, V; Papamitsou, T; Samara, P; Shkliarava, NM; Sioga, A; Starodubtseva, MN1
Alexander, AB; Gai, JJ; Highland, MA; Horgan, MD; Innis, C; Liguori, BL; Norton, TM; Ossiboff, RJ; Pesavento, PA; Stacy, BA; Wellehan, JFX1
Cai, DH; Fang, XL; Wang, J1
de Lima-Neto, RG; de Melo, HRL; de Sousa, BR; Neves, RP; Silva, GM; Torres, KB1
Aliakbarian, M; Khaleghi, E; Khodashahi, M; Khodashahi, R; Moghaddam, MD; Naderi, HR; Pasand, MM; Rezayat, KA1
Kwon, T; Maish, D; Martinez, RM; Shelly, MA; Tabliago, NRA; Yablonski, B1
Gómez-López, A; Martín-Gómez, MT; Salavert Lletí, M1
Ding, C; He, X; Li, B; Peng, J1
Bryson, AL; Doern, CD; Pierce, J; Sayeed, S1
Boyd, S; Mahmoudjafari, Z; Martin, GA; Perry, C; Scott, SA; Thomas, B; Thompson, J1
An, L; Jia, G; Li, L; Tan, J; Wang, Y; Yang, L1
Chen, J; Shen, X; Tang, G; Yan, K; Yan, L; Yao, H; Yuan, X1
Farkas, M; Hauser, P; Kassa, C; Kelemen, Á; Pásztor-Bazsó, V; Puskás, N; Varga, Á1
Hustrini, NM; Panggabean, SD1
Andes, DR; Cattaneo, D; Christian, R; Davis, MR; Johnson, MD; Lewis, RE; McCreary, EK; Narayanan, N; Watt, KM; Wiederhold, NP1
Cao, CW; Fu, YJ; Guo, J; Huang, CY; Li, BK; Li, TM; Pan, KS; Wei, FL; Zheng, YQ1
Akune, Y; Inoshima, Y; Kobayashi, M; Ohno, Y1
Abbas-Aghababazadeh, F; Caceres, G; Fridley, BL; Greene, JN; Hicks, JK; Kelly, K; Komrokji, RS; Kubal, TE; Lancet, JE; McLeod, HL; Pasikhova, Y; Qin, D; Quilitz, RE; Salchert, YS; Shahbazian, K; So, W; Velez, AP1
Li, R; Sun, L; Wan, Z; Yu, J1
Feng, RZ; Jiang, HL; Liu, W1
Akune, Y; Inoshima, Y; Kano, R; Ohno, Y1
Andrade, A; Bodden-Mendoza, BA; Espinosa-Mora, JE; González, GM; Martínez-Reséndez, MF; Treviño-Rangel, RJ; Villanueva-Lozano, H1
Główka, FK; Kosicka, K; Krawiec, J; Resztak, M; Zalewska, P1
Almeida-Paes, R; Brito-Santos, F; Coelho, RA; da Silva Chaves, AL; de Oliveira, JCA; Figueiredo-Carvalho, MHG; Monteiro, RV1
Barbeito Castiñeiras, G; Bardán García, B; Belles Medall, D; Blanco Hortas, A; Blanco-Dorado, S; Campos-Toimil, M; Carracedo, Á; Durán Piñeiro, G; Fernández-Ferreiro, A; Gómez Márquez, A; Lamas, MJ; Latorre-Pellicer, A; López-Vizcaíno, A; Maroñas, O; Otero Espinar, F; Pérez Del Molino Bernal, ML; Rodríguez Jato, MT; Zarra Ferro, I1
Biswas, J; Kumar, A; Madhuravasal Krishnan, J; Roy, R; Singh, P1
Carlesse, F; Cheng, MP; Cornely, OA; Falces-Romero, I; Hassler, A; Herbrecht, R; Jover Sáenz, A; Klimko, N; Koehler, P; Lass-Flörl, C; Lehrnbecher, T; Mareş, M; Mellinghoff, SC; Pana, Z; Salmanton-García, J; Seidel, D; Soler-Palacín, P; Wisplinghoff, H1
Li, H; Luo, J; Shi, L; Wang, L; Zeng, G; Zhang, Z; Zhu, M1
Aram, JA; Freivogel, K; Lem, J; Lewis, A; Moosavi, S; Sobel, RE; Younus, M1
Bhaskaran, V; Chandran, S; Dinesh, K; Khan, S; Kumar, A1
Enoki, Y; Ikegame, K; Izumikawa, K; Matsumoto, K; Mayumi, T; Miyazaki, T; Miyazaki, Y; Okinaka, K; Takada, T; Takesue, Y; Uchino, M; Ueda, T; Yamashita, C1
Krishnan, T; Lietman, TM; Narayana, S; Pickel, J; Porco, TC; Ramakrishnan, S; Redd, T; Rose-Nussbaumer, J; Samantaray, PP1
Aggarwal, A; Banerjee, S; Biswas, A; George, N; Gupta, N; Jorwal, P; Kodan, P; Kumar, P; Kumar, R; Malla, S; Ramteke, P; Ray, Y; Singh, G; Soneja, M1
Kraft, L; Ribeiro, VST; Telles, JP; Tuon, FF1
Chen, T; Gao, L; Li, H; Li, M; Li, Q; Qiang, W; Shi, Q; Wang, J; Wang, T; Wang, Y; Yan, J; Zhang, Y; Zheng, J; Zhou, L1
Amanati, A; Badiee, P; Bozorgi, H; Faghihi, MA; Lotfi, M; Manen, RV; Mazinani, NH; Yavarian, M; Zekavat, O1
Fujioka, T; Itoh, H; Iwao, M; Suzuki, Y; Tanaka, R1
Alffenaar, JW; Cotta, MO; Daveson, K; Imani, S; Lau, C; Marriott, D; Penm, J; Roberts, JA; Sandaradura, I; Tabah, A; Trethewy, N; van Hal, S; Williams, P1
Chen, B; Wan, Y; Wang, J; Xu, JY; Zhou, M; Zhou, RF1
Bautista-de Lucio, VM; Calvillo-Medina, RP; Campos Guillén, J; Escudero-Leyva, E; Müller-Morales, CA; Ponce-Angulo, DG; Raymundo, T1
Guarro, J; Pérez-Cantero, A1
Machida, M; Miyazaki, Y; Nakamura, I; Nakamura, S; Sato, A; Watanabe, H1
Cornely, OA; Falces-Romero, I; Hatvani, L; Heinemann, M; Klimko, N; López-Soria, L; Malaj, X; Meletiadis, J; Sal, E; Salmanton-García, J; Seidel, D; Shruti, M; Sprute, R; Steinmann, J; Stemler, J1
Lam, JKW; Liao, Q1
Fujibayashi, A; Harada, S; Hoshino, Y; Niwa, T; Suzuki, A1
Cao, C; Huang, W; Jiang, J; Li, T; Wei, F; Zhou, C1
Cai, J; Chen, H; Shi, T; Wu, L1
Mammen, MD; Rupa, V; Sahni, RD; Varghese, GM1
Beeckmans, H; Bos, S; De Mol, W; Lagrou, K; Spriet, I; Verleden, GM; Vos, R1
Brüggemann, RJ; Bury, D; Muilwijk, EW; Tissing, WJE; Wolfs, TFW1
Carvalhaes, CG; Castanheira, M; Messer, SA; Pfaller, MA; Rhomberg, PR1
Birch, M; Law, D; Wiederhold, NP1
Cohen, N; Eaton, A; Kobos, R; Seo, SK; Seyboth, B; Yan, SQ1
Bachellier, P; Bru, V; Gourieux, B; Herbrecht, R; Launoy, A; Levêque, D; Lutun, P; Nivoix, Y; Poulat, C; Rohr, S; Woehl, ML1
Ahlawat, S; Hazarika, N; Sen, IB; Shirshi, N; Tiwari, P1
Anzawa, K; Mochizuki, T; Watanabe, S1
Karagas, MR; Kuklinski, LF; Kwong, BY; Li, S; Weng, WK1
Chatzistilianou, M; Doganis, D; Grafakos, S; Kattamis, A; Katzilakis, N; Koliouskas, D; Kourti, M; Paisiou, A; Pana, ZD; Papageorgiou, M; Petrikkos, L; Polychronopoulou, S; Roilides, E; Stiakaki, E; Vasilatou-Kosmidis, H; Vikelouda, K; Vlahou, A1
Acharya, NR; Das, M; Krishnan, T; Lietman, TM; McLeod, SD; Oldenburg, CE; Patel, S; Prajna, NV; Rajaraman, R; Ray, KJ; Rose-Nussbaumer, J; Shah, R; Srinivasan, M; Zegans, ME1
Aydin, F; Cebeci Güler, N; Tosun, I1
Allender, MC; Archer, G; Baitchman, E; Chu, CT; Cox, S; Driskell, EA; Hsiao, SH; Kane, L; Lindemann, DM; Rzadkowska, M; Singh, K; Sykes, JM1
Annino, L; Arcioni, F; Barberi, W; Bertaina, A; Carotti, A; Cartoni, C; Caselli, D; Cassetta, MI; Cerchiara, E; Cupelli, L; Fallani, S; Fanci, R; Ferrari, A; Girardi, K; Girmenia, C; Marchesi, F; Mariotti, B; Novelli, A; Proia, A; Ribersani, M; Venditti, A1
Abela, IA; Benden, C; Imkamp, F; Mueller, NJ; Muller, F; Murer, C; Schmitt, JW; Schuurmans, MM1
Benamu, E; Fernandez-Pol, S; Ho, DY; Liu, AY; Xie, L; Yu, AT1
Bes, D; Lede, R; Rosanova, MT; Sberna, N; Serrano Aguilar, P1
Chen, Y; Guo, XB; Jiang, Y; Mao, Q; Yi, XL1
Léguillette, R; Scott, M; Whitehead, AE; Whitty, J1
Akiyama, H; Hirato, J; Hoshino, J; Makimura, K; Todokoro, D; Yo, A1
Asano, S; Kato, K; Sakurada, H; Tachi, T; Teramachi, H; Yamamura, M; Yasuhara, K; Yoshida, M1
Allan, GS; Anderson, KM; Davies, S; Dennis, PM; Malik, R; Rose, JB1
Cai, WP; Chen, WS; Chen, XJ; He, Y; Hu, FY; Lei, HL; Li, LH; Song, WN; Tang, XP1
Fukuoka, N; Imataki, O; Uemura, M; Yamaguchi, K1
Dai, C; Kan, J; Li, M; Shan, W; Yin, M1
Imai, S; Iseki, K; Kagami, K; Koshizuka, Y; Shimamura, T; Sugawara, R; Tazawa, Y; Tomiyama, N; Yamada, T; Yamagami, A1
Fleming, ME; Gordon, WT; Jessie, EM; Khan, M; Malone, DL; Murray, CK; Potter, BK; Rodriguez, CJ; Shackelford, SA; Tribble, DR1
Ge, Y; Hu, Y; Huang, M; Xu, Z1
Arianayagam, M; Jeffery, N; Kam, J; Ling, KY; Winter, M1
Gong, BF; Gong, XY; Gu, RX; Li, Y; Lin, D; Liu, BC; Liu, KQ; Liu, YT; Mi, YC; Qiu, SW; Wang, JX; Wang, Y; Wei, H; Wei, SN; Zhang, GJ; Zhao, XL; Zhou, CL1
Bandettini, R; Cavanna, C; Esposto, MC; Grancini, A; Lallitto, F; Lo Cascio, G; Mularoni, A; Ossi, C; Prigitano, A; Tejada, M; Tortorano, AM1
Barbeito Castiñeiras, G; Blanco-Dorado, S; Campos-Toimil, M; Cea-Arestin, C; Fernández-Ferreiro, A; González Carballo, A; Lamas, MJ; Latorre-Pellicer, A; Maroñas Amigo, O; Pérez Del Molino Bernal, ML1
Bao, SS; Chen, MC; Chen, RJ; Cui, X; Dong, YY; Hu, GX; Lou, D; Pan, WH; Sun, W; Wang, Z1
Carlesse, FAMC; de Araujo, OR; Marques, LMA; Petrilli, AS; Senerchia, AA; Silva, DCBD1
Fang, JP; Huang, K; Li, Y; Liao, XY; Qiu, KY; Xu, HG; Zhou, DH1
Daly, RC; Kennedy, CC; Pennington, KM; Peters, S; Razonable, RR; Scott, JP; Wylam, M1
Chen, YH; Li, DM; Li, RY; Liu, W; Song, YG; Sun, LN; Sun, TT; Zhang, GJ; Zhou, YB1
Gong, N; Jiang, J; Yang, L; Zhou, H1
Kawakami, J; Mino, Y; Naito, T; Yamada, T1
McLaren, A; McLemore, R; Pauken, C; Schmidt, K1
Barreto, JN; Beach, CL; Hogan, WJ; Litzow, MR; Merten, JA; Tosh, PK; Wilson, JW; Wolf, RC1
Al-Badriyeh, D; Bajel, A; Grigg, A; Heng, SC; Kirsa, S; Kong, DC; Nation, RL; Seymour, JF; Slavin, MA; Thursky, K1
Agarwal, K; Chowdhary, A; Gaur, SN; Kathuria, S; Meis, JF; Randhawa, HS; Roy, P; Singh, PK1
Charles, JI; Jeanbourquin, D; Mostofi, K1
Kong, DC; Kotsimbos, T; Levvey, B; Morrissey, CO; Neoh, CF; Slavin, MA; Snell, GI; Stewart, K1
Berry, A; Cardeau-Desangles, I; Cassaing, S; Cointault, O; Esposito, L; Fabre, A; Guitard, J; Iriart, X; Kamar, N; Valentin, A1
Celik, IH; Demirel, G; Dilmen, U; Erdeve, O; Oguz, SS; Uras, N1
Arıkan Akdağlı, S; Aydeniz Ozansoy, F; Dursunoğlu, N; Ergin, C; Kutlu, M; Sarı, I; Sarıbaş, Z1
Acharya, NR; Krishnan, T; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Porco, TC; Prajna, L; Prajna, NV; Raghavan, A; Rajaraman, R; Ray, KJ; Srinivasan, M; Zegans, ME1
Gao, X; Ji, X; Marks, DI; Schlamm, HT; Stephens, JM; Tarallo, M1
Goto, T; Hashinaga, K; Hiramatsu, K; Itoh, H; Kadota, J; Kawasaki, K; Sato, Y; Suzuki, Y; Tokimatsu, I1
Hino, M; Iino, M; Kanamaru, A; Koh, H; Masaoka, T; Ohta, K; Ohyashiki, K; Tamura, K; Tanimoto, M; Urabe, A; Urase, F; Usui, N; Yamaguchi, M; Yamanouchi, J; Yoshida, M1
Heng, SC; Keating, D; Kong, DC; Levvey, B; Morrissey, O; Nation, RL; Slavin, MA; Snell, GI; Westall, GP; Whitford, H; Williams, TJ1
Biswas, C; Chen, SC; Djordjevic, JT; Jolliffe, KA; Sorrell, TC; Zuo, X1
Flynn, PM; Hayden, RT; Knapp, KM; Maron, GM; Rodriguez, A; Rubnitz, JE; Shenep, JL1
Baden, LR; Bolaños-Meade, J; Brown, JM; Chirila, C; Gersten, ID; Graham, J; Horowitz, MH; Kurtzberg, J; Leather, H; Marr, KA; Mauskopf, J; Maziarz, RT; Walsh, TJ; Wingard, JR1
Calzada, JI; Diaz, RI; Randolph, JC; Sigler, EJ1
Aline-Fardin, A; Buot, G; Dannaoui, E; Degulys, A; Guitard, J; Hennequin, C; Lapusan, S; Marie, JP; Rio, B1
Boongird, A; Chongtrakool, P; Jirasiritham, S; Larbcharoensub, N; Sumethkul, V; Watcharananan, SP; Wirojtananugoon, C1
Capilla, J; Fernández-Silva, F; Guarro, J; Hernández, P; Mayayo, E; Sutton, DA1
Leroux, S; Ullmann, AJ1
Bierings, MB; Boelens, JJ; Gerhardt, CE; Hol, JA; Lindemans, CA; Versluys, AB; Wildt de, A; Wolfs, TF1
Mikamo, H; Nishiyama, Y; Ohki, E; Satoh, K; Terada, M; Uchida, K; Yamagishi, Y; Yamaguchi, H1
Goletz, G; Groll, AH; Jürgens, H; Kolve, H; Pieper, S; Yunus, S1
Gomes, MZ; Jiang, Y; Kontoyiannis, DP; Lewis, RE; Mulanovich, VE1
Al-Badriyeh, D; Dinleyici, EC; Kara, A; Kong, DC; Senol, E; Turner, SJ2
Dorazilova, Z; Maly, J; Netuka, I; Pirk, J; Szarszoi, O1
Kim, DY; Lee, YJ; Park, HJ1
Ascioglu, S; Chan, KA1
Acharya, NR; Cevallos, V; Geetha, M; Karpagam, R; Lalitha, P; Lietman, TM; McLeod, SD; O'Brien, KS; Prajna, NV; Sun, CQ1
Mitra, AK; Pal, D; Patel, M; Paturi, DK; Vadlapatla, RK1
Dalbøge, CS; Gøtzsche, PC; Johansen, HK; Jørgensen, KJ1
Davidson-Moncada, J; Drinkwater, DC; Heckendorn, E; Myers, J; Whitman, TJ1
Araoka, H; Asano-Mori, Y; Hayashi, M; Ishiwata, K; Ito, T; Izutsu, K; Kaji, D; Makino, S; Masuoka, K; Matsuno, N; Nishida, A; Ota, H; Takagi, S; Taniguchi, S; Tsuji, M; Uchida, N; Uchida, Y; Wake, A; Yamamoto, G; Yamamoto, H; Yoneyama, A1
Paratz, E; Slavin, MA; Teh, BW; Thursky, KA; Todaro, M; Trubiano, JA; Wolf, M1
Duarte, M; Foppa, M; Goldani, L; Jeffman, M; Rohde, LE; Sprinz, E; Torres, FS1
Kauffman, CA; Kerr, L; Malani, AN; Obear, J; Singal, B1
Bang, J; Felton, E; Fermo, O; Johnson, K; Llinas, R; Nelson, G; Rhee, S; Sullivan, D; Thakur, K; Wilson, L1
Gundlapalli, S; Gupta, KL; Kaur, H; Kohli, HS; Kumar, V; Mohindra, S; Ramachandran, R; Rathi, M; Sakhuja, V1
Barbui, A; Boccadoro, M; Brunello, L; Bruno, B; Ferrando, F; Festuccia, M; Gay, F; Giaccone, L; Maffini, E; Serra, R; Talamo, E1
Enderby, CY; Heckman, MG; Keller, CA; Thomas, CS1
Fung, HC; Peksa, GD; Schultz, K1
Capilla, J; Fothergill, AW; Guarro, J; Mayayo, E; Paredes, K; Sutton, DA1
Clancy, CJ; Johnson, LS; Shields, RK1
Cen, X; Dong, Y; Li, Y; Liang, Z; Liu, W; Ou, J; Qiu, Z; Ren, H; Sun, Y; Wang, L; Wang, M; Wang, Q; Xu, W1
Choong, K; Hirst, LW; Playford, EG1
Tang, S1
Chen, T; Dong, F; Guo, X; Hu, B; Hu, H; Li, S; Li, Z; Liu, G; Wang, Q; Yao, K; Zhang, Z1
Boekhout, T; Doroftei, B; Flonta, MM; Kolecka, A; Lupse, M; Man, A; Marangoci, N; Mares, M; Marincu, I; Minea, B; Moraru, RF; Nastasa, V; Pinteala, M; Toma, F1
Dolton, MJ; McLachlan, AJ1
Huang, X; Li, D; Mylonakis, E; Xi, L1
Fujita, Y; Ikeda, Y; Kasahara, H; Sekine, A; Tsukagoshi, S; Tsutsumi, Y1
Amilien, V; Chauvin, B; Eloy, P; Francois, H; Furlan, V; Lecefel, C; Massias, L; Taburet, AM; Wyplosz, B1
Flynn, HW; Miller, D; Silva, RA; Sridhar, J; Wykoff, CC1
Guo, D; Hawryluk, EB; Huang, JT; London, WB; Sheu, J1
Cassumbhoy, M; Chau, MM; Cooper, CM; Kong, DC; Marriott, DJ; Roberts, JA; Trubiano, JA; Urbancic, K; van Hal, SJ; Wilkes, J; Worth, LJ1
Ahmed, Y; Albrecht, H; Siddiqui, W; Weissman, S1
Dalgıç, B; Demirtaş, Z; Kalkancı, A; Kara, SS; Polat, M; Sarı, S; Tapısız, A; Tezer, H1
Crowe, A; Slavin, MA; Thursky, KA; Trubiano, JA; Worth, LJ1
Akahoshi, Y; Ashizawa, M; Ishihara, Y; Kako, S; Kanda, J; Kanda, Y; Kawamura, K; Kikuchi, M; Kimura, SI; Murata, T; Nakano, H; Nakasone, H; Nishida, J; Sakamoto, K; Sato, M; Tanihara, A; Terasako-Saito, K; Ugai, T; Wada, H; Yamasaki, R; Yamazaki, R1
Botterel, F; Bougnoux, ME; Compain, F; Dannaoui, E; Paugam, A; Sitterlé, E1
Doi, A; Hiramoto, N; Ichikawa, C; Imai, Y; Ishikawa, T; Ochi, Y; Takegawa, H; Yonetani, N1
Barajas, MR; Bartoo, GT; Dierkhising, RA; El-Azhary, RA; Hashmi, SK; Hogan, WJ; Litzow, MR; Merten, JA; Patnaik, MM; Plevak, MF; Wilson, JW; Wojenski, DJ; Wolf, RC1
Lekhanont, K; Nimvorapun, N; Nonpassopon, M; Santanirand, P1
Gong, B; Li, W; Lin, D; Liu, B; Liu, K; Liu, Y; Mi, Y; Wang, J; Wang, Y; Wei, H; Wei, S; Zhang, G; Zhao, X1
Aliyu, SH; Brown, NM; Enoch, DA; Micallef, C; Rosembert, D; Santos, R1
Acharya, NR; Keenan, JD; Krishnan, KT; Lietman, TM; Mascarenhas, J; McLeod, SD; O'Brien, KS; Oldenburg, CE; Porco, TC; Prajna, NV; Raghavan, A; Rajaraman, R; Ray, KJ; Rose-Nussbaumer, J; Srinivasan, M1
Chaptini, C; Gordon, DL; Kennedy, B; Larcombe, R1
Boan, P; Heath, CH; Lavender, M; Lim, KP; Musk, M; Stathakis, A; Wrobel, J1
Marr, K; Ostrander, D; Shoham, S1
Akers, KS; Chung, KK; Graybill, JC; Mende, K; Murray, CK; Niece, KL; Rowan, MP1
Amorim, A; Araujo, R; Oliveira, M; Sampaio-Maia, B1
Akan, H; Atilla, E1
Chayakulkeeree, M; Maneerattanaporn, M; Poovipirom, N; Siengwattana, P1
Ebenezer, J; Maheswaran, S; Mathews, SS; Rupa, V1
Cerar, T; Krivec, U; Matos, T; Pirš, M; Praprotnik, M1
El-Bardissy, A; El-Mekaty, E; Elewa, H; Ensom, MH; Wilby, KJ1
Chemla, C; Huguenin, A; Noel, V; Rogez, A; Toubas, D; Villena, I1
Andreoni, S; Bargiacchi, O; Buccheri, C; Garavelli, PL; Rossati, A; Sainaghi, PP1
Dobson, EC; Eden, P; Hooper, C; Scheelings, TF1
de Sá, FA; Gelfuso, GM; Gratieri, T; Lima, EM; Taveira, SF1
Blooi, M; Haesebrouck, F; Martel, A; Pasmans, F; Rouffaer, L; Vercammen, F1
Akagi, T; Ishida, Y; Ito, S; Kowata, S; Kubo, K; Murai, K; Oyake, T; Sawada, K1
Bell, GC; Greene, JN; Mason, NT; McLeod, HL; Quilitz, RE1
Cheng, SC; Kuo, CN; Lai, LJ; Lin, YY1
Agarwal, R; Delproposto, Z; Rheinboldt, M1
Peghin, M; Ruiz-Camps, I1
Badali, H; Chowdhary, A; de Hoog, GS; Fakhim, H; Khodavaisy, S; Meis, JF1
Kauffman, CA; Kerr, LE; Malani, AN1
Chen, L; Dong, H; Dong, Y; Lei, J; Wang, T; Wang, X; Wang, Y; Xie, J; Xing, J; Yang, Q; Zheng, X1
Block, C; Moses, AE; Or, R; Shapira, MY; Strahilevitz, J; Tzadok, R1
Allizond, V; Banche, G; Barbui, A; Cuffini, AM; Fucale, G; Li Vigni, N; Mandras, N; Newell, VA; Roana, J; Scalas, D; Tullio, V1
Conrad, D; Turner, LD1
Barajas, MR; Bartoo, GT; Dierkhising, RA; Hashmi, SK; Hogan, WJ; Litzow, MR; McCullough, KB; Merten, JA; Patnaik, MM; Wermers, RA; Wilson, JW; Wolf, RC1
Chai, LY; Khoo, AL; Lim, BP; Ong, B; Tan, BH; Tan, G; Tee, C; Teng, M; Zhao, YJ1
Cho, EY; Choi, EH; Kang, HJ; Kang, HM; Lee, H; Lee, HJ; Lee, JW; Park, KD; Shin, HY; Yu, KS1
Hishiki, H; Ishiwada, N; Kamei, K; Nagasawa, K; Shimojo, N; Takeshita, K; Takeuchi, N; Watanabe, A; Yaguchi, T1
Sharma, A; Singh, D1
Barletta, V; Bongiorni, MG; Cardinali, G; Colabella, C; Consorte, A; Corte, L; Di Paolo, A; Leonildi, A; Menichetti, F; Pasticci, MB; Roscini, L; Tascini, C; Zucchelli, G1
Matsumoto, Y; Ogawa, A; Shimmura, S; Tsubota, K; Yaguchi, T1
Davies, S; Dell, S; Filipovich, A; Fukuda, T; Kissell, D; Lane, A; Mehta, P; Nortman, S; Teusink, A; Vinks, A; Zhang, K1
Kishimoto, K; Kobayashi, K; Kobayashi, R; Sano, H; Suzuki, D; Yasuda, K1
Slavin, MA; Thursky, KA1
Aoun, M; Baddley, JW; Bow, EJ; Cornely, OA; Giladi, M; Heinz, WJ; Herbrecht, R; Hope, W; Karthaus, M; Kontoyiannis, DP; Lee, DG; Lee, M; Lortholary, O; Maertens, JA; Maher, RM; Marr, KA; Morrison, VA; Neofytos, D; Oren, I; Patterson, TF; Raad, II; Rahav, G; Schmitt-Hoffmann, AH; Selleslag, D; Shoham, S; Thompson, GR; Ullmann, AJ; Zeiher, B1
Compagnon, P; Duflot, T; El Kholy, M; Lamoureux, F; Metsu, D; Morisse-Pradier, H; Pereira, T; Stojanova, J; Thiberville, L; Thuillez, C; Woillard, JB1
Capilla, J; Guarro, J; Mayayo, E; Paredes, K1
Kachuei, R; Khodavaisy, S; Rezaie, S; Sharifynia, S1
Meenakshi, R; Ramakrishnan, R; Rameshkumar, G; Rathi, H; Venugopal, A1
Feng, B; Shen, JL; Tang, XF; Xu, HQ; Xu, SX1
Azie, N; Franks, B; Goff, D; Horn, D; Khandelwal, N; Shi, F; Shorr, AF; Spalding, J1
Chen, K; Falcione, BA; Hui, J; Jin, H; Olsen, KM; Tang, H; Wang, T; Zhai, S1
Lanternier, FL; Lortholary, O; Pilmis, B1
Acharya, NR; Keenan, JD; Krishnan, T; Lalitha, P; Lietman, TM; McLeod, SD; O'Brien, KS; Prajna, NV; Raghavan, A; Rajaraman, R; Rose-Nussbaumer, J; Srinivasan, M; Zegans, M1
Siddiqui, AS; Zimmerman, JL1
Al-Dabbagh, M; Groll, AH; Husain, S; Luong, ML; Mitsani, D; Nannya, Y; Racil, Z1
Altınbas, R; Ilkit, M; Kiraz, N; Ozdemir, HG; Sav, H; Seyedmousavi, S1
Augustynowicz-Kopeć, E; Garczewska, B; Jarzynka, S; Kuś, J; Skorupa, W1
Chen, K; Li, X; Tang, H; Wang, T; Yu, C; Zhai, S1
Kato, S; Konuma, T; Kurokawa, Y; Takahashi, S; Tojo, A; Yasu, T1
Rathi, HS; Ravindran, M; Rengappa, R; Venugopal, A1
McLaren, O; Potter, C1
Melnychuk, EM; Sole, DP1
Gwee, A; Phillips, D; Wen, SC1
Cai, S; Guo, X; Ren, J; Yuan, W1
Capilla, J; González, GM; Guarro, J; Lackner, M; Lass-Flörl, C; Martin-Vicente, A1
Akyürek, N; Aydın Kaynar, L; Aygencel, G; Güzel Tunçcan, Ö; Kalkancı, A; Özkurt, ZN; Ülküden, B1
González, GM; Renpenning-Carrasco, EW; Treviño-Rangel, RJ; Villanueva-Lozano, H1
Buer, J; Dittmer, S; Haase, G; Kirchhoff, L; Olsowski, M; Rath, PM; Sedlacek, L; Steinmann, E; Steinmann, J; Zilmans, K1
Altman, RB; Barbarino, JM; Klein, TE; Owusu Obeng, A1
Fujimoto, Y; Ikawa, K; Kanbayashi, Y; Nomura, K; Taniwaki, M1
Barcia, M; De-Domingo-Barón, B; Pardo-Sánchez, F; Rodríguez-Ares, T; Romero-Jung, P; Touriño-Peralba, R1
Balasubramaniam, B; Dick, A; Johnson, E; Mayer, E; Narendran, N1
Espinel-Ingroff, A; Hockey, H; Johnson, E; Szekely, A; Troke, P1
Alves, AF; Anjos, J; de Hoog, GS; Estevão, H; Faria, E; Gonçalves, T; Hipolito, E; Morais, PV1
Buchta, V; Vale-Silva, LA; Vejsova, M1
Imai, K; Kobayashi, D; Kogawa, K; Nonoyama, S; Nozaki, M; Sugita, T; Tokimatsu, I; Tsuji, Y1
Al-Badriyeh, D; Kong, DC; Liew, D; Stewart, K1
Bijie, H; Diekema, DJ; Dzierzanowska, D; Gibbs, DL; Klimko, NN; Letscher-Bru, V; Lisalova, M; Muehlethaler, K; Newell, VA; Pfaller, MA; Rennison, C; Zaidi, M1
Alastruey-Izquierdo, A; Cuenca-Estrella, M; Hazar, V; Ogunc, D; Ongut, G; Ozhak-Baysan, B; Rodriguez-Tudela, JL; Tezcan, G; Yildiran, ST1
Chang, BP; Chen, YC; Huang, FY; Lee, MD; Lin, CC; Sheu, JC; Sun, PL; Tsai, JD; Tsai, TC1
Maesaki, S; Tarumoto, N1
Fujii, Y; Inase, N; Yoshizawa, Y1
Fothergill, AW; Rinaldi, MG; Sutton, DA1
Anaissie, E; Chang, C; Fishman, J; Horn, D; Marr, K; Neofytos, D; Olyaei, A; Pfaller, M; Steinbach, W; Webster, K1
Azuma, E; Hosoki, K; Iwamoto, S; Komada, Y; Kumamoto, T1
Aralikatti, A; Dean, S; Mitra, A; Savant, V; Shah, S1
Arsenis, G; Kafetzis, D; Lebessi, E; Pasparakis, D; Stripeli, F; Tsolia, M; Velegraki, A1
Baird, K; Cowen, EW; Gea-Banacloche, J; Mitchell, S; Patel, AR; Pavletic, SZ; Turner, ML; Wise, B1
Alaggio, R; Alessia, B; Cesaro, S; Gamba, P; Marinello, S; Putti, MC; Rossi, L; Toffolutti, T1
Adams, AI; Bergold, AM; Meneghini, LZ; Morimoto, LN1
Maertens, J; Meersseman, W; Van Bleyenbergh, P1
Amrein, C; Batisse, A; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Dannaoui, E; Guillemain, R; Lillo-Le Louet, A; Loriot, MA; Pham, MH1
Bellemore, MC; Ellis, DH; Kesson, AM; O'Mara, TJ; Sorrell, TC1
Hangaishi, A; Imai, Y; Kumano, K; Kurokawa, M; Nannya, Y; Takahashi, T; Ueda, K1
Amrein, C; Benammar, M; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Guillemain, R; Lefeuvre, S1
Bluemel, A; Ghebremedhin, B; Koenig, B; Koenig, W; Neumann, KH1
Maschmeyer, G1
Castel, V; Gonzalez-Esteban, J; Madero, L; Sanchez de Toledo, J; Sanz-Rodriguez, C; Sevilla, J1
Hasegawa, A; Imaji, M; Kano, R; Maruyama, H; Murakami, Y; Okabayashi, K; Osumi, T; Watanabe, T1
Ayats, J; Cabellos, C; Fernandez-Viladrich, P; Ferran, E; Font, F; Garcia-Vidal, C1
Dinc, BM; Kalkanci, A; Kekilli, M; Kurt, M; Odemis, B; Oztas, E; Parlak, E; Sasmaz, N1
Autthateinchai, R; Ikeda, R; Mekha, N; Nishikawa, A; Poonwan, N; Sawanpanyalert, P; Sugita, T1
Aggermann, T; Binder, S; Haas, P; Hochwarter, A; Krepler, K1
Angel, LF; Brady, R; Cadena, J; Levine, DJ; Levine, SM; Maxwell, PR; Michalek, JE; Restrepo, MI; Sanchez, JF1
Acharya, NR; Hong, K; Lee, S; Loh, AR; Mannis, M1
Lass-Flörl, C; Perkhofer, S1
Delaere, L; Lagrou, K; Maertens, J; Peetermans, WE; Spriet, I; Willems, L1
Anasetti, C; Field, T; Gergis, U; Greene, J; Huang, Y; Kharfan-Dabaja, M; Markey, K; Perkins, J; Schell, MJ; Wetzstein, G1
Frueh, BE; Goldblum, D; Muehlethaler, K; Theoulakis, P; Zimmerli, S1
Abderrahim, E; Ben Abdallah, T; Ben Hamida, F; Ben Maïz, H; Bezzine, H; Hedri, H; Khaled, S; Kheder, A; Ounissi, M; Trabelsi, S1
Damon, L; Guglielmo, BJ; Hwang, J; Kaplan, L; Linker, C; Martin, T; O'Malley, R; Sharma, M; Working, M1
Marriott, D; Miyakis, S; Ray, J; van Hal, SJ1
Capote, M; Gómez, P; Martín, C; Martín, V; Martínez, F; Molina, JR; Rojas, R; Sánchez-García, J; Serrano, J; Tabares, S; Torres, A1
Böhme, A; Cornely, OA; Drzisga, I; Frommolt, P; Hallek, M; Harnischmacher, U; Mousset, S; Müller, C; Rüping, MJ; Vehreschild, JJ; Wassmer, G1
Akin, M; Ay, Y; Balkan, C; Karapinar, B; Kavakli, K; Yilmaz, D1
Blijlevens, NM; Brüggemann, RJ; Burger, DM; Donnelly, JP; Franke, B; Troke, PF1
Lewis, JS; Thompson, GR1
Drusano, GL1
Hoffman, J; Jelliffe, R; Kovacs, A; Neely, M; Rushing, T1
Alvarado, G; Blamble, D; Cortes, J; Faderl, S; Hernandez, M; Kantarjian, H; Koller, C; Mattiuzzi, GN; Pierce, S; Verstovsek, S; Xiao, L1
Alagöz, N; Bozkurt, E; Cakir, M; Cekiç, O; Imamoğlu, S; Oksüz, L; Yilmaz, OF1
Ethier, MC; Maloney, AM; Mitchell, D; Sung, L; Zaoutis, T1
Guarro, J; Madrid, H; Pastor, J; Ruíz-Cendoya, M1
Nehls, S; Ogawa, GS; Pariseau, B; Romanelli, AM; Sutton, DA; Wickes, BL1
Celik, U; Clancy, CJ; Crespo, M; Kwak, EJ; Mitsani, D; Nguyen, MH; Nguyen, ML; Pilewski, J; Silveira, FP; Toyoda, Y; Vadnerkar, A; Yousem, SA1
Hsiao, CH; Lai, CH; Ma, DH; Tan, HY; Wu, PC1
Guarro, J; Pastor, FJ; Rodríguez, MM; Serena, C1
Miharu, M; Osumi, T; Shima, H; Shimada, H; Takahashi, T1
Li, H; Lu, Q; Wan, Z; Zhang, J1
Basara, N; Bierbach, U; Frenzel, K; Lange, T; Mauz-Körholz, C; Michael, C; Niederwieser, D; Preiss, R2
Buzina, W; Horré, R; Lackner, M; Tintelnot, K1
Al-Badriyeh, D; Bajel, A; Downey, M; Grigg, A; Kong, DC; Liew, D; Slavin, M; Stewart, K; Thursky, K1
Agoglia, L; Alves, J; Araujo, A; Balbi, E; Carius, L; Covelo, M; Enne, M; Gonzalez, AC; Guedes, C; Halpern, M; Martinho, JM; Pacheco, L; Roma, J1
Ailani, H; Cohen, EJ; Eagle, RC; Hammersmith, KM; Rapuano, CJ; Yildiz, EH1
Baert, K; Beernaert, L; de Backer, P; Haesebrouck, F; Hellebuyck, T; Martel, A; Pasmans, F; van Rooij, P; Van Waeyenberghe, L1
Burhenne, J; Burkhardt, O; Kielstein, JT; Thon, S; Welte, T1
Corey, M1
Cooperstock, MS; Griffard, EA; Guajardo, JR; Scoville, CL1
Frick, MA; Guarner, ME; Martín Nalda, A; Nadal, CF; Soler-Palacín, P1
Ito, E; Kamio, T; Kudo, K; Sasaki, S; Sato, T; Terui, K1
Elston, DM1
Borman, AM; Houbraken, J; Rijs, AJ; Samson, RA; Verweij, PE1
Arron, ST; Ibrahim, SF; Singer, JP1
Acharya, NR; Hong, KC; Krishnan, T; Lee, SM; Lietman, TM; Mascarenhas, J; McLeod, SD; Porco, TC; Prajna, L; Prajna, NV; Reddy, PR; Srinivasan, M; Vaitilingam, CM; Zegans, ME1
Kondori, N; Mattsby-Baltzer, I; Svensson, E1
Bermudez, C; Clancy, CJ; Crespo, M; Kwak, EJ; Mitsani, D; Nguyen, MH; Pilewski, J; Silveira, FP; Toyoda, Y; Vadnerkar, A1
Falzone, E; Guarneri, L; Gugliara, C; Maffeo, F; Pasqua, P; Pulvirenti, F1
Hou, Z; Li, C; Liu, G; Liu, Z; Lu, M; Sha, X; Tan, D; Xie, J; Xie, Y1
Bienvenu, AL; Biswas, P; Caillot, D; Chachaty, E; Cornet, M; Greene, J; Grenouillet, F; Herbrecht, R; Lacroix, C; Lortholary, O; Obenga, G; Raad, I; Sitbon, K; Troke, P1
Biassoni, C; Borghi, E; Cuna, T; Iatta, R; Montagna, MT; Morace, G; Sciota, R1
Abecasis, M; Bilger, K; Bofarull, RM; Cordonnier, C; Cornely, OA; de la Cámara, R; Einsele, H; Faucher, C; Heussel, CP; Liakopoulou, E; Ljungman, P; Maertens, J; Olavarria, E; Pigneux, A; Pineau, M; Rovira, M; Ullmann, AJ; Weisser, M1
Arrieta, AC; Driscoll, T; Groll, AH; Jafri, H; Klein, NJ; Lutsar, I; Milligan, PA; Schlamm, H; Walsh, TJ; Wood, ND1
Cordonnier, C; Cornely, OA; Flückiger, U; Frêre, P; Gachot, B; Heinz, WJ; Herbrecht, R; Lass-Flörl, C; Maertens, J; Marchetti, O; Ribaud, P; Thiebaut, A1
Baert, K; Debacker, P; Ducatelle, R; Garner, TW; Haesebrouck, F; Martel, A; Pasmans, F; Van Rooij, P; Van Waeyenberghe, L; Vercauteren, G; Woeltjes, T1
Fisher, C; Jones, RL; Judson, IR; Ratnayake, G; Scurr, M; Thway, K1
Díaz-Llopis, M; Garcia-Delpech, S; Salom, D; Udaondo, P1
Bleyzac, N; Goutelle, S; Larcher, R; Mialou, V; Padoin, C1
Anandbabu, K; Basu, G; Devasia, A; Sundaram, M; Tamilarasi, V1
Guarro, J; Pastor, J; Ruíz-Cendoya, M1
Accoceberry, I; Gabriel, F; Noel, T1
Auffarth, GU; Dithmar, S; Thomas, BC; Völcker, HE; Zimmermann, S1
Cecil, JA; Wenzel, RP1
Balestrazzi, A; Ciompi, L; Franceschini, R; Martone, G; Moramarco, A; Pichierri, P; Tosi, GM1
Arora, R; Goyal, J; Gupta, D; Kaur, R1
Balasingham, A; Balasingham, S; Chalkias, S; Saul, Z; Sutton, DA; Wickes, BL1
Brüggemann, RJ; Burger, DM; van der Linden, JW; Verweij, PE; Warris, A1
Al-Badriyeh, D; Heng, SC; Kong, DC; Neoh, CF; Slavin, M; Stewart, K1
Böhme, A; Heinz, WJ; Silling, G1
Charles, JF; Daikh, DI; Eberle, C; Rooney, T1
Ciecko, SC; Scher, R1
Askari, E; Cáceres Agra, JJ; Jarque, I; Nicolás Franco, S1
Bloomer, MM; Fintelmann, RE; Gilmer, W; Jeng, BH1
Chiba, S; Hara, A; Homma, M; Kohda, Y; Momo, K; Okoshi, Y; Wada, T; Watanabe, M1
Cordonnier, C; Cornely, OA; Einsele, H; Ljungman, P; Maertens, J; Rovira, M1
Chang, FY; Ho, SJ; Lin, JC; Shang, ST; Wang, NC; Yang, YS1
Deuel, T; Folkerth, R; Jiang, JX; Kesari, S; Lechpammer, M; Marty, FM; Milner, DA; Rosow, L; Zamani, AA1
Davis, JL; Goldstein, SC; Lombardi, LR; Miano, TA; Mitra, N; Morgan, SC; Vardhanabhuti, S; Vozniak, JM1
Ananda-Rajah, MR; Cheng, A; Dooley, M; Morrissey, CO; Neville, AM; Slavin, M; Spelman, T1
Cheah, FK; Chlebicka, NL; Goh, YT; Kurup, A; Lin, RT; Low, JG; Tan, BH; Wong, GC1
Huang, CY; Sun, PL; Tseng, HK1
Daneshgar, F; Khodabande, A; Siatiri, H; Siatiri, N1
Katragkou, A; Roilides, E1
Askari, E; Fernandez Guerrero, ML; Gadea, I; Prieto, E; Román, A1
Barnes, A; Barr, FJ; Hotston-Moore, A; Malik, R; Murphy, KF; Pearson, GR1
He, L; Ji, WB; Liang, YR; Lu, F; Lü, SC; Luo, Y; Shi, XJ; Zhao, ZM1
Garcia-Hermoso, D; Gay-Andrieu, F; Haloun, A; Le Pape, P; Leclair, F; Lepoivre, T; Miegeville, M; Miossec, C; Morio, F; Treilhaud, M1
Alvarez, MA; Gómez, P; Martín, C; Martín, V; Martínez, F; Molina, JR; Rodríguez, G; Rodríguez-Villa, A; Rojas, R; Sánchez-García, J; Serrano, J; Tallón, D; Torres, A1
Delaunay, J; Fraissinet, F; Gastinne, T; Gibas, CF; Le Pape, P; Miegeville, M; Morio, F; Sigler, L1
Chvojka, J; Karvunidis, T; Krouzecky, A; Matejovic, M; Novak, I; Radej, J; Stehlik, P; Sykora, R1
Chavala, SH; Ehlers, JP; Postel, EA; Woodward, JA1
Williams, D1
Blanche, S; Bougnoux, ME; Elie, C; Gerin, M; Jullien, V; Lanternier, F; Lortholary, O; Mahlaoui, N1
Hockey, HP; Hope, WW; Troke, PF1
Lingegowda, PB; Tan, AL; Tan, BH; Tan, CK1
Banerjee, R; Dhiman, N; Henry, NK; Huskins, WC; Joshi, AY; Santillan Salas, CF; Wengenack, NL1
Dickmeyer, NJ; Kiel, PJ1
Cook, G; Glasmacher, A; Heussel, CP; Kantecki, M; Kibbler, CC; Marks, DI; Miller, PJ; Pagliuca, A; Ribaud, P; Schlamm, HT; Solano, C1
Haagsma, CJ; Hendrix, R; Ruinemans, GM1
de Hoog, GS; Hell, M; Lackner, M; Neureiter, J; Presterl, E; Willinger, B; Wojna, A1
Cui, Y; Jin, C; Li, X; Wu, N1
Bakhshi, S; Kabra, SK; Mandhaniya, S; Swaroop, C; Thulkar, S; Vishnubhatla, S; Xess, I1
Blanche, S; Chosidow, O; Epaulard, O; Leccia, MT; Lortholary, O; Mamzer-Bruneel, MF; Ravaud, P; Thiebaut, A; Villier, C1
Labbé, AC; Laverdière, M; Levallois, J; Nadeau-Fredette, AC; Ouimet, D; Vallée, M1
Ananda-Rajah, MR; Bajel, A; Cheng, A; Downey, MT; Grigg, A; Slavin, MA; Spelman, T; Thursky, KT; Vincent, J1
Cendejas-Bueno, E; Cuenca-Estrella, M; Cuesta, I; García Rodríguez, J; Gómez-López, A; Gutiérrez-Altés, A; Rodríguez-Tudela, JL1
Lass-Flörl, C1
Chiche, L; Dicostanzo, MP; Durand, JM; Eldin, C; Harle, JR; Ranque, S; Thomas, G1
de Heredia, CD; Figueras, C; Frick, MA; Lanaspa, M; Martín-Nalda, A; Pou, L; Roselló, E; Soler-Palacín, P1
Chan, C; Chen, J; Colantonio, D; Seto, W1
Feng, AM; Wei, JY; Yu, WJ1
Hamada, Y; Kuroyama, M; Seto, Y; Yago, K1
Lombardi, LR; Marr, KA; Neofytos, D; Nguyen, MH; Ostrander, D; Shields, RK; Thompson, CB; Warren, L1
Ahmad, S; Al-Ghimlas, F; Al-Mutairi, S; Chandy, R; Guarro, J; Joseph, L; Khan, Z; Sutton, DA1
Bermudez, C; Bhama, JK; Clancy, CJ; Crespo, MM; Kwak, EJ; Mitsani, D; Nguyen, MH; Pilewski, JM; Shields, RK; Silveira, FP; Toyoda, Y1
Acharya, NR; Krishnan, T; Lalitha, P; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Porco, TC; Prajna, NV; Srinivasan, M; Vaitilingam, CM; Zegans, ME1
Shen, YF; Sun, HL; Zhou, X1
Newton, EJ1
Deering, KM; Dunn, JL; Field, CL; Frasca, S; Gilbert-Marcheterre, K; Meegan, J; Nyaoke, A; Risatti, G; Romano, TA; Sidor, IF; Spoon, T; Tuttle, AD1
Blyth, CC; Cole, C; Gottardo, NG; Hansford, JR1
Arron, ST; Binstock, M; Boettger, R; Boker, A; Glidden, DV; Golden, JA; Metchnikoff, C; Singer, JP1
Campbell, WN; Fothergill, AW; Keshtkar-Jahromi, M; McTighe, AH; Segalman, KA1
Eberhard, R; Fleischhauer, J; Kocher, C; Trachsler, S1
Aebi, C; Ammann, RA; Bernhard, S; Diepold, M; Kernland Lang, K; Leibundgut, K; Lüer, S1
Carroll, KC; Illei, PB; Lederman, HM; Marr, KA; Meriden, Z; Riedel, S; Villa, K; Zhang, SX1
Chen, SC; Lawrence, C; Lemos, BD; Marshall Lyon, G; Spratt, M; Veledar, E; Zwald, FO1
Chakrabarty, A; Gupta, A; Gupta, N; Parchand, S; Ram, J1
Andes, D; Lepak, A1
Bille, J; Bolay, S; Buclin, T; Calandra, T; Csajka, C; Marchetti, O; Pascual, A1
Abdi, RF; Al-Tawfiq, JA; Tarazi, AE1
Fukushima, K; Goto, H; Miharu, M; Mori, M; Shoji, S; Yoshida, M1
Feng, G; Li, J; Liu, W; Pang, X; Shang, W; Sun, R; Wang, X; Wang, Y; Zhang, S; Zhang, W1
Chen, SC; Dolton, MJ; McLachlan, AJ; Ng, K; Pont, LG; Ray, JE1
Das, S; Gupta, N; Jain, S; Malik, JN1
Atkinson, G; Lee, GA; McLintock, CA1
Hashimoto, N; Hattori, Y; Kato, J; Koda, Y; Mori, T; Okamoto, S; Sadahira, K; Shimizu, T; Tsukada, Y; Yamane, A; Yokoyama, K1
Chen, SC; Chu, YZ; Fan, H; Hu, TS; Hu, ZD; Kong, F; Liao, K; Lu, J; Ni, YX; Shao, HF; Sun, ZY; Wang, H; Xiao, M; Xu, YC; Yan, Y; Zou, GL1
Lu, HZ; Shen, YZ; Wang, ZY1
Berzins, IK; Naples, LM; Poll, CP1
Chen, J; Liang, L; Liu, D1
Buer, J; Dittmer, S; Hamprecht, A; Lackner, M; Rath, PM; Schemuth, H; Sedlacek, L; Steinmann, E; Steinmann, J1
Arzeni, D; Astolfi, D; Catavitello, C; D'Antonio, D; Farina, C; Favaro, M; Fazii, P; Fontana, C; Hendrickx, M; Masciarelli, G; Pitzurra, L; Polilli, E; Savini, V; Sisti, M; Stubbe, D1
Aversa, F; Cesaro, S; de Rosa, FG; Girmenia, C; Micozzi, A; Mikulska, M; Novelli, A; Sanguinetti, M; Viscoli, C1
Estes, LL; Wilson, JW; Zeuli, JD1
Cornely, OA; Heinz, WJ; Hertenstein, B; Horst, HA; Löffler, J; Maschmeyer, G; Requadt, C; Ruhnke, M; Wagner, T1
Ahmed, R; Akdal, G; Ananda, A; Chan, R; Chiu, AL; Crompton, JL; Francis, I; Ghabrial, R; Gibson, J; Goold, LA; Halmagyi, GM; Madge, SN; McCluskey, PJ; Rodriguez, M; Selva, D; Thompson, EO; Thurtell, MJ1
Allen, PB; Baer, MR; Kleinberg, ME; Koka, R1
Lilly, CM; Luke, DR; Mayer, T; Meisner, J; Ranauro, P; Welch, VL1
Yoshida, M1
Gibas, CF; Malejczyk, K; Sigler, L; Smith, SW1
Stevens, DA1
Banerjee, D; Khetan, A; Mandal, SM; Saha, S; Sengupta, J1
Golden, JA; Kukreja, J; Leard, LE; Sayah, DM; Schwartz, BS; Singer, JP1
Greenberg, RN; Martin, CA; Roberts, S1
Garbino, J; Hirschel, B1
Baglivo, E; Baligvo, E; Bouchuiguir-Wafa, K; Garbino, J; Lew, D; Ondrusova, A; Rohner, P1
Deplus, S; Dombret, H; Feuillhade, M; Fournier, S; Molina, JM; Pavageau, W; Verola, O; Zagdanski, AM1
Falk, R; Polacheck, I; Shapiro, M; Wolf, DG1
Adderson, EE; Andreansky, M; Luján-Zilbermann, J; Rodriguez, CA; Woodard, P1
Chapman, SW; Cleary, JD; Pearson, MM; Rogers, PD1
Chan, J1
Holzgrabe, U; Schäfer-Korting, M1
Bocanegra, R; Gonzalez, GM; Graybill, JR; Hernandez, S; Najvar, LK1
Sutton, DA1
Alvarez, ME; Fortún, J; Martín-Dávila, P; Moreno, S; Pintado, V; Sánchez, MA; Sánchez-Sousa, A1
Choquet, S; Chosidow, O; Consigny, S; Datry, A; Dhedin, N; Leblond, V1
Girmenia, C; Martino, P1
Diekema, DJ; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA1
Lutsar, I; Roffey, S; Troke, P1
Schäfer-Korting, M1
Gupta, AK; Tomas, E1
Giles, SS; Kurtzberg, J; Perfect, JR; Schell, WA; Steinbach, WJ; Trinh, JV1
Jacobs, RF; Maples, HD; Saccente, SL; Stowe, CD1
Capilla, J; Guarro, J; Ortoneda, M; Pastor, FJ; Serena, C1
Ehlert, K; Groll, AH; Kolve, H; Paulussen, M; Vormoor, J1
Martin, PL; Miller, JL; Perfect, JR; Schell, WA; Steinbach, WJ1
Baden, LR; DelVecchio, A; Doran, M; Fishman, JA; Katz, JT; Koziol, C; Rubin, RH1
Baden, LR; Cosimi, LA; Marty, FM1
Gothard, P; Rogers, TR1
Rubin, ZA; Somani, J1
Alfonso, EC; Giaconi, JA; Marangon, FB; Miller, D2
Ausin, I; Badia, X; Carreras, E; Herrera, L; Roset, M1
Alaggio, R; Calore, E; Cesaro, S; Cusinato, R; Messina, C; Pillon, M; Toffolutti, T; Zanesco, L1
Anderson, KL; Mitra, S; Pham, TA; Salouti, R; Taylor, HR1
Aoun, M1
Bigley, VH; Duarte, RF; Gosling, RD; Kibbler, CC; Potter, M; Seaton, S1
Kuijper, EJ; Kullberg, BJ; van 't Wout, JW; Verweij, PE1
Klastersky, J1
Alkan, Y; Burhenne, J; Haefeli, WE; Shalit, I; Stein, J; Yaniv, I1
Herbrecht, R1
Wingard, JR1
Comair, Y; Kanafani, ZA; Kanj, SS1
Mastromarino, A; Polizzi, A; Saccà, SC; Siniscalchi, C1
Agrawal, AK; Sherman, LK1
Perfect, JR1
Marr, K1
Danaher, PJ1
Lowry, CM; Marty, FM1
Balwierz, W1
Chen, A; Sobel, JD1
Cudillo, L; de Fabritiis, P; Dentamaro, T; Girmenia, C; Picardi, A; Santilli, S; Tendas, A1
Garbino, J; Lew, D; Rohner, P; Uckay, I; Van Delden, C1
Mohammedi, I; Padoin, C; Piens, MA; Robert, D1
Antachopoulos, C; Bibashi, E; Dotis, J; Koliouskas, D; Papakonstantinou, E; Roilides, E; Tamiolaki, M1
Eggink, CA; Klont, RR; Rijs, AJ; Verweij, PE; Wesseling, P1
Böhme, A; Haas, A; Maschmeyer, G1
Berthou, C; Eveillard, JR; Ianoto, JC; Karam, A; Le Flohic, AM; Le Roy, JP; Misery, L; Quinio, D1
Boisseau-Garsaud, AM; Calès-Quist, D; Desbois, N; Diedhou, A; Dutriaux, C; Saint-Cyr, I1
Steinbach, WJ1
Kofla, G; Ruhnke, M1
Auvrignon, A; Boccon-Gibod, L; Landman-Parker, J; Leverger, G; Moissenet, D; Petit, A; Tabone, MD1
Keady, S; Thacker, M1
Fothergill, AW; González, GM; Loebenberg, D; Rinaldi, MG; Sutton, DA1
Morace, G; Polonelli, L1
Jiménez-Cabello, T; Morera-López, Y; Torres-Rodríguez, JM1
Aguado, JM; Cisneros, JM; Díaz Pedroche, C; Lumbreras, C1
Azar, DT; D'Amico, DJ; Durand, ML; Kieval, SJ; Kim, IK; Loewenstein, JI; Lujan, BJ; Martin, SS; Miller, FS; Miller, JW; Tobin, EH1
Bagg, J; Brailsford, S; Davies, AN; Jackson, MS; Sweeney, MP1
Bauer, M; Graninger, W; Joukhadar, C; Kulemann, V1
Chan-Tack, KM1
Baker, CJ; Pannaraj, PS; Walsh, TJ1
Barak, A; Bash, E; Loewenstein, A; Neudorfer, M; Siegman-Igra, Y; Zayit-Soudry, S1
Colombo, GL; Morlotti, L; Serra, G1
Bertz, H; Finke, J; Kern, WV; Sander, A; Wagner, D1
Chamilos, G; Kontoyiannis, DP1
Chamilos, G; Kontoyiannis, DP; Lewis, RE1
Gøtzsche, PC; Johansen, HK; Jørgensen, KJ1
Ellis, D; Harkness, J; Kwong, T; Marriott, D1
Magalhaes, EP; Nehemy, MB; Torqueti-Costa, L; Vasconcelos-Santos, DV1
Baccari, P; Fumagalli, L; Lazzarin, A; Magnani, P; Prigitano, A; Sagnelli, C1
Carde, A; Faure, P; Papy, E; Ribaud, P; Touratier, S1
Delikou, S; Kitra, V; Miyakis, S; Papadakis, V; Papadatos, I; Parcharidou, A; Polychronopoulou, S; Velegraki, A1
Al-Attar, A; Redett, RJ; Williams, CG1
de Marie, S; den Hollander, JG; Levin, MD; Lugtenburg, PJ; Rijnders, BJ; van Arkel, C1
Agostinelli, C; Arpinati, M; Baccarani, M; Bandini, G; Bonifazi, F; Giannini, B; Paolini, S; Ricci, P; Stanzani, M; Vianelli, N1
Antin, JH; Baden, LR; Campbell, BJ; Cutler, CS; Fiumara, K; Lowry, CM; Marty, FM1
Crum-Cianflone, N; Dull, M; Teneza-Mora, N1
Amorosa, V; Bridges, CR; Isidro, AM; Pentz, WH; Rutenberg, HL; Stopyra, GA1
Jarque, I; Salavert, M1
Black, TA; Hare, R; Loebenberg, D; Mann, PA; McNicholas, PM; Mendrick, CA; Norris, CC; Patel, R; Sabatelli, F1
Gilgado, F; Guarro, J; Mariné, M; Pastor, FJ; Serena, C1
Craven, DE; Gorman, SR; Magiorakos, AP; Zimmerman, SK1
Derendorf, H; Ihle, F; Theuretzbacher, U1
Almyroudis, NG; Bhatti, Z; Segal, BH; Shaukat, A1
Asada, N; Komatsu, M; Koseki, M; Matsue, K; Takeuchi, M; Uryu, H1
Pemán, J; Zaragoza, R1
Arechavala, A; Bianchi, MH; López Daneri, G; Negroni, R; Robles, AM; Santiso, G1
Björkholm, M; Cherif, H; Kalin, M1
Rokicka, M1
Chusid, MJ; Destino, L; Havens, PL; Helon, AL; Sutton, DA; Thometz, JG; Willoughby, RE1
Aperis, G; Mylonakis, E; Spanakis, EK1
Akiyama, H; Honma, M; Ito, T; Muramatsu, T; Negishi, K; Ohashi, K; Sakai, M; Sakamaki, H; Shitara, M; Suzuki, T; Ueki, T; Yamashita, T1
Georgopoulos, A; Graninger, W; Kratzer, C; Schmoll, M; Tobudic, S1
Beck, R; Kaben, U; Tintelnot, K1
Gopal, L; Sen, P; Sen, PR1
Burhenne, J; Haefeli, WE; Kaufmann, C; Thiel, MA; Zinkernagel, AS1
Crespo, M; Husain, S; Johnson, B; Kwak, EJ; McCurry, KR; Pakstis, DL; Paterson, DL; Pilewski, J; Shutt, K; Studer, S; Zaldonis, D; Zeevi, A1
Barrao, ME; García-Gil, FA; Jiménez, B; Larraga, J; Luque, P; Serrano, MT; Tomé-Zelaya, E1
Galluzzo, ML; Holland, SM; Piontelli, E; Rosenzweig, SD; Santos, PE; Shea, YR; Zelazko, ME1
Boggild, AK; Mohan, S; Ostrowski, MA; Poutanen, SM1
Belousov, DIu; Veselov, AV1
Ayres, BD; Bunya, VY; Cohen, EJ; Hammersmith, KM; Rapuano, CJ1
Campbell, C; Johnson, E; Lamagni, TL; Pezzoli, L1
Scott, LJ; Simpson, D1
Maesaki, S2
Evens, A; Frankfurt, O; Golf, M; Gordon, L; Kaniecki, K; Mehta, J; Pennick, G; Pi, J; Singhal, S; Tallman, M; Trifilio, S; Williams, S; Winter, J; Zook, J1
Alvárez-Espejo, T; Cobo, M; Fernández, I; Muñez, E; Muñoz, M; Ramos, A; Toquero, J1
Jhanji, V; Mannan, R; Sharma, N; Titiyal, JS; Vajpayee, RB1
Ho, DY; Lee, JD; Montoya, JG; Rosso, F1
Alonso, N; Bajo, R; Casado, MS; de la Llana, FG; Fajardo, M; Garcia-Dominguez, M; Sanz-Rodriguez, C; Vagace, JM; Zarallo, L1
Kontoyiannis, DP; Lewis, RE1
Arisaka, O; Fujisawa, M; Fukushima, K; Hagisawa, S; Kurosawa, H; Matsunaga, T; Nakajima, D; Sugita, K1
Evens, A; Frankfurt, O; Gordon, L; Mehta, J; Pi, J; Singhal, S; Tallman, M; Trifilio, S; Williams, S; Winter, J1
Braverman, RM; Davis, CM; Dishop, MK; Noroski, LM; Paul, ME; Rosenblatt, HM; Sutton, DA1
Freifeld, A; Iwen, PC; Kalil, A; Lesiak, B; Sutton, DA; Van Schooneveld, T1
Choe, L; Guglielmo, BJ; Inciardi, J; Martin, T; Riedel, A; Yuen, C1
Hall, GS; Jeng, BH; Meisler, DM; Schoenfield, L1
Esmore, DS; Griffiths, AP; Levvey, BJ; Oto, T; Rowland, M; Snell, GI; Williams, TJ1
Drees, M; Gupta, M; Hadley, S; Wickes, BL1
Schlamm, HT; Supparatpinyo, K1
Geiger, S; Herold, T; Nickenig, C; Ostermann, H; Rieger, C1
Park, AJ; Tu, EY1
Kauffman, CA; Malani, AN1
Ferhanoglu, B; Mert, A; Sili, U; Yilmaz, M1
Arenz, D; Böhme, A; Buchheidt, D; Cornely, OA; Drzisga, I; Frommolt, P; Harnischmacher, U; Heussel, CP; Hummel, M; Mousset, S; Ullmann, AJ; Vehreschild, JJ; Wassmer, G1
Fuhrmann, V; Holzinger, U; Jaeger, W; Kitzberger, R; Kneidinger, N; Miksits, M; Schenk, P; Thalhammer, F; Warszawska, J1
Del Palacio, A; Pontón, J; Quindós, G1
Cantón, E; Carrillo-Muñoz, AJ; Eraso, E; Pemán, J; Quindós, G1
Alvarez Lerma, F1
Jarque, I; Sanz, MA1
Salavert, M; Solé, A1
Guarro, J; Pastor, FJ1
Chen, SC; Sorrell, TC1
Cetinkaya, Z; Ermis, SS; Inan, UU; Kiraz, N; Küsbeci, T; Oztürk, F; Yavas, GF1
Anten, S; Heddema, ER; Visser, O; Zweegman, AS1
Dunand, J; Paugam, A1
Conti, S; Drago, M; Fanti, F; Morace, G; Polonelli, L; Scaltrito, MM1
Erwin, GE; Fitzgerald, JE1
Buadi, FK; McClune, B; Przepiorka, D1
Bille, J; Bolay, S; Buclin, T; Calandra, T; Marchetti, O; Pascual, A1
Chamilos, G; Kontoyiannis, DP; Lamaris, GA; Lewis, RE1
Fozza, C; La Nasa, G; Longinotti, M; Nieddu, R; Paglietti, B; Podda, L; Sanna, S; Vacca, A1
Boot, B; Danho, C; Huynh, A; Mejdoubi, M1
Conlon, JD; Dauenhauer, M; Drolet, BA; Fairley, JA; Margolis, D; Talano, J; Tonkovic-Capin, V1
Arenz, D; Böhme, A; Cornely, OA; Kiehl, MG; Kochanek, M; Pankraz, K; Reichert, D; Ullmann, AJ; Vehreschild, JJ1
Ali, S; Whittle, AM1
Bahari, IS; Deris, ZZ; Harun, A; Ravichandran, M; Roziawati, Y; Shareef, BT1
Chandler, A; Greene, JN; Houston, SH; Silapunt, S; Sriaroon, C; Vincent, AL1
Andes, D; Smith, J1
Barale, PO; Chaumeil, C; Errera, MH; Guez, A; Nourry, H; Sahel, JA; Warnet, JM; Zamfir, O1
Aragane, N; Fukuno, Y; Fukuoka, M; Hayashi, S; Kawaura, F; Kobayashi, H; Matsuishi, E; Sano, A; Tanaka, M1
Alanio, A; Baruchel, A; Brethon, B; de Kerviler, E; Feuilhade de Chauvin, M; Lacroix, C; Leblanc, T; Menotti, J1
Lipp, HP1
Guarro, J; Mariné, M; Ruíz-Cendoya, M1
Johnson, EM; Radford, SA; Warnock, DW1
Baquero, F1
Johnson, EM; Szekely, A; Warnock, DW1
Jones, RN; Marco, F; Messer, SA; Pfaller, MA1
Arikan, S; Lozano-Chiu, M; Nangia, S; Paetznick, V; Rex, JH1
Chiou, CC; Groll, AH; Walsh, TJ1
Arnadóttir, M; Asmundsson, P; Bödvarsson, M; Hilmarsdóttir, I; Thorsteinsson, SB1
Niki, Y1
McDougal, EC; Nesky, MA; Peacock, JE1
Arikan, S; Kocagöz, S; Sancak, B; Unal, S; Uzun, O1
Espinel-Ingroff, A1
Gigliotti, F; Wellington, M1
Anaissie, E; Arndt, C; Donowitz, G; Finberg, R; Fioritoni, G; Garber, G; Greenberg, R; Hadley, S; Laverdière, M; Lazarus, HM; Lee, J; Pappas, P; Perfect, J; Petersen, F; Raffalli, J; Reboli, A; Reinhardt, J; Schuster, M; Stiff, P; Walsh, TJ; Wingard, J; Winston, DJ; Yanovich, S1
Marr, KA1
Dixon, CA; Goldberger, MJ; Powers, JH1
Hoffman, HL; Rathbun, RC1
Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA1
Blumer, JL; Lazarus, HM; Romero, A; Schlamm, H; Yanovich, S1
Dismukes, WE; Lee, J; Walsh, TJ1
Driscoll, T; Dupont, B; Ghahramani, P; Groll, AH; Hodges, M; Lutsar, I; Perfect, JR; Roden, M; Walsh, TJ1
Johnson, JR1
Cornely, OA; Heussel, CP; Ullmann, AJ1
Ghannoum, MA; Kuhn, DM1

Reviews

121 review(s) available for voriconazole and Mycoses

ArticleYear
Tetrazole hybrids and their antifungal activities.
    European journal of medicinal chemistry, 2019, May-15, Volume: 170

    Topics: Animals; Antifungal Agents; Azoles; Fungi; Humans; Mycoses; Pyridines; Pyrimidines; Quinolines; Structure-Activity Relationship; Tetrazoles

2019
Combined Phialemonium curvatum and Acanthamoeba Keratitis: The Importance of Early Diagnosis and Specific Therapy.
    Cornea, 2021, Oct-01, Volume: 40, Issue:10

    Topics: Acanthamoeba Keratitis; Administration, Ophthalmic; Anti-Bacterial Agents; Antifungal Agents; Ascomycota; Biguanides; Disinfectants; Drug Therapy, Combination; Early Diagnosis; Eye Infections, Fungal; Female; Humans; Keratitis; Microscopy, Confocal; Middle Aged; Moxifloxacin; Mycoses; Ophthalmic Solutions; Slit Lamp Microscopy; Voriconazole

2021
First Case of Subcutaneous Mycoses Caused by
    Frontiers in cellular and infection microbiology, 2021, Volume: 11

    Topics: Aged, 80 and over; Antifungal Agents; Basidiomycota; Echinocandins; Fluconazole; Humans; Microbial Sensitivity Tests; Mycoses; Ustilaginales; Voriconazole

2021
Plain language summary: use of isavuconazole in Chinese patients with an invasive fungal disease.
    Future microbiology, 2022, Volume: 17

    Topics: Antifungal Agents; Aspergillosis; Drug-Related Side Effects and Adverse Reactions; Healthy Volunteers; Humans; Invasive Fungal Infections; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole

2022
Lung infection caused by Blastoschizomyces capitatus without immunodeficiency: a case report and review of the literature.
    Annals of palliative medicine, 2022, Volume: 11, Issue:12

    Topics: Aged; Amphotericin B; Antifungal Agents; Dyspnea; Humans; Lung; Male; Mycoses; Pneumonia; Voriconazole

2022
Emergomyces pasteurianus in Man Returning to the United States from Liberia and Review of the Literature.
    Emerging infectious diseases, 2023, Volume: 29, Issue:3

    Topics: Aged; Humans; Liberia; Mycoses; Onygenales; United States; Voriconazole

2023
Utility of triazole antifungal therapeutic drug monitoring: Insights from the Society of Infectious Diseases Pharmacists: Endorsed by the Mycoses Study Group Education and Research Consortium.
    Pharmacotherapy, 2023, Volume: 43, Issue:10

    Topics: Antifungal Agents; Communicable Diseases; Drug Monitoring; Humans; Mycoses; Pharmacists; Triazoles; Voriconazole

2023
Scedosporium spp lung infection in immunocompetent patients: A systematic review and MOOSE-compliant meta-analysis.
    Medicine, 2019, Volume: 98, Issue:41

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Drug Resistance, Fungal; Female; Humans; Immunocompromised Host; Lung Diseases, Fungal; Male; Middle Aged; Mortality; Mycoses; Observational Studies as Topic; Postoperative Care; Respiratory Tract Infections; Retrospective Studies; Scedosporium; Voriconazole

2019
Echinocandins versus non-echinocandins for empirical antifungal therapy in patients with hematological disease with febrile neutropenia: A systematic review and meta-analysis.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020, Volume: 26, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Echinocandins; Febrile Neutropenia; Humans; Mycoses; Randomized Controlled Trials as Topic; Treatment Outcome; Voriconazole

2020
Pseudozyma spp. human infections: A systematic review.
    Medical mycology, 2021, Jan-04, Volume: 59, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Echinocandins; Fluconazole; Humans; Itraconazole; Mycoses; Voriconazole; Yeasts

2021
Comparison of Antifungal Prophylaxis Drugs in Patients With Hematological Disease or Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Review and Network Meta-analysis.
    JAMA network open, 2020, 10-01, Volume: 3, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Pre-Exposure Prophylaxis; Triazoles; Voriconazole

2020
Sarocladium and Acremonium infections: New faces of an old opportunistic fungus.
    Mycoses, 2020, Volume: 63, Issue:11

    Topics: Acremonium; Animals; Antifungal Agents; Arthritis; Blood; Central Nervous System Infections; Dermatomycoses; Drug Resistance, Fungal; Endocarditis; Eye Infections; Humans; Hypocreales; Invasive Fungal Infections; Mycetoma; Mycoses; Onychomycosis; Opportunistic Infections; Osteomyelitis; Peritonitis; Respiratory Tract Infections; Voriconazole

2020
Inhaled Antifungal Agents for the Treatment and Prophylaxis of Pulmonary Mycoses.
    Current pharmaceutical design, 2021, Volume: 27, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Humans; Itraconazole; Mycoses; Voriconazole

2021
Antifungal Prophylaxis After Lung Transplantation: Where Are We Now?
    Transplantation, 2021, 12-01, Volume: 105, Issue:12

    Topics: Adult; Antifungal Agents; Humans; Lung Transplantation; Mycoses; Transplant Recipients; Voriconazole

2021
Clinical Pharmacokinetics of Triazoles in Pediatric Patients.
    Clinical pharmacokinetics, 2021, Volume: 60, Issue:9

    Topics: Adult; Antifungal Agents; Child; Fluconazole; Humans; Itraconazole; Mycoses; Triazoles; Voriconazole

2021
A cluster of scedosporiosis in lung transplant candidates and recipients: The Zurich experience and review of the literature.
    Transplant infectious disease : an official journal of the Transplantation Society, 2018, Volume: 20, Issue:1

    Topics: Adult; Antifungal Agents; Cystic Fibrosis; Female; Humans; Lung Transplantation; Male; Mycetoma; Mycoses; Scedosporium; Switzerland; Transplant Recipients; Voriconazole; Young Adult

2018
Scedosporium apiospermum infection of the urinary system with a review of treatment options and cases in the literature.
    Transplant infectious disease : an official journal of the Transplantation Society, 2018, Volume: 20, Issue:1

    Topics: Adult; Antifungal Agents; Bone Marrow Transplantation; Female; Humans; Immunocompromised Host; Itraconazole; Male; Mycoses; Pyrimidines; Scedosporium; Triazoles; Urinary Tract Infections; Voriconazole

2018
Efficacy and safety of voriconazole in immunocompromised patients: systematic review and meta-analysis.
    Infectious diseases (London, England), 2018, Volume: 50, Issue:7

    Topics: Adolescent; Antifungal Agents; Child; Drug-Related Side Effects and Adverse Reactions; Humans; Immunocompromised Host; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Randomized Controlled Trials as Topic; Voriconazole; Young Adult

2018
Scedosporium apiospermum infectious scleritis following posterior subtenon triamcinolone acetonide injection: a case report and literature review.
    BMC ophthalmology, 2018, Feb-13, Volume: 18, Issue:1

    Topics: Aged; Antifungal Agents; Combined Modality Therapy; Debridement; Eye Infections, Fungal; Humans; Immunosuppressive Agents; Injections, Intraocular; Macular Edema; Magnetic Resonance Imaging; Male; Microbial Sensitivity Tests; Mycoses; Postoperative Complications; Scedosporium; Scleritis; Tenon Capsule; Triamcinolone Acetonide; Voriconazole

2018
Fungal Infection Caused by Geotrichum capitatum in a Severe Aplastic Anemia Patient: a Case Report and Review of the Literature.
    Clinical laboratory, 2018, May-01, Volume: 64, Issue:5

    Topics: Adolescent; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Female; Geotrichum; Humans; Mycoses; Severity of Illness Index; Voriconazole

2018
Cervical spondylitis due to Phaeoacremonium venezuelense in an immunocompetent patient. A first case report.
    Journal de mycologie medicale, 2012, Volume: 22, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Cervical Vertebrae; Epidural Abscess; Humans; Immunocompetence; Kidney Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Mycoses; Pyrimidines; Species Specificity; Spondylitis; Tomography, X-Ray Computed; Triazoles; Voriconazole

2012
Management and diagnostic guidelines for fungal diseases in infectious diseases and clinical microbiology: critical appraisal.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2013, Volume: 19, Issue:12

    Topics: Antifungal Agents; Aspergillosis; Candidiasis, Invasive; Evidence-Based Medicine; Humans; Mucormycosis; Mycoses; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole

2013
Fungal infections associated with long-term mechanical circulatory support-diagnosis and management.
    Journal of cardiac surgery, 2014, Volume: 29, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Heart Failure; Heart-Assist Devices; Humans; Incidence; Mycoses; Pyrimidines; Risk Factors; Time Factors; Triazoles; Voriconazole

2014
Clinically relevant drug-drug interactions between antiretrovirals and antifungals.
    Expert opinion on drug metabolism & toxicology, 2014, Volume: 10, Issue:4

    Topics: AIDS-Related Opportunistic Infections; Alkynes; Anti-Retroviral Agents; Antifungal Agents; Benzoxazines; Carbamates; Cyclopropanes; Drug Interactions; Drug Monitoring; Echinocandins; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Itraconazole; Mycoses; Organophosphates; Pyrimidines; Ritonavir; Sulfonamides; Triazoles; Voriconazole

2014
Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia.
    The Cochrane database of systematic reviews, 2014, Feb-24, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2014
[Central nervous system infection caused by Exophiala dermatitidis in a case and literature review].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2014, Volume: 52, Issue:8

    Topics: Amphotericin B; Antifungal Agents; Brain; Central Nervous System Infections; Cerebrospinal Fluid; Child; Drug Therapy, Combination; Exophiala; Fatal Outcome; Fluorouracil; Humans; Magnetic Resonance Imaging; Male; Mycoses; Radiography; Voriconazole

2014
Optimizing azole antifungal therapy in the prophylaxis and treatment of fungal infections.
    Current opinion in infectious diseases, 2014, Volume: 27, Issue:6

    Topics: Antibiotic Prophylaxis; Antifungal Agents; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Itraconazole; Mycoses; Population Surveillance; Precision Medicine; Triazoles; Voriconazole

2014
[A case of filamentous fungal infection showing tumor-like expansion in the cisterns].
    Rinsho shinkeigaku = Clinical neurology, 2014, Volume: 54, Issue:10

    Topics: Aged; Antifungal Agents; Cisterna Magna; Diagnosis, Differential; Encephalitis; Female; Humans; Infusions, Spinal; Magnetic Resonance Imaging; Miconazole; Mycoses; Prednisolone; Pseudallescheria; Treatment Outcome; Voriconazole

2014
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014.
    Internal medicine journal, 2014, Volume: 44, Issue:12b

    Topics: Antifungal Agents; Consensus; Drug Administration Schedule; Drug Delivery Systems; Drug Dosage Calculations; Drug Interactions; Drug Monitoring; Hematologic Neoplasms; Humans; Molecular Sequence Data; Mycoses; Opportunistic Infections; Practice Guidelines as Topic; Rehydration Solutions; Triazoles; Voriconazole

2014
Pseudozyma spp catheter-associated blood stream infection, an emerging pathogen and brief literature review.
    BMJ case reports, 2014, Dec-12, Volume: 2014

    Topics: Amphotericin B; Antifungal Agents; Catheter-Related Infections; Catheterization, Central Venous; Central Venous Catheters; Female; Fluconazole; Fungemia; Humans; Middle Aged; Mycoses; Risk Factors; Voriconazole; Yeasts

2014
Penicillium marneffei infection in a lung transplant recipient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2015, Volume: 17, Issue:3

    Topics: Adult; Antifungal Agents; Female; Humans; Lung Transplantation; Mycoses; Penicillium; Transplant Recipients; Travel; Treatment Outcome; Vietnam; Voriconazole

2015
Unpredictable susceptibility of emerging clinical moulds to tri-azoles: review of the literature and upcoming challenges for mould identification.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015, Volume: 34, Issue:7

    Topics: Antifungal Agents; Azoles; Communicable Diseases, Emerging; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Voriconazole

2015
Therapeutic Drug Monitoring of Voriconazole in the Management of Invasive Fungal Infections: A Critical Review.
    Clinical pharmacokinetics, 2015, Volume: 54, Issue:12

    Topics: Antifungal Agents; Aspergillosis; Candidemia; Drug Monitoring; Humans; Mycoses; Voriconazole

2015
Scedosporium apiospermum Otitis Complicated by a Temporomandibular Arthritis: A Case Report and Mini-Review.
    Mycopathologia, 2015, Volume: 180, Issue:3-4

    Topics: Aged, 80 and over; Antifungal Agents; Arthritis; Head; Humans; Male; Mycoses; Otitis Externa; Scedosporium; Temporomandibular Joint; Temporomandibular Joint Disorders; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole

2015
Cladosporium keratitis - a case report and literature review.
    BMC ophthalmology, 2015, Aug-19, Volume: 15

    Topics: Administration, Topical; Antifungal Agents; Cladosporium; Corneal Ulcer; Eye Infections, Fungal; Humans; Male; Middle Aged; Mycoses; Slit Lamp; Visual Acuity; Voriconazole

2015
[Filamentous fungal infections in immunosuppressed patients: prophylaxis and treatment].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2015, Volume: 28 Suppl 1

    Topics: Anidulafungin; Antifungal Agents; Drug Combinations; Echinocandins; Fungi; Humans; Immunocompromised Host; Immunosuppression Therapy; Mycoses; Voriconazole

2015
Voriconazole: How to Use This Antifungal Agent and What to Expect.
    Seminars in respiratory and critical care medicine, 2015, Volume: 36, Issue:5

    Topics: Antifungal Agents; Drug Interactions; Drug Monitoring; Humans; Mycoses; Voriconazole

2015
Network Meta-analysis and Pharmacoeconomic Evaluation of Fluconazole, Itraconazole, Posaconazole, and Voriconazole in Invasive Fungal Infection Prophylaxis.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Adult; Antifungal Agents; Aspergillus; Candida; Cost-Benefit Analysis; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Economic; Mycoses; Singapore; Survival Analysis; Triazoles; Voriconazole

2016
First Case of Trichoderma longibrachiatum CIED (Cardiac Implantable Electronic Device)-Associated Endocarditis in a Non-immunocompromised Host: Biofilm Removal and Diagnostic Problems in the Light of the Current Literature.
    Mycopathologia, 2016, Volume: 181, Issue:3-4

    Topics: Adult; Amphotericin B; Antifungal Agents; Base Sequence; Biofilms; Defibrillators, Implantable; DNA, Intergenic; Endocarditis; Heart; Humans; Male; Mycoses; Sequence Analysis, DNA; Trichoderma; Voriconazole

2016
Newer antifungal agents micafungin and voriconazole for fungal infection prevention during hematopoietic cell transplantation: a meta-analysis.
    European review for medical and pharmacological sciences, 2016, Volume: 20, Issue:2

    Topics: Antifungal Agents; Echinocandins; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Itraconazole; Lipopeptides; Micafungin; Mycoses; Randomized Controlled Trials as Topic; Voriconazole

2016
Trough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:7

    Topics: Antifungal Agents; Drug Monitoring; Humans; Invasive Fungal Infections; Liver; Mycoses; Nervous System; Treatment Outcome; Voriconazole

2016
Utility of voriconazole therapeutic drug monitoring: a meta-analysis.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:7

    Topics: Antifungal Agents; Drug Monitoring; Humans; Invasive Fungal Infections; Mycoses; Treatment Outcome; Voriconazole

2016
Effect of cytochrome P450 2C19 polymorphisms on the clinical outcomes of voriconazole: a systematic review and meta-analysis.
    European journal of clinical pharmacology, 2016, Volume: 72, Issue:10

    Topics: Antifungal Agents; Cytochrome P-450 CYP2C19; Genotype; Humans; Mycoses; Phenotype; Polymorphism, Genetic; Treatment Outcome; Voriconazole

2016
[Oral antifungal agents].
    Nihon rinsho. Japanese journal of clinical medicine, 2008, Volume: 66, Issue:12

    Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Diabetes Complications; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Mycoses; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole

2008
[Clinical efficacies of antifungal injections].
    Nihon rinsho. Japanese journal of clinical medicine, 2008, Volume: 66, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Drug Delivery Systems; Echinocandins; Fluconazole; Humans; Infusions, Intravenous; Injections; Itraconazole; Lipopeptides; Liposomes; Micafungin; Mycoses; Organophosphates; Pyrimidines; Triazoles; Voriconazole

2008
New therapies for fungal pneumonia.
    Current opinion in infectious diseases, 2009, Volume: 22, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Fungi; Galactose; Humans; Mannans; Mycoses; Pneumonia; Pulmonary Aspergillosis; Pyrimidines; Radiography, Thoracic; Triazoles; Voriconazole

2009
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Prevention of mould infections.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 63 Suppl 1

    Topics: Antifungal Agents; Chemoprevention; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Mycoses; Neutropenia; Patient Isolation; Pyrimidines; Triazoles; Voriconazole

2009
Fungal postoperative spondylodiscitis due to Scedosporium prolificans.
    The spine journal : official journal of the North American Spine Society, 2009, Volume: 9, Issue:9

    Topics: Anti-Bacterial Agents; Antifungal Agents; Arthrodesis; Debridement; Discitis; Female; Humans; Intervertebral Disc Displacement; Magnetic Resonance Imaging; Middle Aged; Mycoses; Orthopedic Procedures; Postoperative Complications; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2009
Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination.
    Expert opinion on investigational drugs, 2009, Volume: 18, Issue:9

    Topics: Anidulafungin; Animals; Antifungal Agents; Clinical Trials, Phase III as Topic; Drug Combinations; Drug Synergism; Echinocandins; Humans; Molecular Structure; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2009
Pharmacology and clinical use of voriconazole.
    Expert opinion on drug metabolism & toxicology, 2010, Volume: 6, Issue:1

    Topics: Animals; Antifungal Agents; Drug Interactions; Drug Monitoring; Drug Resistance, Fungal; Fungi; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2010
Modern antifungal therapy for neutropenic fever.
    Current hematologic malignancy reports, 2006, Volume: 1, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fever; Humans; Immunocompromised Host; Kidney Diseases; Lipopeptides; Liposomes; Liver Diseases; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2006
Voriconazole: a broad-spectrum triazole for the treatment of invasive fungal infections.
    Expert review of hematology, 2009, Volume: 2, Issue:3

    Topics: Antifungal Agents; Drug Resistance, Fungal; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2009
Pharmacoeconomics of voriconazole in the management of invasive fungal infections.
    Expert review of pharmacoeconomics & outcomes research, 2010, Volume: 10, Issue:6

    Topics: Antifungal Agents; Cost-Benefit Analysis; Drug Costs; Economics, Pharmaceutical; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2010
The emerging life-threatening opportunistic fungal pathogen Kodamaea ohmeri: optimal treatment and literature review.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2010, Volume: 43, Issue:3

    Topics: Aged; Antifungal Agents; Diabetes Mellitus, Type 2; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Opportunistic Infections; Pyrimidines; Risk Factors; Saccharomycetales; Treatment Outcome; Triazoles; Voriconazole

2010
Best practice in treating infants and children with proven, probable or suspected invasive fungal infections.
    Current opinion in infectious diseases, 2011, Volume: 24, Issue:3

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Child; Echinocandins; Fever of Unknown Origin; Humans; Infant; Mycoses; Pyrimidines; Triazoles; Voriconazole

2011
Emerging infectious endocarditis due to Scedosporium prolificans: a model of therapeutic complexity.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2011, Volume: 30, Issue:11

    Topics: Adult; Amphotericin B; Antifungal Agents; Communicable Diseases, Emerging; Embolectomy; Endocarditis; Fatal Outcome; Female; Femoral Artery; Humans; Immunocompromised Host; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Pyrimidines; Scedosporium; Thrombosis; Tomography, X-Ray Computed; Triazoles; Voriconazole

2011
Observational study of the clinical efficacy of voriconazole and its relationship to plasma concentrations in patients.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:10

    Topics: Adult; Antifungal Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Monitoring; Female; Fungi; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2011
Phototoxicity and photocarcinogenesis associated with voriconazole.
    Medecine et maladies infectieuses, 2011, Volume: 41, Issue:12

    Topics: Antifungal Agents; Biotransformation; Carcinoma, Squamous Cell; Clinical Trials as Topic; Cocarcinogenesis; Comorbidity; Dermatitis, Phototoxic; Drug Interactions; Humans; Immunocompromised Host; Melanoma; Mycoses; Neoplasms, Radiation-Induced; Photochemistry; Postoperative Complications; Pyrimidines; Retinoids; Retrospective Studies; Skin Neoplasms; Sunlight; Transplantation; Triazoles; Voriconazole

2011
Ten-year experience with fungal peritonitis in peritoneal dialysis patients: antifungal susceptibility patterns in a North-American center.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2012, Volume: 16, Issue:1

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Mycoses; North America; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole

2012
Triazole antifungal agents in invasive fungal infections: a comparative review.
    Drugs, 2011, Dec-24, Volume: 71, Issue:18

    Topics: Antifungal Agents; Fluconazole; Fungi; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole

2011
Scedosporium apiospermum catheter-related soft-tissue infection: a case report and review of the literature.
    Medical mycology, 2012, Volume: 50, Issue:6

    Topics: Aged; Catheter-Related Infections; DNA, Fungal; Genes, Fungal; Humans; Male; Mycoses; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Scedosporium; Sequence Analysis, DNA; Soft Tissue Infections; Treatment Outcome; Triazoles; Voriconazole

2012
Therapeutic drug monitoring of voriconazole in children.
    Therapeutic drug monitoring, 2012, Volume: 34, Issue:1

    Topics: Antifungal Agents; Child; Drug Monitoring; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2012
Investigation and threshold of optimum blood concentration of voriconazole: a descriptive statistical meta-analysis.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2012, Volume: 18, Issue:4

    Topics: Age Factors; Antifungal Agents; Drug Monitoring; Female; Humans; Liver Diseases; Male; Mycoses; Odds Ratio; Pyrimidines; Triazoles; Voriconazole

2012
Unusual case of cutaneous and synovial Paecilomyces lilacinus infection of hand successfully treated with voriconazole and review of published literature.
    Mycopathologia, 2012, Volume: 174, Issue:3

    Topics: Adult; Aged; Antifungal Agents; Bursa, Synovial; Dermatomycoses; Female; Hand; Histocytochemistry; Humans; Male; Microscopy; Middle Aged; Mycoses; Paecilomyces; Pyrimidines; Synovitis; Treatment Outcome; Triazoles; Voriconazole

2012
Ochroconis gallopava infection in a patient with chronic granulomatous disease: case report and review of the literature.
    Medical mycology, 2012, Volume: 50, Issue:8

    Topics: Antifungal Agents; Ascomycota; Granulomatous Disease, Chronic; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2012
Voriconazole in clinical practice.
    Journal of chemotherapy (Florence, Italy), 2012, Volume: 24, Issue:6

    Topics: 14-alpha Demethylase Inhibitors; Animals; Antifungal Agents; Aspergillosis; Candidiasis, Invasive; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Fungal; Evidence-Based Medicine; Fungi; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2012
Neuro-ophthalmology of invasive fungal sinusitis: 14 consecutive patients and a review of the literature.
    Clinical & experimental ophthalmology, 2013, Volume: 41, Issue:6

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Cause of Death; Eye Infections, Fungal; Female; Fungi; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Risk Factors; Sinusitis; Tomography, X-Ray Computed; Triazoles; Voriconazole

2013
Scedosporium prolificans pericarditis and mycotic aortic aneurysm in a lung transplant recipient receiving voriconazole prophylaxis.
    Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:2

    Topics: Aged; Aneurysm, Infected; Antifungal Agents; Aortic Aneurysm; Drug Resistance, Fungal; Female; Humans; Lung Transplantation; Mycoses; Pericarditis; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2013
Successful treatment of Paecilomyces lilacinus endophthalmitis with voriconazole.
    Scandinavian journal of infectious diseases, 2002, Volume: 34, Issue:9

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Endophthalmitis; Female; Humans; Male; Middle Aged; Mycoses; Paecilomyces; Pyrimidines; Triazoles; Voriconazole

2002
Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2002, Volume: 21, Issue:12

    Topics: Antifungal Agents; Humans; Leukemia, Myeloid; Male; Middle Aged; Mycoses; Neutropenia; Pyrimidines; Risk Factors; Triazoles; Trichosporon; Voriconazole

2002
Voriconazole: a new triazole antifungal agent.
    The Annals of pharmacotherapy, 2003, Volume: 37, Issue:3

    Topics: Antifungal Agents; Drug Administration Schedule; Drug Interactions; Formularies as Topic; Humans; Length of Stay; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2003
[A silver lining on the horizon: new antimycotics].
    Pharmazie in unserer Zeit, 2003, Volume: 32, Issue:2

    Topics: Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Echinocandins; Fungi; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2003
Laboratory evaluation of new antifungal agents against rare and refractory mycoses.
    Current opinion in infectious diseases, 2002, Volume: 15, Issue:6

    Topics: Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Echinocandins; Fungi; Humans; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole

2002
New antifungal drugs and new clinical trials: interpreting results may be difficult.
    Current opinion in oncology, 2003, Volume: 15, Issue:4

    Topics: Animals; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Data Interpretation, Statistical; Echinocandins; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2003
[New systemic antifungal drugs: mechanisms of action, drug interactions and side effects].
    Mycoses, 2003, Volume: 46 Suppl 1

    Topics: Anti-Bacterial Agents; Antifungal Agents; Azoles; Caspofungin; Drug Interactions; Drug Resistance, Fungal; Echinocandins; Fungi; Glucosyltransferases; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2003
New antifungal agents.
    Dermatologic clinics, 2003, Volume: 21, Issue:3

    Topics: Administration, Oral; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Drug Approval; Echinocandins; Humans; Lipopeptides; Macrolides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole

2003
Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patients.
    The Journal of infection, 2004, Volume: 48, Issue:1

    Topics: Antifungal Agents; Caspofungin; Child; Echinocandins; Fatal Outcome; Humans; Immunocompromised Host; Lipopeptides; Male; Mitosporic Fungi; Mycoses; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole

2004
Voriconazole for serious fungal infections.
    International journal of clinical practice, 2004, Volume: 58, Issue:1

    Topics: Antifungal Agents; Aspergillus; Candida; Controlled Clinical Trials as Topic; Drug Interactions; Humans; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2004
New options for the treatment of invasive fungal infections.
    Seminars in oncology, 2004, Volume: 31, Issue:2 Suppl 4

    Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Female; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Male; Middle Aged; Mycetoma; Mycoses; Neoplasms; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2004
[Meta-analysis on safety and efficacy of liposomal amphotericin B in the empirical treatment of febrile neutropenia].
    Medicina clinica, 2004, May-01, Volume: 122, Issue:16

    Topics: Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Fever; Humans; Liposomes; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2004
[Voriconazole: a new weapon against invasive fungal infections].
    Revue medicale de Bruxelles, 2004, Volume: 25, Issue:3

    Topics: Antifungal Agents; Humans; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Safety; Tissue Distribution; Triazoles; Voriconazole

2004
[New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin].
    Nederlands tijdschrift voor geneeskunde, 2004, Aug-21, Volume: 148, Issue:34

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Carriers; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Species Specificity; Treatment Outcome; Triazoles; Voriconazole

2004
Voriconazole: therapeutic review of a new azole antifungal.
    Expert review of anti-infective therapy, 2004, Volume: 2, Issue:4

    Topics: Animals; Antifungal Agents; Azoles; Clinical Trials as Topic; Drug Interactions; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2004
Pseudallescheria boydii cranial osteomyelitis and subdural empyema successfully treated with voriconazole: a case report and literature review.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2004, Volume: 23, Issue:11

    Topics: Adult; Antifungal Agents; Empyema, Subdural; Female; Humans; Mycoses; Osteomyelitis; Pseudallescheria; Pyrimidines; Triazoles; Voriconazole

2004
Use of newer antifungal therapies in clinical practice: what do the data tell us?
    Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:13 Suppl 7

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Liposomes; Mycoses; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis

2004
Combination antifungal therapy: where are we now, and where are we going?
    Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:13 Suppl 7

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Caspofungin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2004
Emerging azole antifungals.
    Expert opinion on emerging drugs, 2005, Volume: 10, Issue:1

    Topics: Animals; Antifungal Agents; Azoles; Drugs, Investigational; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2005
Fusarium peritonitis concomitant to kidney transplantation successfully managed with voriconazole: case report and review of the literature.
    Transplant international : official journal of the European Society for Organ Transplantation, 2005, Volume: 18, Issue:5

    Topics: Antifungal Agents; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fusarium; Humans; Kidney Transplantation; Middle Aged; Mycoses; Organ Transplantation; Peritonitis; Pyrimidines; Triazoles; Voriconazole

2005
[Update on therapy of invasive mycoses in hematology and oncology].
    Deutsche medizinische Wochenschrift (1946), 2005, Jun-03, Volume: 130, Issue:22

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Drug Combinations; Echinocandins; Hematologic Neoplasms; Humans; Itraconazole; Lipopeptides; Liposomes; Mycoses; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Risk Factors; Stem Cell Transplantation; Triazoles; Voriconazole; Zygomycosis

2005
Antifungal agents in children.
    Pediatric clinics of North America, 2005, Volume: 52, Issue:3

    Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole

2005
Voriconazole: review of a broad spectrum triazole antifungal agent.
    Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:7

    Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Cryptococcosis; Cyclic N-Oxides; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Injections, Intravenous; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2005
Safety and potential of drug interactions of caspofungin and voriconazole in multimorbid patients.
    Pharmacology, 2005, Volume: 75, Issue:4

    Topics: Anti-Bacterial Agents; Anticonvulsants; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Cross Infection; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Monitoring; Echinocandins; Food-Drug Interactions; Humans; Immunocompromised Host; Intensive Care Units; Lipopeptides; Liver; Mycoses; Peptides, Cyclic; Polypharmacy; Pyrimidines; Reverse Transcriptase Inhibitors; Triazoles; Voriconazole

2005
Voriconazole versus amphotericin B in cancer patients with neutropenia.
    The Cochrane database of systematic reviews, 2006, Jan-25, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2006
Invasive Acremonium strictum infection in a bone marrow transplant recipient.
    The Pediatric infectious disease journal, 2006, Volume: 25, Issue:3

    Topics: Acremonium; Antifungal Agents; Bone Marrow Transplantation; Child; Female; Humans; Male; Mycoses; Opportunistic Infections; Osteomyelitis; Pyrimidines; Tibia; Triazoles; Urine; Voriconazole

2006
Fungal prosthetic mitral valve endocarditis caused by Scopulariopsis species: case report and review of the literature.
    The Journal of thoracic and cardiovascular surgery, 2006, Volume: 131, Issue:5

    Topics: Aged; Amphotericin B; Antifungal Agents; Arterial Occlusive Diseases; Cardiac Surgical Procedures; Device Removal; Endarterectomy; Endocarditis; Fatal Outcome; Female; Femoral Artery; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Leg; Mitosporic Fungi; Mitral Valve; Mycoses; Prosthesis-Related Infections; Pyrimidines; Reoperation; Triazoles; Voriconazole

2006
Pharmacokinetic/pharmacodynamic profile of voriconazole.
    Clinical pharmacokinetics, 2006, Volume: 45, Issue:7

    Topics: Animals; Antifungal Agents; Biotransformation; Drug Interactions; Fungi; Half-Life; Humans; Mycoses; Protein Binding; Pyrimidines; Tissue Distribution; Triazoles; Voriconazole

2006
Review of epidemiology, diagnosis, and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients.
    Mycopathologia, 2006, Volume: 162, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Drug Therapy, Combination; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2006
Invasive fungal infections in critically ill patients: different therapeutic options and a uniform strategy.
    Revista iberoamericana de micologia, 2006, Volume: 23, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Critical Illness; Cross Infection; Deoxycholic Acid; Drug Combinations; Fluconazole; Humans; Intensive Care Units; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2006
New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Oct-15, Volume: 43, Issue:8

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Clinical Trials as Topic; Cryptococcosis; Echinocandins; Fever; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2006
Disseminated phaeohyphomycosis due to Ochroconis gallopavum in the setting of advanced HIV infection.
    Medical mycology, 2006, Volume: 44, Issue:8

    Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Ascomycota; Biopsy; Fatal Outcome; Histocytochemistry; Humans; Male; Marijuana Abuse; Mycoses; Pyrimidines; Triazoles; Voriconazole

2006
[Voriconazole safety: short review of clinical data].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2006, Volume: 51, Issue:3-4

    Topics: Antifungal Agents; Drug Interactions; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2006
Voriconazole : a review of its use in the management of invasive fungal infections.
    Drugs, 2007, Volume: 67, Issue:2

    Topics: Adolescent; Adult; Antifungal Agents; Child; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2007
[The future of antifungal agents].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2007, Volume: 48, Issue:1

    Topics: Amphotericin B; Animals; Antifungal Agents; Drug Therapy; Echinocandins; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole

2007
Aspergillus infection of implantable cardioverter-defibrillators and pacemakers: case report and literature review.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2007, Volume: 26, Issue:5

    Topics: Aged; Antifungal Agents; Aspergillus flavus; Defibrillators, Implantable; Female; Humans; Mycoses; Prosthesis-Related Infections; Pyrimidines; Triazoles; Voriconazole

2007
Treating disseminated fusariosis: amphotericin B, voriconazole or both?
    Mycoses, 2007, Volume: 50, Issue:3

    Topics: Aged; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Fever; Fusarium; Humans; Immunocompromised Host; Liposomes; Male; Mycoses; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2007
Paecilomyces lilacinus infection in a liver transplant patient: case report and review of the literature.
    Transplant infectious disease : an official journal of the Transplantation Society, 2008, Volume: 10, Issue:2

    Topics: Antifungal Agents; Humans; International Cooperation; Liver Transplantation; Male; Middle Aged; Mycoses; Paecilomyces; Postoperative Complications; Pyrimidines; Triazoles; Voriconazole

2008
Changing epidemiology of rare mould infections: implications for therapy.
    Drugs, 2007, Volume: 67, Issue:13

    Topics: Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Fusarium; Humans; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole; Zygomycosis

2007
[In vitro antifungal activity of voriconazole: New data after the first years of clinical experience].
    Revista iberoamericana de micologia, 2007, Sep-30, Volume: 24, Issue:3

    Topics: Antifungal Agents; Aspergillus; Biofilms; Candida; Cryptococcus; Drug Resistance, Fungal; Drug Synergism; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole; Yeasts

2007
[Role of voriconazole in critically ill patients with invasive mycoses].
    Revista iberoamericana de micologia, 2007, Sep-30, Volume: 24, Issue:3

    Topics: Antifungal Agents; Comorbidity; Critical Care; Fungemia; Humans; Intensive Care Units; Kidney; Multicenter Studies as Topic; Mycoses; Prospective Studies; Pyrimidines; Spain; Triazoles; Voriconazole

2007
[Current indications for voriconazole in onco-hematological patients].
    Revista iberoamericana de micologia, 2007, Sep-30, Volume: 24, Issue:3

    Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Drug Resistance, Fungal; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Multicenter Studies as Topic; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Salvage Therapy; Spain; Triazoles; Voriconazole; Zygomycosis

2007
[Voriconazole for the therapy of mycoses in recipients of solid organ transplants].
    Revista iberoamericana de micologia, 2007, Sep-30, Volume: 24, Issue:3

    Topics: Antibiotic Prophylaxis; Antifungal Agents; Drug Interactions; Humans; Immunosuppressive Agents; Lung Diseases, Fungal; Lung Transplantation; Mycoses; Organ Transplantation; Postoperative Complications; Pyrimidines; Triazoles; Voriconazole

2007
[The role of voriconazole in the treatment of emerging mycoses].
    Revista iberoamericana de micologia, 2007, Sep-30, Volume: 24, Issue:3

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Communicable Diseases, Emerging; Fusarium; Humans; Mycoses; Opportunistic Infections; Paecilomyces; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2007
Antifungal agents.
    The Medical journal of Australia, 2007, Oct-01, Volume: 187, Issue:7

    Topics: Antifungal Agents; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fluconazole; Flucytosine; Half-Life; Humans; Itraconazole; Mycoses; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2007
[New development in the treatment of deep-seated mycoses].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2007, Sep-10, Volume: 96, Issue:9

    Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Echinocandins; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Pyrimidines; Triazoles; Voriconazole

2007
Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations.
    Therapeutic drug monitoring, 2008, Volume: 30, Issue:2

    Topics: Antifungal Agents; Drug Monitoring; Fluconazole; Flucytosine; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole

2008
Antifungal agents--clinical pharmacokinetics and drug interactions.
    Mycoses, 2008, Volume: 51 Suppl 1

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Echinocandins; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole

2008
New drugs and novel targets for treatment of invasive fungal infections in patients with cancer.
    The oncologist, 2000, Volume: 5, Issue:2

    Topics: Anidulafungin; Antifungal Agents; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neoplasms; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2000
Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000, Volume: 31, Issue:3

    Topics: Antifungal Agents; Brain Abscess; Central Nervous System; Drainage; Humans; Male; Middle Aged; Mycoses; Pseudallescheria; Pyrimidines; Triazoles; Voriconazole

2000
Update on antifungal agents.
    The Pediatric infectious disease journal, 2001, Volume: 20, Issue:10

    Topics: Antifungal Agents; Azoles; Drug Resistance, Fungal; Enzyme Inhibitors; Glucosyltransferases; Humans; Membrane Proteins; Mycoses; Pyrimidines; Schizosaccharomyces pombe Proteins; Treatment Outcome; Triazoles; Voriconazole

2001
Review of the safety and efficacy of voriconazole.
    Expert opinion on investigational drugs, 2002, Volume: 11, Issue:3

    Topics: Animals; Antifungal Agents; Humans; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Pyrimidines; Triazoles; Voriconazole

2002
Voriconazole -- better chances for patients with invasive mycoses.
    European journal of medical research, 2002, May-31, Volume: 7, Issue:5

    Topics: Antifungal Agents; Candida; Candidiasis; Drug Interactions; Drug Resistance, Fungal; Drug Tolerance; Humans; Mycoses; Pyrimidines; Safety; Triazoles; Voriconazole

2002

Trials

39 trial(s) available for voriconazole and Mycoses

ArticleYear
Topical Chlorhexidine 0.2% versus Topical Natamycin 5% for the Treatment of Fungal Keratitis in Nepal: A Randomized Controlled Noninferiority Trial.
    Ophthalmology, 2022, Volume: 129, Issue:5

    Topics: Adult; Antifungal Agents; Chlorhexidine; Corneal Ulcer; Eye Infections, Fungal; Fungi; Humans; Keratitis; Mycoses; Natamycin; Nepal; Treatment Outcome; Voriconazole

2022
The Prognostic Value of Persistent Culture Positivity in Fungal Keratitis in the Mycotic Antimicrobial Localized Injection Trial.
    American journal of ophthalmology, 2020, Volume: 215

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Corneal Perforation; Corneal Stroma; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Injections, Intraocular; Keratoplasty, Penetrating; Male; Middle Aged; Mycoses; Natamycin; Prognosis; Time Factors; Visual Acuity; Voriconazole; Young Adult

2020
Predictors of Corneal Perforation or Need for Therapeutic Keratoplasty in Severe Fungal Keratitis: A Secondary Analysis of the Mycotic Ulcer Treatment Trial II.
    JAMA ophthalmology, 2017, 09-01, Volume: 135, Issue:9

    Topics: Administration, Oral; Adult; Antifungal Agents; Corneal Perforation; Corneal Ulcer; Double-Blind Method; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Mycoses; Natamycin; Suppuration; Visual Acuity; Voriconazole

2017
The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.
    JAMA ophthalmology, 2013, Volume: 131, Issue:4

    Topics: Administration, Topical; Adult; Antifungal Agents; Corneal Perforation; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Pyrimidines; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole; Wound Healing

2013
Empirical voriconazole therapy for febrile neutropenic patients with hematological disorders: a prospective multicenter trial in Japan.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2013, Volume: 19, Issue:6

    Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Antigens, Fungal; Febrile Neutropenia; Female; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Triazoles; Voriconazole; Young Adult

2013
Voriconazole prophylaxis in children with cancer: changing outcomes and epidemiology of fungal infections.
    The Pediatric infectious disease journal, 2013, Volume: 32, Issue:12

    Topics: Adolescent; Adult; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Mycoses; Treatment Outcome; Voriconazole; Young Adult

2013
Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2013, Sep-01, Volume: 70, Issue:17

    Topics: Antifungal Agents; Case-Control Studies; Cohort Studies; Cost-Benefit Analysis; Decision Support Techniques; Double-Blind Method; Fluconazole; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole

2013
In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial.
    American journal of ophthalmology, 2014, Volume: 157, Issue:2

    Topics: Adult; Antifungal Agents; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Inhibitory Concentration 50; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Natamycin; Pyrimidines; Triazoles; Voriconazole

2014
[Clinical investigation of reduced-dose voriconazole on primary prevention in invasive fungal disease after allogeneic hematopoietic stem cell transplantation].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2014, Volume: 35, Issue:7

    Topics: Administration, Intravenous; Adolescent; Adult; Antifungal Agents; Child; Child, Preschool; Female; Fluconazole; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Postoperative Complications; Treatment Outcome; Voriconazole; Young Adult

2014
Vision-Related Quality-of-Life Outcomes in the Mycotic Ulcer Treatment Trial I: A Randomized Clinical Trial.
    JAMA ophthalmology, 2015, Volume: 133, Issue:6

    Topics: Administration, Topical; Adult; Aged; Antifungal Agents; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Male; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Quality of Life; Sickness Impact Profile; Surveys and Questionnaires; Vision, Ocular; Visual Acuity; Voriconazole

2015
Comparison of micafungin and voriconazole as empirical antifungal therapies in febrile neutropenic patients with hematological disorders: a randomized controlled trial.
    European journal of haematology, 2016, Volume: 96, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Echinocandins; Febrile Neutropenia; Female; Hematologic Diseases; Hematologic Neoplasms; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Mycoses; Treatment Outcome; Voriconazole; Young Adult

2016
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
    Lancet (London, England), 2016, Feb-20, Volume: 387, Issue:10020

    Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Aspergillosis; Double-Blind Method; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Male; Middle Aged; Mycoses; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole

2016
Hospital resource use of patients receiving isavuconazole vs voriconazole for invasive mold infections in the phase III SECURE trial.
    Journal of medical economics, 2016, Volume: 19, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Body Mass Index; Double-Blind Method; Female; Glomerular Filtration Rate; Hospital Charges; Humans; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole; Young Adult

2016
Changing Azole Resistance: A Secondary Analysis of the MUTT I Randomized Clinical Trial.
    JAMA ophthalmology, 2016, Jun-01, Volume: 134, Issue:6

    Topics: Adult; Antifungal Agents; Corneal Ulcer; Double-Blind Method; Drug Resistance, Multiple, Fungal; Eye Infections, Fungal; Female; Fungi; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Natamycin; Visual Acuity; Voriconazole

2016
Preemptive Antifungal Therapy for Febrile Neutropenic Hematological Malignancy Patients in China.
    Medical science monitor : international medical journal of experimental and clinical research, 2016, Nov-07, Volume: 22

    Topics: Adolescent; Adult; Aged; Antifungal Agents; China; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Survival Rate; Voriconazole; Young Adult

2016
Cost-effectiveness evaluation of voriconazole versus liposomal amphotericin B as empirical therapy for febrile neutropenia in Australia.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 63, Issue:1

    Topics: Amphotericin B; Australia; Cost-Benefit Analysis; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2009
Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia.
    European journal of haematology, 2010, Volume: 84, Issue:3

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Caspofungin; Child; Child, Preschool; Drug Therapy, Combination; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Middle Aged; Mycoses; Neutropenia; Prospective Studies; Pyrimidines; Transplantation Conditioning; Triazoles; Voriconazole; Young Adult

2010
Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2011, Volume: 19, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Bilirubin; Drug Monitoring; Female; Humans; Infusions, Intravenous; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2011
Voriconazole pharmacokinetics and safety in immunocompromised children compared to adult patients.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:8

    Topics: Adult; Antifungal Agents; Area Under Curve; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Immunocompromised Host; Injections, Intravenous; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2010
Comparison of natamycin and voriconazole for the treatment of fungal keratitis.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2010, Volume: 128, Issue:6

    Topics: Administration, Topical; Anti-Infective Agents, Local; Antifungal Agents; Cornea; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Male; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Pyrimidines; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole

2010
Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study.
    Haematologica, 2010, Volume: 95, Issue:10

    Topics: Adult; Aged; Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Leukemia; Male; Middle Aged; Mycoses; Pyrimidines; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2010
Pharmacokinetics, safety, and tolerability of voriconazole in immunocompromised children.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:10

    Topics: Antifungal Agents; Child; Child, Preschool; Female; Humans; Immunocompromised Host; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole

2010
Voriconazole versus natamycin as primary treatment in fungal corneal ulcers.
    Clinical & experimental ophthalmology, 2011, Volume: 39, Issue:5

    Topics: Administration, Topical; Adult; Antifungal Agents; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Male; Microbiological Techniques; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Pilot Projects; Prospective Studies; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole

2011
Utilisation, efficacy and safety of voriconazole: prospective, non-interventional study on treatment of IFIs in clinical practice.
    Current medical research and opinion, 2011, Volume: 27, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Child, Preschool; Critical Illness; Female; Humans; Infant; Injections, Intravenous; Male; Middle Aged; Mycoses; Professional Practice; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2011
Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2011, Volume: 15, Issue:5

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Fever; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Prospective Studies; Pyrimidines; Radiography, Thoracic; Risk Factors; Singapore; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2011
Voriconazole as primary antifungal prophylaxis in children undergoing allo-SCT.
    Bone marrow transplantation, 2012, Volume: 47, Issue:4

    Topics: Acute Disease; Adolescent; Antifungal Agents; Child; Child, Preschool; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Male; Mycoses; Pyrimidines; Stem Cell Transplantation; Time Factors; Triazoles; Voriconazole

2012
Pharmacokinetic evaluation of voriconazole treatment in critically ill patients undergoing continuous venovenous hemofiltration.
    Therapeutic drug monitoring, 2011, Volume: 33, Issue:4

    Topics: Anti-Infective Agents; Area Under Curve; Critical Illness; Drug Monitoring; Half-Life; Hemofiltration; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2011
Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation.
    British journal of haematology, 2011, Volume: 155, Issue:3

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Female; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Male; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole; Young Adult

2011
Oral voriconazole versus intravenous low dose amphotericin B for primary antifungal prophylaxis in pediatric acute leukemia induction: a prospective, randomized, clinical study.
    Journal of pediatric hematology/oncology, 2011, Volume: 33, Issue:8

    Topics: Administration, Oral; Adolescent; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Child; Child, Preschool; Female; Humans; Infant; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Mycoses; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2011
Organism, minimum inhibitory concentration, and outcome in a fungal corneal ulcer clinical trial.
    Cornea, 2012, Volume: 31, Issue:6

    Topics: Antifungal Agents; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Natamycin; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole

2012
Voriconazole for fungal corneal ulcers.
    Ophthalmology, 2012, Volume: 119, Issue:5

    Topics: Acremonium; Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Ascomycota; Aspergillus flavus; Aspergillus niger; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Humans; Itraconazole; Middle Aged; Mycoses; Natamycin; Prospective Studies; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2012
Comparison of micafungin and voriconazole in the treatment of invasive fungal infections in kidney transplant recipients.
    Journal of clinical pharmacy and therapeutics, 2012, Volume: 37, Issue:6

    Topics: Adult; Aged; Antifungal Agents; China; Echinocandins; Female; Humans; Kidney Transplantation; Lipopeptides; Male; Micafungin; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Survival Rate; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2012
Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2013, Volume: 32, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Double-Blind Method; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Male; Middle Aged; Mycoses; Neutropenia; Placebos; Pyrimidines; Triazoles; Voriconazole

2013
Plasma levels of voriconazole administered via a nasogastric tube to critically ill patients.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2005, Volume: 24, Issue:5

    Topics: Aged; Antifungal Agents; Critical Illness; Female; Humans; Intubation, Gastrointestinal; Male; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Triazoles; Voriconazole

2005
Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:1

    Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Aqueous Humor; Aspergillus fumigatus; Candida albicans; Humans; Keratitis; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2007
A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
    The Journal of infection, 2007, Volume: 55, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Humans; Incidence; Length of Stay; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Male; Middle Aged; Mycoses; Placebos; Prospective Studies; Pyrimidines; Triazoles; Voriconazole

2007
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
    The New England journal of medicine, 2002, Jan-24, Volume: 346, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Chemical and Drug Induced Liver Injury; Child; Chronic Disease; Female; Fever; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses; Neoplasms; Neutropenia; Prospective Studies; Pyrimidines; Triazoles; Voriconazole

2002
Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study.
    Journal of clinical pharmacology, 2002, Volume: 42, Issue:4

    Topics: Administration, Oral; Adult; Antifungal Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Graft Rejection; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Neoplasms; Pyrimidines; Risk Factors; Triazoles; Voriconazole

2002
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children.
    The Pediatric infectious disease journal, 2002, Volume: 21, Issue:3

    Topics: Adolescent; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Administration Schedule; Female; Granulomatous Disease, Chronic; Hematologic Neoplasms; Humans; Infant; Male; Mycoses; Pyrimidines; Treatment Failure; Triazoles; Voriconazole

2002

Other Studies

462 other study(ies) available for voriconazole and Mycoses

ArticleYear
Combined therapies in a murine model of blastoschizomycosis.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Flucytosine; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Trichosporon; Voriconazole

2007
In vitro susceptibility to posaconazole of 1,903 yeast isolates recovered in France from 2003 to 2006 and tested by the method of the European committee on antimicrobial susceptibility testing.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9

    Topics: Antifungal Agents; Fluconazole; France; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole; Yeasts

2007
Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Culture Media; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Reproducibility of Results; Yeasts

2008
In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Antifungal Agents; Aspergillus; Candida; Fluconazole; Fungi; Fusarium; Humans; Microbial Sensitivity Tests; Mycoses; Nitriles; Opportunistic Infections; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2008
In vitro and in vivo antifungal activities of T-2307, a novel arylamidine.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Benzamidines; Candida albicans; Candidiasis; Cryptococcosis; Cryptococcus neoformans; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Mycoses; Specific Pathogen-Free Organisms; Treatment Outcome

2008
In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6

    Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Fusarium; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Naphthalenes; Sequence Analysis, DNA; Terbinafine; Triazoles; Tubulin

2008
Species distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from northern Italy.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7

    Topics: Antifungal Agents; Base Sequence; DNA Primers; DNA, Fungal; Drug Resistance, Fungal; Fusarium; Humans; Italy; Microbial Sensitivity Tests; Mycoses; Species Specificity

2008
Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Europe; Fungi; Guidelines as Topic; Humans; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Triazoles; Yeasts

2008
Interactions between triazoles and amphotericin B in treatment of disseminated murine infection by Fusarium oxysporum.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Drug Therapy, Combination; Fusarium; Male; Mice; Mycoses; Pyrimidines; Triazoles; Voriconazole

2009
Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Acremonium; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Echinocandins; Fungi; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Penicillium; Scedosporium; Spain

2009
Serial plasma voriconazole concentrations after allogeneic hematopoietic stem cell transplantation.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Adult; Antifungal Agents; Chemoprevention; Dose-Response Relationship, Drug; Drug Monitoring; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole

2009
In vitro antifungal activities of bis(alkylpyridinium)alkane compounds against pathogenic yeasts and molds.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:8

    Topics: Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyridinium Compounds; Yeasts

2010
Synthesis and antifungal evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:10

    Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Fungi; Humans; Models, Molecular; Mycoses; Sterol 14-Demethylase; Triazoles

2010
Evaluation of hepatotoxicity with off-label oral-treatment doses of voriconazole for invasive fungal infections.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:1

    Topics: Aged; Antifungal Agents; Female; Humans; Liver; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2011
New azoles with antifungal activity: Design, synthesis, and molecular docking.
    Bioorganic & medicinal chemistry letters, 2011, Jan-15, Volume: 21, Issue:2

    Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Azoles; Fungi; Humans; Microbial Sensitivity Tests; Models, Molecular; Mycoses; Protein Binding; Sterol 14-Demethylase; Structure-Activity Relationship

2011
Novel alkylated azoles as potent antifungals.
    European journal of medicinal chemistry, 2017, Jun-16, Volume: 133

    Topics: Alkylation; Animals; Antifungal Agents; Azoles; Candida albicans; Candidiasis; Cell Line; Ergosterol; Fungi; Hemolysis; Humans; Mice; Microbial Sensitivity Tests; Mycoses

2017
    Journal of medical microbiology, 2021, Volume: 70, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Benzoates; Biofilms; Cinnamates; Drug Combinations; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Terpenes; Voriconazole

2021
Effectiveness and antimicrobial susceptibility profiles during primary antimicrobial prophylaxis for pediatric acute myeloid leukemia.
    Scientific reports, 2021, 10-27, Volume: 11, Issue:1

    Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Bacteremia; Child; Ciprofloxacin; Febrile Neutropenia; Female; Humans; Imipenem; Leukemia, Myeloid, Acute; Male; Mycoses; Vancomycin; Voriconazole

2021
Allergic fungal rhinosinusitis caused by Neoscytalidium dimidiatum: A case report: Allergic fungal rhinosinusitis due to Neoscytalidium dimidiatum.
    Journal de mycologie medicale, 2022, Volume: 32, Issue:1

    Topics: Adult; Ascomycota; Female; Humans; Iran; Mycoses; Sinusitis; Voriconazole

2022
Successful treatment of Talaromyces marneffei infection in a kidney transplant recipient with voriconazole followed by itraconazole for the first time.
    Journal de mycologie medicale, 2022, Volume: 32, Issue:1

    Topics: Antifungal Agents; Humans; Itraconazole; Kidney Transplantation; Mycoses; Voriconazole

2022
Molds and More: Rare Fungal Infections in Preterm Infants <24 Weeks of Gestation.
    The Pediatric infectious disease journal, 2022, 04-01, Volume: 41, Issue:4

    Topics: Antifungal Agents; Aspergillosis; Female; Fungi; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Mycoses; Pregnancy; Voriconazole

2022
Severe Polyarthralgia After Kidney Transplant.
    JAMA, 2022, Jan-04, Volume: 327, Issue:1

    Topics: Agaricales; Alkaline Phosphatase; Antifungal Agents; Arthralgia; Female; Hand; Humans; Kidney Transplantation; Middle Aged; Mycoses; Radiography; Voriconazole

2022
Patterns of Antifungal Resistance in Adult Patients With Fungal Keratitis in South India: A Post Hoc Analysis of 3 Randomized Clinical Trials.
    JAMA ophthalmology, 2022, Feb-01, Volume: 140, Issue:2

    Topics: Adult; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Female; Fusarium; Humans; India; Keratitis; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Natamycin; Randomized Controlled Trials as Topic; Voriconazole

2022
Formulation and characterization studies of inclusion complexes of voriconazole for possible ocular application.
    Pharmaceutical development and technology, 2022, Volume: 27, Issue:2

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; beta-Cyclodextrins; Mice; Mycoses; Solubility; Voriconazole

2022
The Effects of Intravitreal Administration of Antifungal Drugs on the Structure and Mechanical Properties Peripheral Blood Erythrocyte Surface in Rabbits.
    International journal of molecular sciences, 2022, Sep-09, Volume: 23, Issue:18

    Topics: Animals; Antifungal Agents; Erythrocytes; Micafungin; Mycoses; Rabbits; Voriconazole

2022
PULMONARY AND COELOMIC MYCOSES DUE TO
    Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2022, Volume: 53, Issue:3

    Topics: Alligators and Crocodiles; Animals; Beauveria; Fluconazole; Itraconazole; Metarhizium; Mycoses; Pest Control, Biological; Terbinafine; Turtles; Voriconazole

2022
Successful treatment of Talaromyces marneffei pneumonia in a HIV-negative renal transplantation recipient: A case report.
    Medicine, 2022, Oct-07, Volume: 101, Issue:40

    Topics: Antifungal Agents; HIV Infections; Humans; Kidney Transplantation; Moxifloxacin; Mycoses; Pneumonia; Tacrolimus; Talaromyces; Voriconazole

2022
Fungal esophagitis associated with tuberculous pericarditis in an human immunodeficiency virus-positive patient: a case report.
    Journal of medical case reports, 2022, Nov-07, Volume: 16, Issue:1

    Topics: Adult; Antifungal Agents; Candidiasis; Esophagitis; Fluconazole; HIV; Humans; Male; Mycoses; Pericarditis, Tuberculous; Voriconazole

2022
Manifestations, Prevalence, Management and Outcome of Invasive
    Current drug safety, 2024, Volume: 19, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Cross-Sectional Studies; Humans; Liver Transplantation; Mycoses; Prevalence; Pulmonary Aspergillosis; Retrospective Studies; Voriconazole

2024
Acremonium (Sarocladium) periprosthetic joint infection: case report, literature review, and proposed antifungal regimen.
    BMC infectious diseases, 2022, Dec-29, Volume: 22, Issue:1

    Topics: Acremonium; Antifungal Agents; Female; Humans; Middle Aged; Mycoses; Prosthesis-Related Infections; Voriconazole

2022
A survey to describe common practices on antifungal monitoring among Spanish clinicians.
    Enfermedades infecciosas y microbiologia clinica (English ed.), 2023, Volume: 41, Issue:1

    Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Mycoses; Voriconazole

2023
Incidence of breakthrough fungal infections on isavuconazole prophylaxis compared to posaconazole and voriconazole.
    Transplant infectious disease : an official journal of the Transplantation Society, 2023, Volume: 25, Issue:2

    Topics: Antifungal Agents; Female; Humans; Incidence; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Mycoses; Prospective Studies; Retrospective Studies; Voriconazole

2023
Analysis of the synergistic antifungal activity of everolimus and antifungal drugs against dematiaceous fungi.
    Frontiers in cellular and infection microbiology, 2023, Volume: 13

    Topics: Amphotericin B; Antifungal Agents; Everolimus; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Voriconazole

2023
Palatal perforation caused by Alternaria alternata infection in an immunocompetent adolescent.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2023, Volume: 134

    Topics: Adolescent; Alternaria; Biopsy; Humans; Male; Mycoses; Opportunistic Infections; Voriconazole

2023
[First Hungarian report of Geotrichum capitatum/Saprochaete capitata infection in an immunocompromised child].
    Orvosi hetilap, 2023, Jul-02, Volume: 164, Issue:26

    Topics: Antifungal Agents; Child; Female; Humans; Hungary; Immunocompromised Host; Infant; Leukemia, Myeloid, Acute; Mycoses; Voriconazole

2023
A successful management of fungal peritonitis caused by Rhodotorula glutinis in CAPD patient, coincident with onychomycosis by Penicillium sp: Case report.
    Medicine, 2023, Jul-14, Volume: 102, Issue:28

    Topics: Adult; Dialysis Solutions; Fluconazole; Humans; Male; Mycoses; Onychomycosis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Voriconazole

2023
Characteristics and Prognosis of Talaromyces marneffei Infection in Non-HIV-Infected Children in Southern China.
    Mycopathologia, 2019, Volume: 184, Issue:6

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Child; Child, Preschool; China; Female; HIV-1; Humans; Infant; Itraconazole; Male; Mycoses; Retrospective Studies; Talaromyces; Voriconazole

2019
Placental and breastmilk transfer of voriconazole to offspring from pregnant and lactating bottlenose dolphins (Tursiops truncatus).
    Medical mycology, 2020, Jun-01, Volume: 58, Issue:4

    Topics: Animals; Bottle-Nosed Dolphin; Female; Fetal Blood; Japan; Lactation; Maternal-Fetal Exchange; Milk; Mycoses; Placenta; Pregnancy; Respiratory Tract Infections; Voriconazole

2020
Prospective CYP2C19-Guided Voriconazole Prophylaxis in Patients With Neutropenic Acute Myeloid Leukemia Reduces the Incidence of Subtherapeutic Antifungal Plasma Concentrations.
    Clinical pharmacology and therapeutics, 2020, Volume: 107, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Alleles; Antifungal Agents; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Female; Genotype; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Neutropenia; Prospective Studies; Risk Management; Voriconazole; Young Adult

2020
    Journal of medical microbiology, 2019, Volume: 68, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Triazoles; Voriconazole

2019
First isolation of voriconazole-resistant Candida albicans, C. tropicalis, and Aspergillus niger from the blowholes of bottlenose dolphins (Tursiops truncatus).
    The Journal of veterinary medical science, 2019, Nov-29, Volume: 81, Issue:11

    Topics: Animals; Antifungal Agents; Aspergillus niger; Bottle-Nosed Dolphin; Candida albicans; Candida tropicalis; Drug Resistance, Fungal; Itraconazole; Japan; Microbial Sensitivity Tests; Mycoses; Voriconazole

2019
Evaluation of the expanding spectrum of sertraline against uncommon fungal pathogens.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020, Volume: 26, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Drug Repositioning; Drug Synergism; Humans; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Sertraline; Voriconazole

2020
Determination of total and free voriconazole in human plasma: Application to pharmacokinetic study and therapeutic monitoring.
    Journal of pharmaceutical and biomedical analysis, 2020, 01-30, Volume: 178

    Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Fluorescence; Humans; Male; Mycoses; Reproducibility of Results; Voriconazole

2020
Molecular identification and antifungal susceptibility testing of Pucciniomycotina red yeast clinical isolates from Rio de Janeiro, Brazil.
    Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2020, Volume: 51, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Blood Culture; Brazil; Diffusion; DNA, Intergenic; Humans; Microbial Sensitivity Tests; Mycoses; Rhodotorula; Voriconazole

2020
Impact of CYP2C19 Genotype and Drug Interactions on Voriconazole Plasma Concentrations: A Spain Pharmacogenetic-Pharmacokinetic Prospective Multicenter Study.
    Pharmacotherapy, 2020, Volume: 40, Issue:1

    Topics: Adult; Antifungal Agents; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Genotype; Humans; Male; Mycoses; Prevalence; Prospective Studies; Spain; Voriconazole

2020
Cladosporium Endogenous Endophthalmitis Mimicking Toxoplasma Retinochoroiditis.
    Ocular immunology and inflammation, 2021, Apr-03, Volume: 29, Issue:3

    Topics: Adult; Antifungal Agents; Aqueous Humor; Chorioretinitis; Cladosporium; DNA, Fungal; Endophthalmitis; Eye Infections, Fungal; Humans; Male; Mycoses; Polymerase Chain Reaction; Toxoplasmosis, Ocular; Vitreous Body; Voriconazole

2021
Invasive Scedosporium spp. and Lomentospora prolificans infections in pediatric patients: Analysis of 55 cases from FungiScope® and the literature.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 92

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Female; Humans; Infant; Male; Mycoses; Risk Factors; Scedosporium; Voriconazole

2020
Variability of voriconazole concentrations in patients with hematopoietic stem cell transplantation and hematological malignancies: influence of loading dose, procalcitonin, and pregnane X receptor polymorphisms.
    European journal of clinical pharmacology, 2020, Volume: 76, Issue:4

    Topics: Antifungal Agents; Drug Monitoring; Female; Genotype; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Pharmacogenetics; Polymorphism, Single Nucleotide; Pregnane X Receptor; Procalcitonin; Retrospective Studies; Voriconazole

2020
Evaluation of the Effectiveness of Additional Risk Minimization Measures for Voriconazole in the EU: Findings and Lessons Learned from a Healthcare Professional Survey.
    Pharmaceutical medicine, 2019, Volume: 33, Issue:2

    Topics: Antifungal Agents; Carcinoma, Squamous Cell; Checklist; Chemical and Drug Induced Liver Injury; Cross-Sectional Studies; Dermatitis, Phototoxic; Drug-Related Side Effects and Adverse Reactions; European Union; Health Care Surveys; Health Personnel; Humans; Invasive Pulmonary Aspergillosis; Mycoses; Pamphlets; Pharmacovigilance; Risk Reduction Behavior; Self Report; Skin Neoplasms; Voriconazole

2019
Chronic fungal osteomyelitis of the tibia due to
    The Pan African medical journal, 2019, Volume: 34

    Topics: Acremonium; Antifungal Agents; Chronic Disease; Humans; Immunocompetence; Male; Middle Aged; Mycoses; Osteomyelitis; Tibia; Treatment Outcome; Voriconazole

2019
Brain abscess in patients with chronic kidney disease: A case-based approach to management in resource-limited settings.
    Drug discoveries & therapeutics, 2020, May-06, Volume: 14, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Brain Abscess; Female; Humans; Kidney Transplantation; Linezolid; Male; Meropenem; Mycoses; Renal Insufficiency, Chronic; Trimethoprim, Sulfamethoxazole Drug Combination; Voriconazole

2020
Voriconazole therapeutic drug monitoring in critically ill patients improves efficacy and safety of antifungal therapy.
    Basic & clinical pharmacology & toxicology, 2020, Volume: 127, Issue:6

    Topics: Administration, Intravenous; Age Factors; Aged; Antifungal Agents; China; Chromatography, High Pressure Liquid; Critical Illness; Drug Monitoring; Female; Humans; Male; Middle Aged; Mycoses; Patient Safety; Predictive Value of Tests; Retrospective Studies; Risk Assessment; Risk Factors; Serum Albumin, Human; Sex Factors; Voriconazole

2020
Potential voriconazole associated posterior reversible leukoencephalopathy in children with malignancies: Report of two cases.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2021, Volume: 27, Issue:2

    Topics: Antifungal Agents; Child; Child, Preschool; Female; Humans; Magnetic Resonance Imaging; Male; Mycoses; Neoplasms; Posterior Leukoencephalopathy Syndrome; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Voriconazole; Wilms Tumor

2021
A Prospective Study on the Usefulness of Initial Voriconazole Dose Adjustment Based on CYP2C19 Gene Polymorphism Analysis.
    Chemotherapy, 2020, Volume: 65, Issue:3-4

    Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Genotype; Humans; Male; Middle Aged; Mycoses; Phenotype; Polymorphism, Genetic; Prospective Studies; Voriconazole

2020
Therapeutic drug monitoring of commonly used anti-infective agents: A nationwide cross-sectional survey of Australian hospital practices.
    International journal of antimicrobial agents, 2020, Volume: 56, Issue:6

    Topics: Anti-Infective Agents; Australia; Bacteria; Bacterial Infections; Clinical Decision-Making; Cross-Sectional Studies; Drug Monitoring; Fungi; Gentamicins; Health Personnel; Humans; Microbial Sensitivity Tests; Mycoses; Surveys and Questionnaires; Vancomycin; Voriconazole

2020
Purpureocillium roseum sp. nov. A new ocular pathogen for humans and mice resistant to antifungals.
    Mycoses, 2021, Volume: 64, Issue:2

    Topics: Aged; Amphotericin B; Animals; Antifungal Agents; Cornea; DNA, Fungal; Drug Resistance, Fungal; Female; Humans; Hypocreales; Itraconazole; Keratitis; Mexico; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycological Typing Techniques; Mycoses; Phylogeny; Voriconazole

2021
Hypertrophic pachymeningitis caused by Schizophyllum sp.: a novel case report.
    Infection, 2021, Volume: 49, Issue:4

    Topics: Aged; Female; Humans; Magnetic Resonance Imaging; Meningitis; Mycoses; Schizophyllum; Sinusitis; Voriconazole

2021
Characterization and outcome of invasive infections due to Paecilomyces variotii: analysis of patients from the FungiScope® registry and literature reports.
    The Journal of antimicrobial chemotherapy, 2021, 02-11, Volume: 76, Issue:3

    Topics: Antifungal Agents; Byssochlamys; Humans; Mycoses; Paecilomyces; Registries; Voriconazole

2021
Influence of switching from intravenous to oral administration on serum voriconazole concentration.
    Journal of clinical pharmacy and therapeutics, 2021, Volume: 46, Issue:3

    Topics: Administration, Intravenous; Administration, Oral; Adrenal Cortex Hormones; Adult; Aged; Antifungal Agents; Drug Administration Routes; Drug Interactions; Female; Humans; Male; Middle Aged; Mycoses; Retrospective Studies; Voriconazole

2021
Voriconazole Versus Amphotericin B as Induction Therapy for Talaromycosis in HIV/AIDS Patients: A Retrospective Study.
    Mycopathologia, 2021, Volume: 186, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Humans; Induction Chemotherapy; Mycoses; Retrospective Studies; Talaromyces; Voriconazole

2021
An Iris Tumor Secondary to
    Ocular immunology and inflammation, 2022, Volume: 30, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Fluconazole; Humans; Iris Neoplasms; Male; Mycoses; Ophthalmic Solutions; Syphilis; Voriconazole

2022
Clinical utility of antifungal susceptibility testing in patients with fungal rhinosinusitis.
    Indian journal of medical microbiology, 2021, Volume: 39, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Azoles; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Mycoses; Sinusitis; Triazoles; Voriconazole

2021
In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years.
    Diagnostic microbiology and infectious disease, 2021, Volume: 101, Issue:3

    Topics: Antifungal Agents; Azoles; Drug Resistance, Fungal; Europe; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; North America; Opportunistic Infections; Triazoles; Voriconazole

2021
Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans.
    The Journal of antimicrobial chemotherapy, 2017, 07-01, Volume: 72, Issue:7

    Topics: Antifungal Agents; Ascomycota; Caspofungin; Dihydroorotate Dehydrogenase; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Oxidoreductases Acting on CH-CH Group Donors; Scedosporium; Triazoles; Voriconazole

2017
Voriconazole Dosing in Children Younger Than 3 Years Undergoing Cancer Chemotherapy or Hematopoietic Stem Cell Transplantation.
    Journal of the Pediatric Infectious Diseases Society, 2018, May-15, Volume: 7, Issue:2

    Topics: Antifungal Agents; Antineoplastic Agents; Child, Preschool; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Mycoses; Myelodysplastic Syndromes; Retrospective Studies; Voriconazole

2018
Assessment of high-priced systemic antifungal prescriptions.
    Medecine et maladies infectieuses, 2017, Volume: 47, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Middle Aged; Multiple Organ Failure; Mycoses; Organ Transplantation; Retrospective Studies; Survival Rate; Treatment Outcome; Voriconazole; Young Adult

2017
Paecilomyces as a Cause of Lymph Nodes Enlargement in Hodgkin's Lymphoma.
    Indian journal of pediatrics, 2017, Volume: 84, Issue:11

    Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Child, Preschool; Diagnosis, Differential; Hodgkin Disease; Humans; Immunocompromised Host; Lymphadenopathy; Male; Mycoses; Paecilomyces; Positron Emission Tomography Computed Tomography; Voriconazole

2017
Case of mycotic cyst caused by Scedosporium apiospermum developed liver dysfunction following administration of voriconazole.
    The Journal of dermatology, 2017, Volume: 44, Issue:11

    Topics: Aged, 80 and over; Antifungal Agents; Chemical and Drug Induced Liver Injury; Cysts; Female; Humans; Mycoses; Scedosporium; Voriconazole

2017
Effect of voriconazole on risk of nonmelanoma skin cancer after hematopoietic cell transplantation.
    Journal of the American Academy of Dermatology, 2017, Volume: 77, Issue:4

    Topics: Adult; Age Factors; Aged; Antifungal Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Retrospective Studies; Risk Factors; Sex Factors; Skin Neoplasms; Transplantation, Autologous; Transplantation, Homologous; Voriconazole

2017
Voriconazole Antifungal Prophylaxis in Children With Malignancies: A Nationwide Study.
    Journal of pediatric hematology/oncology, 2018, Volume: 40, Issue:1

    Topics: Antifungal Agents; Child; Female; Greece; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Mycoses; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Premedication; Retrospective Studies; Treatment Outcome; Voriconazole

2018
The identification of Meyerozyma guilliermondii from blood cultures and surveillance samples in a university hospital in Northeast Turkey: A ten-year survey.
    Journal de mycologie medicale, 2017, Volume: 27, Issue:4

    Topics: Antifungal Agents; Blood Culture; Candida; Candidiasis; Drug Resistance, Fungal; Epidemiological Monitoring; Fluconazole; Hospitalization; Hospitals, University; Humans; Intensive Care Units; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pichia; Surveys and Questionnaires; Time Factors; Turkey; Voriconazole

2017
PHARMACOKINETICS, EFFICACY, AND SAFETY OF VORICONAZOLE AND ITRACONAZOLE IN HEALTHY COTTONMOUTHS (AGKISTRODON PISCIVORUS) AND MASSASAUGA RATTLESNAKES (SISTRURUS CATENATUS) WITH SNAKE FUNGAL DISEASE.
    Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2017, Volume: 48, Issue:3

    Topics: Agkistrodon; Animals; Antifungal Agents; Ascomycota; Cloaca; Crotalus; Drug Delivery Systems; Itraconazole; Mycoses; Pilot Projects; Voriconazole

2017
Voriconazole treatment in adults and children with hematological diseases: can it be used without measurement of plasma concentration?
    Medical mycology, 2018, Apr-01, Volume: 56, Issue:3

    Topics: Adolescent; Adult; Age Factors; Aged; Antifungal Agents; Body Weight; Child; Child, Preschool; Female; Hematologic Diseases; Humans; Infant; Male; Middle Aged; Mycoses; Treatment Outcome; Voriconazole; Young Adult

2018
[Treatment of Invasive Fungal Infection in Childhood Acute Lymphoblastic Leukemia with Amphotericin B and Voriconazole].
    Zhongguo shi yan xue ye xue za zhi, 2017, Volume: 25, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Child; Humans; Invasive Fungal Infections; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Voriconazole

2017
Reversible dysphagia secondary to guttural pouch mycosis in a gelding treated medically with voriconazole and surgically with carotid occlusion and esophagostomy.
    The Canadian veterinary journal = La revue veterinaire canadienne, 2018, Volume: 59, Issue:2

    Topics: Animal Structures; Animals; Antifungal Agents; Carotid Arteries; Deglutition Disorders; Esophagostomy; Horse Diseases; Horses; Male; Mycoses; Voriconazole

2018
An investigation of visual hallucinations associated with voriconazole administration to patients with hematological malignancies.
    Die Pharmazie, 2016, Nov-02, Volume: 71, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hallucinations; Hematologic Neoplasms; Humans; Incidence; Male; Middle Aged; Mycoses; Retrospective Studies; Vision Disorders; Voriconazole

2016
TREATMENT OF MYCOTIC RHINOSINUSITIS IN A BENNETT'S WALLABY ( MACROPUS RUFOGRISEUS) USING TOPICAL VORICONAZOLE SUSPENDED IN A REVERSE THERMODYNAMIC PLURONIC GEL.
    Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2018, Volume: 49, Issue:1

    Topics: Administration, Topical; Animals; Animals, Zoo; Antifungal Agents; Drug Compounding; Female; Gels; Macropodidae; Mycoses; Rhinitis; Sinusitis; Voriconazole

2018
Susceptibility profile of echinocandins, azoles and amphotericin B against yeast phase of Talaromyces marneffei isolated from HIV-infected patients in Guangdong, China.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018, Volume: 37, Issue:6

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Echinocandins; HIV Infections; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Reagent Kits, Diagnostic; Talaromyces; Voriconazole

2018
Voriconazole concentration is inversely correlated with corticosteroid usage in immunocompromised patients.
    Transplant infectious disease : an official journal of the Transplantation Society, 2018, Volume: 20, Issue:4

    Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Biological Variation, Population; Comorbidity; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Female; Glucocorticoids; Hematologic Diseases; Humans; Immunocompromised Host; Male; Middle Aged; Mycoses; Voriconazole

2018
Necessity for a Significant Maintenance Dosage Reduction of Voriconazole in Patients with Severe Liver Cirrhosis (Child-Pugh Class C).
    Biological & pharmaceutical bulletin, 2018, Jul-01, Volume: 41, Issue:7

    Topics: Administration, Oral; Antifungal Agents; Drug Monitoring; Female; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Mycoses; Retrospective Studies; Severity of Illness Index; Voriconazole

2018
Treatment of Suspected Invasive Fungal Infection in War Wounds.
    Military medicine, 2018, 09-01, Volume: 183, Issue:suppl_2

    Topics: Administration, Topical; Afghan Campaign 2001-; Amphotericin B; Antifungal Agents; beta-Cyclodextrins; Debridement; Excipients; Humans; Mycoses; Recurrence; Risk Factors; Tobramycin; Treatment Outcome; Triazoles; Vancomycin; Voriconazole; Wounds and Injuries

2018
Successful voriconazole treatment of Talaromyces marneffei infection in an HIV-negative patient with osteolytic lesions.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2019, Volume: 25, Issue:3

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Humans; Immunocompromised Host; Male; Middle Aged; Mycoses; Skull; Talaromyces; Voriconazole

2019
Fungal prostatic abscess erupting through the penis.
    British journal of hospital medicine (London, England : 2005), 2018, Oct-02, Volume: 79, Issue:10

    Topics: Adult; Antifungal Agents; Humans; Male; Mycoses; Penile Diseases; Pichia; Prostatic Diseases; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole

2018
[Primary Prophylatic Effect of Voriconazole Against Invasive Infection of Pulmonary Aspergillosis during Remission-Induction Chemotherapy for Acute Myeloid Leukemia].
    Zhongguo shi yan xue ye xue za zhi, 2018, Volume: 26, Issue:5

    Topics: Antifungal Agents; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Mycoses; Pulmonary Aspergillosis; Retrospective Studies; Voriconazole

2018
Yeast-like filamentous fungi: Molecular identification and in vitro susceptibility study.
    Medical mycology, 2019, Oct-01, Volume: 57, Issue:7

    Topics: Antifungal Agents; DNA, Fungal; Fluconazole; Fungi; Humans; Italy; Microbial Sensitivity Tests; Mycoses; Triazoles; Voriconazole

2019
An Observational Study of the Efficacy and Safety of Voriconazole in a Real-Life Clinical Setting.
    Journal of chemotherapy (Florence, Italy), 2019, Volume: 31, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Drug Interactions; Female; Humans; Male; Middle Aged; Mycoses; Retrospective Studies; Voriconazole; Young Adult

2019
Effects of ketoconazole, voriconazole, and itraconazole on the pharmacokinetics of apatinib in rats.
    Drug development and industrial pharmacy, 2019, Volume: 45, Issue:4

    Topics: Animals; Antifungal Agents; Antineoplastic Agents; Drug Evaluation, Preclinical; Drug Interactions; Drug Monitoring; Itraconazole; Ketoconazole; Male; Mycoses; Pyridines; Rats; Rats, Sprague-Dawley; Stomach Neoplasms; Voriconazole

2019
A pharmacokinetic model for voriconazole in a highly diversified population of children and adolescents with cancer.
    Mycoses, 2019, Volume: 62, Issue:4

    Topics: Adolescent; Antifungal Agents; Child; Female; Humans; Male; Mycoses; Neoplasms; Retrospective Studies; Voriconazole

2019
Combination antifungal treatment for invasive fungal disease after hematopoietic stem cell transplantation in children with hematological disorders.
    Transplant infectious disease : an official journal of the Transplantation Society, 2019, Volume: 21, Issue:3

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Child; Child, Preschool; Drug Therapy, Combination; Female; Hematologic Diseases; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Invasive Fungal Infections; Male; Mycoses; Retrospective Studies; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Voriconazole

2019
Why do lung transplant patients discontinue triazole prophylaxis?
    Transplant infectious disease : an official journal of the Transplantation Society, 2019, Volume: 21, Issue:3

    Topics: Adult; Aged; Antifungal Agents; Drug Interactions; Female; Humans; Invasive Fungal Infections; Itraconazole; Lung Transplantation; Male; Medication Adherence; Middle Aged; Mycoses; Retrospective Studies; Triazoles; Voriconazole

2019
Application of laser capture microdissection and polymerase chain reaction in the diagnosis of Trichoderma longibrachiatum infection: a promising diagnostic tool for 'fungal contaminants' infection.
    Medical mycology, 2020, Apr-01, Volume: 58, Issue:3

    Topics: Antifungal Agents; Humans; Immunocompromised Host; Laser Capture Microdissection; Male; Middle Aged; Molecular Diagnostic Techniques; Mycoses; Polymerase Chain Reaction; Treatment Outcome; Trichoderma; Voriconazole

2020
The pathogen spectrum and resistance in patients with peritoneal dialysis-associated peritonitis: A single-center, observational clinical study
.
    Clinical nephrology, 2019, Volume: 92, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Cefazolin; Ceftriaxone; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Imipenem; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Peritoneal Dialysis; Peritonitis; Vancomycin; Voriconazole; Young Adult

2019
Impact of flavin-containing monooxygenase 3 and CYP2C19 genotypes on plasma disposition and adverse effects of voriconazole administered orally in immunocompromised patients.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2019, Volume: 25, Issue:12

    Topics: Administration, Oral; Aged; Antifungal Agents; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2C19; Female; Genotype; Humans; Immunocompromised Host; Incidence; Japan; Liver Function Tests; Male; Middle Aged; Mycoses; Oxygenases; Voriconazole

2019
Voriconazole is cytotoxic at locally delivered concentrations: a pilot study.
    Clinical orthopaedics and related research, 2013, Volume: 471, Issue:10

    Topics: Animals; Antifungal Agents; Cell Line; Cell Proliferation; Cell Survival; Fibroblasts; Mice; Mycoses; Osteoblasts; Pilot Projects; Pyrimidines; Triazoles; Voriconazole

2013
The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole.
    American journal of hematology, 2013, Volume: 88, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus; Female; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Pyrimidines; Recurrence; Remission Induction; Retrospective Studies; Rhizopus; Triazoles; Voriconazole

2013
Pharmacoeconomic evaluation of fluconazole, posaconazole and voriconazole for antifungal prophylaxis in patients with acute myeloid leukaemia undergoing first consolidation chemotherapy.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:7

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Consolidation Chemotherapy; Economics, Pharmaceutical; Female; Fluconazole; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2013
Molecular characterization and in vitro antifungal susceptibility profile of Schizophyllum commune, an emerging basidiomycete in bronchopulmonary mycoses.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Pyrimidines; Schizophyllum; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole

2013
Preemptive treatment with voriconazole in lung transplant recipients.
    Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:4

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillus fumigatus; Cohort Studies; Female; Humans; Incidence; Lung Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2013
Disseminated Ochroconis gallopava infection in a heart transplant patient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:3

    Topics: Antifungal Agents; Ascomycota; Brain; Fatal Outcome; Heart Transplantation; Humans; Lung; Male; Middle Aged; Mycoses; Peritoneum; Pyrimidines; Triazoles; Voriconazole

2013
Compassionate use of voriconazole in newborn infants diagnosed with severe invasive fungal sepsis.
    European review for medical and pharmacological sciences, 2013, Volume: 17, Issue:6

    Topics: Antifungal Agents; Compassionate Use Trials; Female; Humans; Infant; Infant, Newborn; Male; Mycoses; Pyrimidines; Sepsis; Triazoles; Voriconazole

2013
[Isolation of Scedosporium apiospermum (teleomorph: Pseudallescheria apiosperma) from an acute myeloid leukemia patient].
    Mikrobiyoloji bulteni, 2013, Volume: 47, Issue:2

    Topics: Antifungal Agents; Bronchoalveolar Lavage Fluid; Caspofungin; Echinocandins; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Lung; Male; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2013
Association between drug tolerability and medical resource use in prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplant.
    Journal of medical economics, 2013, Volume: 16, Issue:8

    Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Child; Female; Health Services; Hematopoietic Stem Cell Transplantation; Hospitalization; Humans; Itraconazole; Male; Middle Aged; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Retrospective Studies; Triazoles; Voriconazole; Young Adult

2013
Association of sustained high plasma trough concentration of voriconazole with the incidence of hepatotoxicity.
    Clinica chimica acta; international journal of clinical chemistry, 2013, Sep-23, Volume: 424

    Topics: Adolescent; Aged; Aged, 80 and over; Antifungal Agents; Child; Drug Dosage Calculations; Drug Monitoring; Female; Humans; Liver; Liver Function Tests; Logistic Models; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2013
Relationship between trough plasma and epithelial lining fluid concentrations of voriconazole in lung transplant recipients.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:9

    Topics: Adult; Antifungal Agents; Bronchoalveolar Lavage Fluid; Female; Humans; Lung; Lung Transplantation; Male; Middle Aged; Mycoses; Pilot Projects; Prospective Studies; Pyrimidines; Triazoles; Voriconazole

2013
In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:12

    Topics: Antifungal Agents; Drug Synergism; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Phosphorylcholine; Pyrimidines; Triazoles; Voriconazole

2013
Subacute exogenous Rhizoctonia solani endophthalmitis following cataract extraction with intraocular lens implantation.
    Journal of cataract and refractive surgery, 2013, Volume: 39, Issue:10

    Topics: Acute Disease; Antifungal Agents; Cataract Extraction; Combined Modality Therapy; Device Removal; Endophthalmitis; Eye Infections, Fungal; Humans; Intravitreal Injections; Lens Implantation, Intraocular; Male; Middle Aged; Mycoses; Postoperative Complications; Pyrimidines; Rhizoctonia; Triazoles; Vitrectomy; Voriconazole

2013
Acremonium sclerotigenum-Acremonium egyptiacum: a multi-resistant fungal pathogen complicating the course of aplastic anaemia.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2014, Volume: 20, Issue:1

    Topics: Acremonium; Adult; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Male; Mycoses; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2014
Treatment of a brain abscess caused by Scedosporium apiospermum and Phaeoacremonium parasiticum in a renal transplant recipient.
    The Southeast Asian journal of tropical medicine and public health, 2013, Volume: 44, Issue:3

    Topics: Antifungal Agents; Brain Abscess; Cerebral Phaeohyphomycosis; Coinfection; Humans; Immunocompromised Host; Kidney Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2013
Evaluation of the efficacies of Amphotericin B, Posaconazole, Voriconazole, and Anidulafungin in a murine disseminated infection by the emerging opportunistic Fungus Sarocladium (Acremonium) kiliense.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12

    Topics: Acremonium; Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Echinocandins; Male; Mice; Mycoses; Pyrimidines; Triazoles; Voriconazole

2013
Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients.
    Bone marrow transplantation, 2014, Volume: 49, Issue:1

    Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fusariosis; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lipopeptides; Logistic Models; Male; Mycoses; Neutrophils; Prospective Studies; Pyrimidines; Retrospective Studies; Risk; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2014
Fungal peritonitis associated with Curvularia geniculata and Pithomyces species in a patient with vulvar cancer who was successfully treated with oral voriconazole.
    The Journal of antibiotics, 2014, Volume: 67, Issue:2

    Topics: Antifungal Agents; Antineoplastic Agents; Ascomycota; Diabetic Nephropathies; Female; Humans; Immunocompromised Host; Medroxyprogesterone; Middle Aged; Mycoses; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole; Vulvar Neoplasms

2014
Azole-based chemoprophylaxis of invasive fungal infections in paediatric patients with acute leukaemia: an internal audit.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:3

    Topics: Adolescent; Antifungal Agents; Chemoprevention; Child; Child, Preschool; Cohort Studies; Female; Humans; Infant; Leukemia; Male; Mycoses; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2014
Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Pyrimidines; Remission Induction; Retrospective Studies; Secondary Prevention; Tertiary Care Centers; Triazoles; Voriconazole

2014
Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey.
    BMC infectious diseases, 2013, Nov-26, Volume: 13

    Topics: Amphotericin B; Antifungal Agents; Cost-Benefit Analysis; Economics, Pharmaceutical; Humans; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Turkey; Voriconazole

2013
Factors affecting voriconazole plasma concentrations in patients with invasive fungal infections.
    International journal of clinical pharmacology and therapeutics, 2014, Volume: 52, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Female; Humans; Male; Middle Aged; Mycoses; Polymorphism, Genetic; Pyrimidines; Triazoles; Voriconazole

2014
Utilization and comparative effectiveness of caspofungin and voriconazole early after market approval in the U.S.
    PloS one, 2014, Volume: 9, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Caspofungin; Child; Drug Approval; Echinocandins; Female; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Off-Label Use; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; United States; Voriconazole; Young Adult

2014
Photo quiz: A patient with ulcerated nodules on his face.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Volume: 58, Issue:6

    Topics: Aged; Carcinoma, Squamous Cell; Dermatitis, Phototoxic; Face; Fatal Outcome; Humans; Male; Mycoses; Scedosporium; Skin Neoplasms; Voriconazole

2014
Cost effectiveness of caspofungin vs. voriconazole for empiric therapy in Turkey.
    Mycoses, 2014, Volume: 57, Issue:8

    Topics: Antifungal Agents; Caspofungin; Cost-Benefit Analysis; Echinocandins; Health Care Costs; Humans; Lipopeptides; Mycoses; Treatment Failure; Treatment Outcome; Turkey; Voriconazole

2014
A prospective feasibility study of primary prophylaxis against invasive fungal disease with voriconazole following umbilical cord blood transplantation with fludarabine-based conditioning.
    International journal of hematology, 2014, Volume: 99, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Cord Blood Stem Cell Transplantation; Drug Interactions; Female; Graft Survival; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycoses; Premedication; Prospective Studies; Risk Factors; Transplantation Conditioning; Vidarabine; Voriconazole; Young Adult

2014
Disseminated Scedosporium prolificans infection in an 'extensive metaboliser': navigating the minefield of drug interactions and pharmacogenomics.
    Mycoses, 2014, Volume: 57, Issue:9

    Topics: Aged; Antifungal Agents; Cimetidine; Cytochrome P-450 CYP2C19; Debridement; Drug Interactions; Humans; Leukemia, Myeloid, Acute; Male; Mycoses; Pharmacogenetics; Scedosporium; Voriconazole

2014
Tumorlike cardiac fungal mycetoma caused by Scedosporium apiospermum presenting as symptomatic ventricular tachycardia.
    Circulation, 2014, May-13, Volume: 129, Issue:19

    Topics: Adult; Antifungal Agents; Heart; Hemodynamics; Humans; Male; Mycetoma; Mycoses; Pyrimidines; Scedosporium; Tachycardia, Ventricular; Treatment Outcome; Triazoles; Voriconazole

2014
Alopecia and nail changes associated with voriconazole therapy.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Aug-01, Volume: 59, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Antifungal Agents; Cross-Sectional Studies; Disease Outbreaks; Female; Humans; Male; Methylprednisolone; Michigan; Middle Aged; Mycoses; Nails; Prevalence; Triazoles; Voriconazole

2014
Resolution of a fungal mycotic aneurysm after a contaminated steroid injection: a case report.
    BMC research notes, 2014, May-31, Volume: 7

    Topics: Adult; Aneurysm; Antifungal Agents; Female; Humans; Meningitis, Fungal; Mycoses; Voriconazole

2014
A rare case of Cytomegalovirus, Scedosporium apiospermum and Mycobacterium tuberculosis in a renal transplant recipient.
    BMC infectious diseases, 2014, May-14, Volume: 14

    Topics: Antifungal Agents; Antitubercular Agents; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Developing Countries; Female; Ganciclovir; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Mycobacterium tuberculosis; Mycoses; Postoperative Complications; Scedosporium; Transplant Recipients; Transplantation, Homologous; Tuberculosis; Voriconazole

2014
Trichoderma species fungemia after high-dose chemotherapy and autologous stem cell transplantation: a case report.
    Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:4

    Topics: Antifungal Agents; Antineoplastic Agents; Fungemia; Humans; Male; Middle Aged; Mycoses; Stem Cell Transplantation; Trichoderma; Voriconazole

2014
Tacrolimus dosage requirements in lung transplant recipients receiving antifungal prophylaxis with voriconazole followed by itraconazole: a preliminary prospective study.
    Clinical transplantation, 2014, Volume: 28, Issue:8

    Topics: Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Itraconazole; Lung Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Prognosis; Prospective Studies; Tacrolimus; Voriconazole

2014
Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem cell transplantation.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2015, Volume: 21, Issue:6

    Topics: Adult; Aged; Algorithms; Antifungal Agents; Azoles; Drug Dosage Calculations; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycoses; Retrospective Studies; Sirolimus; Tacrolimus; Triazoles; Voriconazole; Young Adult

2015
Experimental treatment of Curvularia infection.
    Diagnostic microbiology and infectious disease, 2014, Volume: 79, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Disease Models, Animal; Immunocompromised Host; Male; Mice; Mycoses; Treatment Outcome; Triazoles; Voriconazole

2014
Epidemiology, clinical manifestations, and outcomes of Scedosporium infections among solid organ transplant recipients.
    Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:4

    Topics: Adult; Antifungal Agents; Drug Resistance, Fungal; Female; Humans; Immunosuppressive Agents; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Organ Transplantation; Retrospective Studies; Scedosporium; Voriconazole

2014
Nontraumatic paecilomyces anterior segment infection: a pathognomonic clinical appearance.
    Cornea, 2014, Volume: 33, Issue:10

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Eye Infections, Fungal; Female; Humans; Keratitis; Male; Middle Aged; Mycoses; Paecilomyces; Retrospective Studies; Scleritis; Voriconazole; Young Adult

2014
[Treatment recommendations for invasive fungal disease in pediatric patients with cancer or blood disease].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2014, Volume: 52, Issue:6

    Topics: Antifungal Agents; Candidiasis; Caspofungin; Child; Echinocandins; Hematologic Diseases; Humans; Lipopeptides; Mycoses; Neoplasms; Pediatrics; Practice Guidelines as Topic; Voriconazole

2014
Species distribution and susceptibility profile to fluconazole, voriconazole and MXP-4509 of 551 clinical yeast isolates from a Romanian multi-centre study.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015, Volume: 34, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Child; Child, Preschool; Drug Resistance, Fungal; Female; Fluconazole; Fungemia; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Romania; Saccharomyces cerevisiae; Triazoles; Voriconazole; Yeasts; Young Adult

2015
Caenorhabditis elegans: a simple nematode infection model for Penicillium marneffei.
    PloS one, 2014, Volume: 9, Issue:9

    Topics: Amphotericin B; Animals; Antifungal Agents; Caenorhabditis elegans; Disease Models, Animal; Fluconazole; Host-Pathogen Interactions; Hyphae; Itraconazole; Mycoses; Naphthalenes; Penicillium; Pigments, Biological; Survival Analysis; Terbinafine; Voriconazole

2014
Worsening pneumonitis due to a pharmacokinetic drug-drug interaction between everolimus and voriconazole in a renal transplant patient.
    Journal of clinical pharmacy and therapeutics, 2015, Volume: 40, Issue:1

    Topics: Administration, Oral; Aged; Antifungal Agents; Drug Interactions; Everolimus; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycoses; Pneumonia; Sirolimus; Voriconazole

2015
Exogenous fungal endophthalmitis: an analysis of isolates and susceptibilities to antifungal agents over a 20-year period (1990-2010).
    American journal of ophthalmology, 2015, Volume: 159, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Endophthalmitis; Eye Infections, Fungal; Fluconazole; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Voriconazole

2015
Voriconazole phototoxicity in children: a retrospective review.
    Journal of the American Academy of Dermatology, 2015, Volume: 72, Issue:2

    Topics: Adolescent; Antifungal Agents; Boston; Carcinoma, Squamous Cell; Causality; Child; Comorbidity; Cystic Fibrosis; Dermatitis, Phototoxic; Female; Humans; Immunocompromised Host; Incidence; Male; Mycoses; Retrospective Studies; Risk Factors; Skin Neoplasms; Voriconazole; White People

2015
Successful treatment of Paecilomyces variotii peritonitis in a liver transplant patient.
    Mycopathologia, 2015, Volume: 179, Issue:3-4

    Topics: Adolescent; Antifungal Agents; Humans; Liver Transplantation; Male; Mycoses; Paecilomyces; Peritonitis; Postoperative Complications; Voriconazole

2015
Putting CYP2C19 genotyping to the test: utility of pharmacogenomic evaluation in a voriconazole-treated haematology cohort.
    The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:4

    Topics: Aged; Antifungal Agents; Cohort Studies; Cytochrome P-450 CYP2C19; Female; Genotyping Techniques; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Pharmacogenetics; Pilot Projects; Treatment Outcome; Voriconazole

2015
Economic evaluation of a preemptive treatment strategy for invasive fungal infection in neutropenic patients with hematological diseases.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015, Volume: 34, Issue:5

    Topics: Antifungal Agents; Chemoprevention; Clinical Trials as Topic; Cost-Benefit Analysis; Diagnostic Tests, Routine; Echinocandins; Hematologic Diseases; Humans; Lipopeptides; Micafungin; Mycoses; Neutropenia; Retrospective Studies; Voriconazole

2015
In vitro activity of miltefosine in combination with voriconazole or amphotericin B against clinical isolates of Scedosporium spp.
    Journal of medical microbiology, 2015, Volume: 64, Issue:Pt 3

    Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Mycoses; Phosphorylcholine; Scedosporium; Voriconazole

2015
Infective endocarditis caused by Scedosporium prolificans infection in a patient with acute myeloid leukemia undergoing induction chemotherapy.
    International journal of hematology, 2015, Volume: 101, Issue:6

    Topics: Aged; Antifungal Agents; beta-Glucans; Endocarditis; Female; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Multiple Organ Failure; Mycoses; Naphthalenes; Proteoglycans; Scedosporium; Terbinafine; Voriconazole

2015
Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patients.
    Transplant infectious disease : an official journal of the Transplantation Society, 2015, Volume: 17, Issue:2

    Topics: Adult; Aged; Antifungal Agents; Carcinoma, Squamous Cell; Cohort Studies; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Mycoses; Retrospective Studies; Risk Factors; Skin Neoplasms; Transplantation, Homologous; Voriconazole; Young Adult

2015
Treatment with intrastromal and intracameral voriconazole in 2 eyes with Lasiodiplodia theobromae keratitis: case reports.
    Medicine, 2015, Volume: 94, Issue:6

    Topics: Aged, 80 and over; Anterior Chamber; Antifungal Agents; Corneal Stroma; Eye Infections, Fungal; Female; Humans; Injections; Keratitis; Male; Middle Aged; Mycoses; Voriconazole

2015
Impact of risk stratification on the duration of caspofungin therapy for invasive fungal disease in acute leukemic patients.
    Future microbiology, 2015, Volume: 10, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Aged; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Leukemia; Lipopeptides; Male; Middle Aged; Mycoses; Retrospective Studies; Risk; Treatment Outcome; Voriconazole; Young Adult

2015
Introduction of an antifungal stewardship programme targeting high-cost antifungals at a tertiary hospital in Cambridge, England.
    The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Drug Prescriptions; Drug Utilization; Echinocandins; England; Female; Humans; Male; Middle Aged; Mycoses; Prospective Studies; Tertiary Care Centers; Voriconazole; Young Adult

2015
Interaction between voriconazole and flucloxacillin during treatment of disseminated Scedosporium apiospermum infection.
    The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:7

    Topics: Anti-Bacterial Agents; Antifungal Agents; Drug Interactions; Floxacillin; Humans; Mycoses; Scedosporium; Voriconazole

2015
Posaconazole liquid suspension in solid organ transplant recipients previously treated with voriconazole.
    Transplant infectious disease : an official journal of the Transplantation Society, 2015, Volume: 17, Issue:3

    Topics: Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Mucormycosis; Mycoses; Transplant Recipients; Transplants; Triazoles; Voriconazole

2015
Antifungal wound penetration of amphotericin and voriconazole in combat-related injuries: case report.
    BMC infectious diseases, 2015, Apr-15, Volume: 15

    Topics: Adult; Amphotericin B; Amputation, Surgical; Antifungal Agents; Aspergillosis; Blast Injuries; Burns; Critical Illness; Debridement; Drug Monitoring; Fusariosis; Humans; Male; Mucormycosis; Mycoses; Voriconazole; War-Related Injuries; Wounds, Penetrating

2015
Antifungal Treatment in Stem Cell Transplantation Centers in Turkey.
    Turkish journal of haematology : official journal of Turkish Society of Haematology, 2016, Mar-05, Volume: 33, Issue:1

    Topics: Adult; Allografts; Amphotericin B; Antifungal Agents; Child; Cross Infection; Diagnostic Tests, Routine; Drug Substitution; Drug Therapy, Combination; Drug Utilization; Febrile Neutropenia; Health Care Surveys; Health Facilities; Humans; Infection Control; Mycoses; Stem Cell Transplantation; Transplantation, Autologous; Turkey; Voriconazole

2016
Effect of proton pump inhibitor on plasma voriconazole concentration in Thai patients.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2015, Volume: 98, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Female; Humans; Male; Middle Aged; Mycoses; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Thailand; Voriconazole; Young Adult

2015
Current therapeutic protocols for chronic granulomatous fungal sinusitis.
    Rhinology, 2015, Volume: 53, Issue:2

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Chronic Disease; Combined Modality Therapy; Female; Granuloma; Humans; Itraconazole; Male; Middle Aged; Mycoses; Sinusitis; Treatment Outcome; Voriconazole

2015
First recovery of Rasamsonia argillacea species complex isolated in adolescent patient with cystic fibrosis in Slovenia--case report and review of literature.
    Mycoses, 2015, Volume: 58, Issue:8

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Cystic Fibrosis; Echinocandins; Eurotiales; Humans; Lipopeptides; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Pharynx; Sequence Analysis, DNA; Slovenia; Voriconazole; Young Adult

2015
Arthrographis kalrae arthritis: a new case report.
    Le infezioni in medicina, 2015, Volume: 23, Issue:2

    Topics: Aged; Antifungal Agents; Arthritis; Arthroscopy; Ascomycota; Humans; Knee; Male; Mycoses; Treatment Outcome; Voriconazole

2015
Cutaneous and systemic mycoses from infection with Lecanicillium spp. in captive Guthega skinks (Liopholis guthega).
    Australian veterinary journal, 2015, Volume: 93, Issue:7

    Topics: Animals; Anti-Infective Agents, Local; Antifungal Agents; Autopsy; Benzalkonium Compounds; Biguanides; Endangered Species; Female; Lizards; Male; Mycoses; Sequence Analysis, DNA; Victoria; Voriconazole

2015
Liposomal voriconazole (VOR) formulation for improved ocular delivery.
    Colloids and surfaces. B, Biointerfaces, 2015, Sep-01, Volume: 133

    Topics: Animals; Antifungal Agents; Cattle; Cholesterol; Fatty Acids, Monounsaturated; Keratitis; Liposomes; Microscopy, Electron, Transmission; Mycoses; Phosphatidylcholines; Quaternary Ammonium Compounds; Swine; Voriconazole

2015
Successful treatment of Batrachochytrium salamandrivorans infections in salamanders requires synergy between voriconazole, polymyxin E and temperature.
    Scientific reports, 2015, Jun-30, Volume: 5

    Topics: Animals; Antifungal Agents; Chytridiomycota; Colistin; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Mycoses; Temperature; Urodela; Voriconazole

2015
Budget impact analysis of CYP2C19-guided voriconazole prophylaxis in AML.
    The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:11

    Topics: Chemoprevention; Costs and Cost Analysis; Cytochrome P-450 CYP2C19; Genotyping Techniques; Humans; Leukemia, Myeloid, Acute; Models, Statistical; Mycoses; Voriconazole

2015
Voriconazole-induced periostitis post transplant: an illustrative review of thoracic computed tomography imaging manifestations.
    Transplant infectious disease : an official journal of the Transplantation Society, 2015, Volume: 17, Issue:6

    Topics: Aged; Antifungal Agents; Bone Marrow Transplantation; Female; Humans; Liver Transplantation; Lung Transplantation; Male; Middle Aged; Mycoses; Periostitis; Radiography, Thoracic; Tomography, X-Ray; Voriconazole

2015
In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole

2015
Pharmacokinetic and Pharmacodynamic Properties of Oral Voriconazole in Patients with Invasive Fungal Infections.
    Pharmacotherapy, 2015, Volume: 35, Issue:9

    Topics: Academic Medical Centers; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Area Under Curve; Female; Hospitalization; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Mycoses; Prospective Studies; Voriconazole; Young Adult

2015
Reduction in incidence of invasive fungal infection in patients receiving allogeneic stem cell transplantation using combined diagnostic-driven approach and itraconazole oral solution.
    Mycoses, 2015, Volume: 58, Issue:12

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Child; Child, Preschool; Clinical Protocols; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Itraconazole; Male; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Pharmaceutical Solutions; Survival Rate; Transplantation, Homologous; Voriconazole; Young Adult

2015
In vitro antifungal activity of fluconazole and voriconazole against non-Candida yeasts and yeast-like fungi clinical isolates.
    The new microbiologica, 2015, Volume: 38, Issue:4

    Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; Italy; Microbial Sensitivity Tests; Mycoses; Voriconazole; Yeasts

2015
Retrospective case-series of Paecilomyces lilacinus ocular mycoses in Queensland, Australia.
    BMC research notes, 2015, Oct-31, Volume: 8

    Topics: Adult; Aged; Antifungal Agents; Combined Modality Therapy; Eye Infections, Fungal; Female; Host-Pathogen Interactions; Humans; Immune Tolerance; Immunocompromised Host; Male; Middle Aged; Mycoses; Paecilomyces; Queensland; Retrospective Studies; Treatment Outcome; Visual Acuity; Voriconazole; Young Adult

2015
Correlation of Pain and Fluoride Concentration in Allogeneic Hematopoietic Stem Cell Transplant Recipients on Voriconazole.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2016, Volume: 22, Issue:3

    Topics: Adult; Allografts; Female; Fluorides; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Musculoskeletal Pain; Mycoses; Retrospective Studies; Voriconazole

2016
The Clinical Significance of Voriconazole Therapeutic Drug Monitoring in Children With Invasive Fungal Infections.
    Pediatric hematology and oncology, 2015, Volume: 32, Issue:8

    Topics: Adolescent; Child; Child, Preschool; Female; Hematologic Neoplasms; Humans; Male; Mycoses; Organ Transplantation; Time Factors; Voriconazole

2015
The First Case of Invasive Mixed-Mold Infections Due to Emericella nidulans var. echinulata and Rasamsonia piperina in a Patient with Chronic Granulomatous Disease.
    Mycopathologia, 2016, Volume: 181, Issue:3-4

    Topics: Adolescent; Antifungal Agents; Ascomycota; Coinfection; Echinocandins; Emericella; Granulomatous Disease, Chronic; Humans; Immunocompromised Host; Lipopeptides; Male; Micafungin; Mycoses; Sputum; Voriconazole

2016
Scedosporium apiospermum causing brain abscess in a renal allograft recipient.
    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2015, Volume: 26, Issue:6

    Topics: Adult; Antifungal Agents; Brain Abscess; Combined Modality Therapy; Drainage; Fatal Outcome; Humans; Kidney Transplantation; Magnetic Resonance Imaging; Male; Mycoses; Postoperative Period; Scedosporium; Transplant Recipients; Voriconazole

2015
Successful treatment of Beauveria bassiana fungal keratitis with topical voriconazole.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016, Volume: 22, Issue:4

    Topics: Administration, Ophthalmic; Antifungal Agents; Beauveria; Corneal Ulcer; Female; Humans; Middle Aged; Mycoses; Ophthalmic Solutions; Voriconazole

2016
Genotype-Directed Dosing Leads to Optimized Voriconazole Levels in Pediatric Patients Receiving Hematopoietic Stem Cell Transplantation.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2016, Volume: 22, Issue:3

    Topics: Adolescent; Algorithms; Allografts; Child; Child, Preschool; Cytochrome P-450 CYP2C19; Female; Follow-Up Studies; Genotype; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Polymorphism, Genetic; Precision Medicine; Voriconazole

2016
Voriconazole Concentrations in Cerebrospinal Fluid During Prophylactic Use in Children with Acute Myelogenous Leukemia.
    The Pediatric infectious disease journal, 2016, Volume: 35, Issue:3

    Topics: Adolescent; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Mycoses; Voriconazole; Young Adult

2016
Isavuconazole: a role for the newest broad-spectrum triazole.
    Lancet (London, England), 2016, Feb-20, Volume: 387, Issue:10020

    Topics: Antifungal Agents; Female; Humans; Male; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole

2016
Impact of CYP2C19 genetic polymorphisms on voriconazole dosing and exposure in adult patients with invasive fungal infections.
    International journal of antimicrobial agents, 2016, Volume: 47, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Cytochrome P-450 CYP2C19; Female; Humans; Male; Middle Aged; Mycoses; Polymorphism, Genetic; Retrospective Studies; Voriconazole; White People; Young Adult

2016
Virulence and Resistance to Antifungal Therapies of Scopulariopsis Species.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Cyclophosphamide; Disease Models, Animal; Drug Resistance, Fungal; Humans; Immunocompromised Host; Male; Mice; Mycoses; Neutropenia; Scopulariopsis; Species Specificity; Survival Analysis; Triazoles; Virulence; Voriconazole

2016
In vitro antifungal susceptibility of clinical species belonging to Aspergillus genus and Rhizopus oryzae.
    Journal de mycologie medicale, 2016, Volume: 26, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Base Sequence; Caspofungin; DNA, Fungal; Echinocandins; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Rhizopus; Tubulin; Voriconazole

2016
Fungal Keratitis Caused by Exserohilum, An Emerging Pathogen.
    Cornea, 2016, Volume: 35, Issue:5

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antifungal Agents; Ascomycota; Communicable Diseases, Emerging; Corneal Ulcer; Eye Infections, Fungal; Female; Humans; Male; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Retrospective Studies; Visual Acuity; Voriconazole; Young Adult

2016
[NEW ANTIFUNGAL DRUGS FOR PREVENTION AND TREATMENT OF VISCERAL MYCOSES].
    La Revue du praticien, 2015, Volume: 65, Issue:10

    Topics: Antifungal Agents; Caspofungin; Drug Therapy; Echinocandins; Humans; Lipopeptides; Micafungin; Mycoses; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole

2015
Pulmonary Infection Secondary to Chrysosporium zonatum in an Immunocompetent Man.
    Annals of the American Thoracic Society, 2016, Volume: 13, Issue:5

    Topics: Antifungal Agents; Bronchoalveolar Lavage Fluid; Chrysosporium; Humans; Lung; Male; Middle Aged; Mycoses; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole

2016
Virulence Attributes and Antifungal Susceptibility Profile of Opportunistic Fungi Isolated from Ophthalmic Infections.
    Mycopathologia, 2016, Volume: 181, Issue:9-10

    Topics: Amphotericin B; Antifungal Agents; Biofilms; Drug Resistance, Fungal; Eye Diseases; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Natamycin; Opportunistic Infections; Peptide Hydrolases; Phospholipases; Virulence; Virulence Factors; Voriconazole

2016
Fungal infection of cystic fibrosis patients - single center experience.
    Pneumonologia i alergologia polska, 2016, Volume: 84, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Candida albicans; Candida tropicalis; Cystic Fibrosis; Drug Resistance, Multiple, Fungal; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Scedosporium; Triazoles; Voriconazole; Yeasts

2016
Different effects of lansoprazole and rabeprazole on the plasma voriconazole trough levels in allogeneic hematopoietic cell transplant recipients.
    Annals of hematology, 2016, Volume: 95, Issue:11

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Body Weight; Bone Marrow Transplantation; Cord Blood Stem Cell Transplantation; Drug Interactions; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Injections, Intravenous; Lansoprazole; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Postoperative Complications; Rabeprazole; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous; Voriconazole; Young Adult

2016
Scedosporium Keratitis: An Experience From a Tertiary Eye Hospital in South India.
    Cornea, 2016, Volume: 35, Issue:12

    Topics: Adult; Aged; Antifungal Agents; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Female; Hospitals, Special; Humans; India; Keratoplasty, Penetrating; Male; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Ophthalmology; Prognosis; Retrospective Studies; Scedosporium; Tertiary Care Centers; Visual Acuity; Voriconazole; Young Adult

2016
Scedosporium apiospermum: a rare cause of malignant otitis externa.
    BMJ case reports, 2016, Sep-09, Volume: 2016

    Topics: Aged; Antifungal Agents; Ear, External; Humans; Male; Mycoses; Otitis Externa; Scedosporium; Voriconazole

2016
A Rare Central Nervous System Fungal Infection Resulting from Brown Heroin Use.
    The Journal of emergency medicine, 2017, Volume: 52, Issue:3

    Topics: Antifungal Agents; Candida; Central Nervous System Diseases; Cerebral Ventriculitis; Diagnosis, Differential; Emergency Service, Hospital; Endophthalmitis; Heroin; Humans; Male; Meningitis; Mycoses; Substance Abuse, Intravenous; Visual Fields; Voriconazole; Young Adult

2017
Scedosporium prolificans Otitis Externa.
    The Pediatric infectious disease journal, 2016, Volume: 35, Issue:11

    Topics: Adolescent; Antifungal Agents; Drug Resistance, Fungal; Female; Humans; Mycoses; Naphthalenes; Otitis Externa; Rosaniline Dyes; Scedosporium; Terbinafine; Treatment Outcome; Voriconazole

2016
Voriconazole MICs are predictive for the outcome of experimental disseminated scedosporiosis.
    The Journal of antimicrobial chemotherapy, 2017, 04-01, Volume: 72, Issue:4

    Topics: Animals; Antifungal Agents; Brain; Humans; Mice; Microbial Sensitivity Tests; Mycoses; Predictive Value of Tests; Scedosporium; Voriconazole

2017
[A rare and mortal infection agent in patients with hematological malignancies: Saprochaete capitata].
    Mikrobiyoloji bulteni, 2016, Volume: 50, Issue:4

    Topics: Adult; Amphotericin B; Animals; Antifungal Agents; Caspofungin; Catheter-Related Infections; Echinocandins; Fatal Outcome; Female; Fungemia; Humans; Leukemia; Lipopeptides; Moths; Mycoses; Opportunistic Infections; Saccharomycetales; Voriconazole; Young Adult

2016
Successful treatment of Talaromyces amestolkiae pulmonary infection with voriconazole in an acute lymphoblastic leukemia patient.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2017, Volume: 23, Issue:6

    Topics: Adult; Antifungal Agents; Female; Humans; Immunocompromised Host; Lung Diseases, Fungal; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Talaromyces; Voriconazole; Young Adult

2017
Biofilm formation of the black yeast-like fungus Exophiala dermatitidis and its susceptibility to antiinfective agents.
    Scientific reports, 2017, 02-17, Volume: 7

    Topics: Antifungal Agents; Bacterial Adhesion; beta-Glucans; Biofilms; Catechin; Colistin; Cystic Fibrosis; Echinocandins; Exophiala; Farnesol; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Voriconazole

2017
PharmGKB summary: voriconazole pathway, pharmacokinetics.
    Pharmacogenetics and genomics, 2017, Volume: 27, Issue:5

    Topics: Antifungal Agents; Aspergillus; Candida; Fusarium; Humans; Mycoses; Pharmacogenetics; Scedosporium; Voriconazole

2017
Pharmacokinetic-pharmacodynamic analysis of voriconazole in Japanese patients with hematological malignancies.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2008, Volume: 27, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Asian People; Female; Hematologic Neoplasms; Humans; Male; Metabolic Clearance Rate; Middle Aged; Monte Carlo Method; Mycoses; Pyrimidines; Tissue Distribution; Triazoles; Voriconazole

2008
[Use of topical voriconazole in Alternaria keratitis].
    Archivos de la Sociedad Espanola de Oftalmologia, 2008, Volume: 83, Issue:8

    Topics: Administration, Oral; Adult; Alternaria; Antifungal Agents; Eye Infections, Fungal; Eye Injuries; Humans; Keratitis; Keratoplasty, Penetrating; Male; Mycoses; Ophthalmic Solutions; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2008
Five-year retrospective review of guideline-based management of fungal endophthalmitis.
    Acta ophthalmologica, 2008, Volume: 86, Issue:5

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Costs; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Flucytosine; Guideline Adherence; Health Care Costs; Humans; Male; Medical Audit; Middle Aged; Mycoses; Practice Guidelines as Topic; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole

2008
Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    International journal of antimicrobial agents, 2008, Volume: 32, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Clinical Trials, Phase III as Topic; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole; Yeasts

2008
Alternaria infectoria brain abscess in a child with chronic granulomatous disease.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2009, Volume: 28, Issue:4

    Topics: Alternaria; Antifungal Agents; Brain; Brain Abscess; Caspofungin; Child, Preschool; Echinocandins; Fatal Outcome; Granulomatous Disease, Chronic; Humans; Lipopeptides; Male; Mycoses; Pyrimidines; Radiography; RNA, Fungal; RNA, Ribosomal, 5.8S; Seizures; Triazoles; Voriconazole

2009
Comparison of disk diffusion test and Etest for voriconazole and fluconazole susceptibility testing.
    Folia microbiologica, 2008, Volume: 53, Issue:2

    Topics: Antifungal Agents; Culture Media; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2008
Quantitative PCR assay used to monitor serum Trichosporon asahii DNA concentrations in disseminated trichosporonosis.
    The Pediatric infectious disease journal, 2008, Volume: 27, Issue:11

    Topics: Adolescent; Antifungal Agents; Antigens, Fungal; Bone Marrow Transplantation; DNA, Fungal; Graft vs Host Disease; Humans; Immunocompromised Host; Latex Fixation Tests; Male; Microbial Sensitivity Tests; Mycoses; Polymerase Chain Reaction; Polysaccharides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Trichosporon; Voriconazole

2008
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
    Journal of clinical microbiology, 2009, Volume: 47, Issue:1

    Topics: Africa; Antifungal Agents; Asia, Southeastern; Drug Resistance, Fungal; Europe; Fluconazole; Humans; Latin America; Microbial Sensitivity Tests; Middle East; Mycoses; North America; Pyrimidines; Triazoles; Voriconazole; Yeasts

2009
Disseminated fusariosis caused by Fusarium verticillioides in an acute lymphoblastic leukemia patient after allogeneic hematopoietic stem cell transplantation.
    Journal of clinical microbiology, 2009, Volume: 47, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Child; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole

2009
Paecilomyces lilacinus peritonitis complicating peritoneal dialysis cured by oral voriconazole and terbinafine combination therapy.
    Journal of medical microbiology, 2008, Volume: 57, Issue:Pt 12

    Topics: Administration, Oral; Adolescent; Antifungal Agents; Drug Therapy, Combination; Humans; Male; Mycoses; Naphthalenes; Paecilomyces; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Pyrimidines; Terbinafine; Treatment Outcome; Triazoles; Voriconazole

2008
Antifungal susceptibility testing of Exophiala spp.: a head-to-head comparison of amphotericin B, itraconazole, posaconazole and voriconazole.
    Medical mycology, 2009, Volume: 47, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Exophiala; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2009
Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Feb-01, Volume: 48, Issue:3

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Candida; Deoxycholic Acid; Drug Combinations; Female; Fungi; Hematopoietic Stem Cell Transplantation; Humans; Logistic Models; Male; Middle Aged; Mucorales; Mycoses; North America; Prevalence; Prospective Studies; Pyrimidines; Risk Factors; Treatment Outcome; Triazoles; Voriconazole

2009
Early detection of breakthrough trichosporonosis by serum PCR in a cord blood transplant recipient being prophylactically treated with voriconazole.
    Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:12

    Topics: Adolescent; Antifungal Agents; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; DNA, Fungal; Fungemia; Humans; Male; Mycoses; Myelodysplastic Syndromes; Polymerase Chain Reaction; Prognosis; Pyrimidines; Triazoles; Trichosporon; Voriconazole

2008
The use of voriconazole in the treatment of cylindrocarpon keratomycosis.
    Cornea, 2009, Volume: 28, Issue:2

    Topics: Antifungal Agents; Ascomycota; Cornea; Corneal Ulcer; Drug Resistance, Fungal; Female; Humans; Keratitis; Microscopy, Confocal; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole

2009
Scedosporium apiospermum skeletal infection in an immunocompetent child.
    Medical mycology, 2009, Volume: 47, Issue:4

    Topics: Antifungal Agents; Child; Female; Humans; Knee; Mycoses; Osteomyelitis; Pyrimidines; Radiography; Scedosporium; Triazoles; Voriconazole

2009
Voriconazole-induced phototoxicity masquerading as chronic graft-versus-host disease of the skin in allogeneic hematopoietic cell transplant recipients.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2009, Volume: 15, Issue:3

    Topics: Adolescent; Adult; Antifungal Agents; Child; Dermatitis, Phototoxic; Diagnosis, Differential; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2009
Successful treatment of disseminated fusariosis in a child with acute myelogenous leukaemia with medical and surgical approach.
    Mycoses, 2010, Mar-01, Volume: 53, Issue:2

    Topics: Antifungal Agents; Child; Debridement; Dermatomycoses; Fusarium; Humans; Leukemia, Myeloid; Leukocyte Transfusion; Lung Diseases, Fungal; Male; Mycoses; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole

2010
Treatment of invasive fungal infections: stability of voriconazole infusion solutions in PVC bags.
    The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2008, Volume: 12, Issue:5

    Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Drug Packaging; Drug Stability; Drug Storage; Hydrogen-Ion Concentration; Infusions, Parenteral; Mycoses; Polyenes; Polyvinyl Chloride; Pyrimidines; Time Factors; Triazoles; Voriconazole

2008
Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
    Transplant infectious disease : an official journal of the Transplantation Society, 2009, Volume: 11, Issue:3

    Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Cystic Fibrosis; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Female; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Mycoses; Pyrimidines; Scedosporium; Tacrolimus; Triazoles; Voriconazole; Young Adult

2009
Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, May-01, Volume: 48, Issue:9

    Topics: Antifungal Agents; Child; Drug Therapy, Combination; Female; Fractures, Bone; Humans; Mycoses; Naphthalenes; Osteomyelitis; Phosphorylcholine; Pyrimidines; Scedosporium; Terbinafine; Treatment Outcome; Triazoles; Voriconazole; Wounds and Injuries

2009
Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders.
    International journal of hematology, 2009, Volume: 89, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Dose-Response Relationship, Drug; Drug Monitoring; Hematologic Neoplasms; Humans; Liver Diseases; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole; Young Adult

2009
Safe management of tacrolimus together with posaconazole in lung transplant patients with cystic fibrosis.
    Therapeutic drug monitoring, 2009, Volume: 31, Issue:3

    Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Cystic Fibrosis; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Female; Graft Rejection; Humans; Immunosuppressive Agents; Itraconazole; Lung Transplantation; Male; Microbial Sensitivity Tests; Mycoses; Prescriptions; Pyrimidines; Tacrolimus; Triazoles; Voriconazole

2009
Peritonitis due to Neosartorya pseudofischeri in an elderly patient undergoing peritoneal dialysis successfully treated with voriconazole.
    Journal of medical microbiology, 2009, Volume: 58, Issue:Pt 5

    Topics: Antifungal Agents; Female; Humans; Kidney Failure, Chronic; Middle Aged; Mycoses; Neosartorya; Peritoneal Dialysis; Peritonitis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2009
Compassionate use study of caspofungin in children with proven or suspected invasive mycosis or persistent febrile neutropenia.
    Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:2

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Child; Child, Preschool; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Infant; Infant, Newborn; Lipopeptides; Male; Mycoses; Neutropenia; Pyrimidines; Retrospective Studies; Salvage Therapy; Triazoles; Voriconazole

2009
Antifungal activity of itraconazole and voriconazole against clinical isolates obtained from animals with mycoses.
    Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology, 2009, Volume: 50, Issue:2

    Topics: Animals; Antifungal Agents; Cat Diseases; Cats; Dog Diseases; Dogs; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole

2009
Systemic phaeohyphomycosis resembling primary sclerosing cholangitis caused by Exophiala dermatitidis.
    Journal of medical microbiology, 2009, Volume: 58, Issue:Pt 9

    Topics: Amphotericin B; Antifungal Agents; Cholangitis, Sclerosing; Diagnosis, Differential; Exophiala; Female; Humans; Lymph Nodes; Mycoses; Pyrimidines; Triazoles; Voriconazole; Young Adult

2009
Genotyping and antifungal drug susceptibility of the pathogenic yeast Trichosporon asahii isolated from Thai patients.
    Mycopathologia, 2010, Volume: 169, Issue:1

    Topics: Antifungal Agents; DNA, Fungal; DNA, Ribosomal Spacer; Drug Resistance, Multiple, Fungal; Genetic Variation; Genome, Fungal; Geography; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Sequence Analysis, DNA; Thailand; Triazoles; Trichosporon; Voriconazole

2010
Fusarium endophthalmitis following refractive lens exchange for correction of high myopia.
    Journal of cataract and refractive surgery, 2009, Volume: 35, Issue:8

    Topics: Anterior Chamber; Antifungal Agents; Endophthalmitis; Eye Infections, Fungal; Female; Fusarium; Humans; Lens Implantation, Intraocular; Middle Aged; Mycoses; Myopia, Degenerative; Pyrimidines; Reoperation; Triazoles; Visual Acuity; Voriconazole

2009
Antifungal prophylaxis with voriconazole or itraconazole in lung transplant recipients: hepatotoxicity and effectiveness.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2009, Volume: 9, Issue:9

    Topics: Aged; Antifungal Agents; Cohort Studies; Female; Humans; Itraconazole; Lung Diseases, Fungal; Lung Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2009
Practice patterns in the management of fungal corneal ulcers.
    Cornea, 2009, Volume: 28, Issue:8

    Topics: Administration, Topical; Amphotericin B; Antifungal Agents; Corneal Ulcer; Debridement; Drug Costs; Drug Therapy, Combination; Humans; Mycoses; Natamycin; Ophthalmology; Patients; Practice Patterns, Physicians'; Pyrimidines; Surveys and Questionnaires; Treatment Outcome; Triazoles; Voriconazole

2009
Intraocular penetration of voriconazole and caspofungin in a patient with fungal endophthalmitis.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:4

    Topics: Antifungal Agents; Caspofungin; Echinocandins; Endophthalmitis; Fusarium; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole

2009
Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD.
    Bone marrow transplantation, 2010, Volume: 45, Issue:4

    Topics: Adult; Antifungal Agents; Chemoprevention; Female; Fluconazole; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2010
Keratitis resulting from Thielavia subthermophila Mouchacca.
    Cornea, 2009, Volume: 28, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Child; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Mycoses; Pyrimidines; Retrospective Studies; Sordariales; Triazoles; Voriconazole

2009
Hyalohyphomycosis caused by Paecilomyces lilacinus after kidney transplantation.
    Transplantation proceedings, 2009, Volume: 41, Issue:7

    Topics: Antifungal Agents; Diabetes Mellitus; Female; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Interferons; Kidney Transplantation; Middle Aged; Mycoses; Paecilomyces; Polycystic Kidney Diseases; Postoperative Complications; Pyrimidines; Renal Replacement Therapy; Ribavirin; Treatment Outcome; Triazoles; Voriconazole

2009
Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2010, Volume: 12, Issue:1

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Chemoprevention; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Mycoses; Pyrimidines; Time Factors; Transplantation, Homologous; Triazoles; Voriconazole; Young Adult

2010
Voriconazole concentrations and outcome of invasive fungal infections.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2010, Volume: 16, Issue:7

    Topics: Adult; Aged; Antifungal Agents; Australia; Chromatography, High Pressure Liquid; Drug Administration Schedule; Drug Monitoring; Female; Humans; Immunosuppression Therapy; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2010
Voriconazole serum concentrations in prophylactically treated acute myelogenous leukaemia patients.
    Mycoses, 2011, Volume: 54, Issue:3

    Topics: Adolescent; Aged; Antifungal Agents; Chemoprevention; Drug Monitoring; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Mycoses; Pyrimidines; Serum; Triazoles; Voriconazole

2011
A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections.
    Mycoses, 2011, Volume: 54, Issue:3

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Child; Child, Preschool; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Female; Fungi; Hematologic Neoplasms; Humans; Infant; Lipopeptides; Male; Mycoses; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole

2011
Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:1

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Blood Chemical Analysis; Cyclosporine; Female; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Mycoses; Pyrimidines; Transplantation; Transplantation, Homologous; Triazoles; Voriconazole; Young Adult

2010
How many steps along the path is too far?
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Jan-01, Volume: 50, Issue:1

    Topics: Antifungal Agents; Child; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2010
Voriconazole pharmacokinetics and pharmacodynamics in children.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Jan-01, Volume: 50, Issue:1

    Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Computer Simulation; Female; Humans; Infant; Linear Models; Male; Models, Biological; Mycoses; Proportional Hazards Models; Pyrimidines; Retrospective Studies; Statistics, Nonparametric; Triazoles; Voriconazole; Young Adult

2010
An outbreak of early-onset endophthalmitis caused by Fusarium species following cataract surgery.
    Current eye research, 2009, Volume: 34, Issue:11

    Topics: Aged; Amphotericin B; Antifungal Agents; Combined Modality Therapy; Disease Outbreaks; Drug Therapy, Combination; Endophthalmitis; Eye Evisceration; Eye Infections, Fungal; Female; Fusarium; Humans; Lens Implantation, Intraocular; Male; Middle Aged; Mycoses; Phacoemulsification; Postoperative Complications; Pyrimidines; Retrospective Studies; Triazoles; Turkey; Visual Acuity; Vitrectomy; Voriconazole

2009
Alternaria sinusitis in children with acute myeloid leukemia: case reports from the Childhood Acute Myeloid Leukemia Infection Research Group.
    Leukemia & lymphoma, 2010, Volume: 51, Issue:2

    Topics: Adolescent; Alternaria; Amphotericin B; Antifungal Agents; Child, Preschool; Female; Humans; Leukemia, Myeloid, Acute; Male; Mycoses; Pyrimidines; Sinusitis; Triazoles; Voriconazole

2010
Evaluation of antifungal therapy in a neutropenic murine model of Neoscytalidium dimidiatum infection.
    International journal of antimicrobial agents, 2010, Volume: 35, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Colony Count, Microbial; Disease Models, Animal; Kidney; Male; Mice; Mycoses; Neutropenia; Pyrimidines; Sepsis; Spleen; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole

2010
Beauveria keratitis and biopesticides: case histories and a random amplification of polymorphic DNA comparison.
    Cornea, 2010, Volume: 29, Issue:2

    Topics: Adult; Antifungal Agents; Beauveria; Contact Lenses, Hydrophilic; Corneal Ulcer; DNA, Fungal; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Middle Aged; Mycoses; Pest Control; Pyrimidines; Random Amplified Polymorphic DNA Technique; Triazoles; Voriconazole

2010
Impact of mold infections in explanted lungs on outcomes of lung transplantation.
    Transplantation, 2010, Jan-27, Volume: 89, Issue:2

    Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antifungal Agents; Female; Heart-Lung Transplantation; Humans; Incidence; Lung; Lung Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Pyrimidines; Retrospective Studies; Survival Rate; Survivors; Triazoles; Voriconazole

2010
The successful medical treatment of a case of Paecilomyces lilacinus keratitis.
    Cornea, 2010, Volume: 29, Issue:3

    Topics: Administration, Topical; Aged; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Humans; Male; Mycoses; Paecilomyces; Pyrimidines; Triazoles; Voriconazole

2010
Efficacy of voriconazole in a murine model of invasive paecilomycosis.
    International journal of antimicrobial agents, 2010, Volume: 35, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Citrus paradisi; Colony Count, Microbial; Diet; Immunocompromised Host; Kidney; Liver; Male; Mice; Mycoses; Paecilomyces; Pyrimidines; Spleen; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole

2010
Differences in voriconazole trough plasma concentrations per oral dosages between children younger and older than 3 years of age.
    Pediatric blood & cancer, 2010, Jul-01, Volume: 54, Issue:7

    Topics: Administration, Oral; Adolescent; Age Factors; Antifungal Agents; Child; Child, Preschool; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infant; Infant, Newborn; Male; Mycoses; Neoplasms; Pyrimidines; Triazoles; Voriconazole

2010
In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii.
    International journal of antimicrobial agents, 2010, Volume: 35, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Synergism; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole

2010
Determination of saliva trough levels for monitoring voriconazole therapy in immunocompromised children and adults.
    Therapeutic drug monitoring, 2010, Volume: 32, Issue:2

    Topics: Adult; Age Factors; Child; Child, Preschool; Drug Monitoring; Female; Humans; Immunocompromised Host; Male; Middle Aged; Mycoses; Pyrimidines; Saliva; Triazoles; Voriconazole

2010
[Near-drowning and cerebral infections caused by fungi belonging to the Pseudallescheria / Scedosporium-complex].
    Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 2010, Volume: 45, Issue:3

    Topics: Adolescent; Adult; Antifungal Agents; Brain; Central Nervous System Infections; Child, Preschool; Female; Germany; Humans; Male; Middle Aged; Mycoses; Near Drowning; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole; Young Adult

2010
Pharmacoeconomic evaluation of voriconazole versus posaconazole for antifungal prophylaxis in acute myeloid leukaemia.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Australia; Chemoprevention; Cost-Benefit Analysis; Female; Hospitals; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2010
Cellulitis and nodular skin lesions due to Fusarium spp in liver transplant: case report.
    Transplantation proceedings, 2010, Volume: 42, Issue:2

    Topics: Amphotericin B; Biopsy; Cellulitis; Fusarium; Graft Rejection; Hepatitis C; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Skin; Treatment Outcome; Triazoles; Voriconazole

2010
Alternaria and paecilomyces keratitis associated with soft contact lens wear.
    Cornea, 2010, Volume: 29, Issue:5

    Topics: Adult; Alternaria; Antifungal Agents; Contact Lens Solutions; Contact Lenses, Hydrophilic; Corneal Ulcer; Eye Infections, Fungal; Female; Humans; Male; Middle Aged; Mycoses; Paecilomyces; Pyrimidines; Triazoles; Voriconazole; Young Adult

2010
Voriconazole, a safe alternative for treating infections caused by the Chrysosporium anamorph of Nannizziopsis vriesii in bearded dragons (Pogona vitticeps).
    Medical mycology, 2010, Volume: 48, Issue:6

    Topics: Animals; Antifungal Agents; Chordata; Chrysosporium; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Reptiles; Triazoles; Voriconazole

2010
Sulphobutylether-beta-cyclodextrin accumulation in critically ill patients with acute kidney injury treated with intravenous voriconazole under extended daily dialysis.
    International journal of antimicrobial agents, 2010, Volume: 36, Issue:1

    Topics: Aged; Animals; Antifungal Agents; beta-Cyclodextrins; Critical Illness; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Renal Dialysis; Renal Insufficiency; Triazoles; Voriconazole

2010
Isolation of Exophiala dermatitidis from pigmented sputum in a cystic fibrosis patient.
    Pediatric pulmonology, 2010, Volume: 45, Issue:5

    Topics: Adolescent; Adrenal Cortex Hormones; Antifungal Agents; Cystic Fibrosis; Exophiala; Female; Humans; Lung Diseases, Fungal; Mycoses; Pyrimidines; Recurrence; Sputum; Triazoles; Voriconazole

2010
Photosensitivity in immunocompromised patients receiving long-term therapy with oral voriconazole.
    The Pediatric infectious disease journal, 2010, Volume: 29, Issue:5

    Topics: Administration, Oral; Adolescent; Antifungal Agents; Child, Preschool; Female; Humans; Immunocompromised Host; Infant; Male; Mycoses; Photosensitivity Disorders; Pyrimidines; Triazoles; Voriconazole

2010
Voriconazole for both successful treatment of disseminated Trichosporon asahii infection and subsequent cord blood transplantation in an infant with acute myelogenous leukemia.
    Bone marrow transplantation, 2011, Volume: 46, Issue:2

    Topics: Antifungal Agents; Cord Blood Stem Cell Transplantation; Female; Humans; Infant; Leukemia, Myeloid, Acute; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole

2011
Fusarium sepsis, voriconazole, and the skin.
    Cutis, 2010, Volume: 85, Issue:4

    Topics: Antifungal Agents; Fusarium; Humans; Mycoses; Pyrimidines; Sepsis; Skin; Triazoles; Voriconazole

2010
Identification of Paecilomyces variotii in clinical samples and settings.
    Journal of clinical microbiology, 2010, Volume: 48, Issue:8

    Topics: Amphotericin B; Antifungal Agents; DNA, Fungal; DNA, Ribosomal; DNA, Ribosomal Spacer; Flucytosine; Fungal Proteins; Genes, rRNA; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Paecilomyces; Pyrimidines; RNA, Fungal; RNA, Ribosomal, 5.8S; Sequence Analysis, DNA; Triazoles; Tubulin; Voriconazole

2010
Catastrophic squamous cell carcinoma in lung transplant patients treated with voriconazole.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2010, Volume: 36, Issue:11

    Topics: Antifungal Agents; Carcinoma, Squamous Cell; Fatal Outcome; Female; Heart Transplantation; Humans; Lung Transplantation; Middle Aged; Mycoses; Neoplasm Invasiveness; Neoplasm Metastasis; Pyrimidines; Skin Neoplasms; Triazoles; Voriconazole

2010
In vitro susceptibility of filamentous fungi to itraconazole, voriconazole and posaconazole by Clinical and Laboratory Standards Institute reference method and E-test.
    Mycoses, 2011, Volume: 54, Issue:5

    Topics: Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2011
Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2010, Volume: 29, Issue:11

    Topics: Adult; Aged; Antifungal Agents; Carcinoma, Squamous Cell; Case-Control Studies; Female; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Multivariate Analysis; Mycoses; Opportunistic Infections; Pyrimidines; Retrospective Studies; Risk Factors; Skin Neoplasms; Sunlight; Triazoles; Voriconazole

2010
[Rhodotorula glutinis sepsis. A case report].
    Le infezioni in medicina, 2010, Volume: 18, Issue:2

    Topics: Aged; Antifungal Agents; Catheter-Related Infections; Catheterization, Central Venous; Communicable Diseases, Emerging; Comorbidity; Diabetes Complications; Fungemia; Humans; Immunocompromised Host; Liver Cirrhosis; Male; Mycoses; Pyrimidines; Rhodotorula; Sepsis; Triazoles; Voriconazole

2010
Clinical characteristics and therapeutic analysis of invasive fungal infection in chronic severe hepatitis patients.
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2010, Volume: 35, Issue:6

    Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Hepatitis, Chronic; Humans; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult

2010
International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:10

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Child, Preschool; Female; Fusarium; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2010
Comparative evaluation of the Vitek 2 yeast susceptibility test and CLSI broth microdilution reference method for testing antifungal susceptibility of invasive fungal isolates in Italy: the GISIA3 study.
    Journal of clinical microbiology, 2010, Volume: 48, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Fluconazole; Geotrichum; Humans; Italy; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2010
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.
    Bone marrow transplantation, 2011, Volume: 46, Issue:5

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Lipopeptides; Micafungin; Mycoses; Neutropenia; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2011
Developing a safe antifungal treatment protocol to eliminate Batrachochytrium dendrobatidis from amphibians.
    Medical mycology, 2011, Volume: 49, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Anura; Chytridiomycota; Clinical Protocols; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2011
Fungal spinal cord compression in metastatic synovial sarcoma.
    Acta oncologica (Stockholm, Sweden), 2011, Volume: 50, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Diagnosis, Differential; Disease Progression; Fatal Outcome; Female; Fractures, Spontaneous; Humans; Lung Neoplasms; Mycoses; Neoplasm Recurrence, Local; Neoplasm Staging; Osteomyelitis; Pneumonectomy; Pyrimidines; Radiotherapy, Adjuvant; Sarcoma, Synovial; Spinal Cord Compression; Spinal Cord Neoplasms; Triazoles; Voriconazole

2011
Fusarium keratitis 3 weeks after healed corneal cross-linking.
    Journal of refractive surgery (Thorofare, N.J. : 1995), 2010, Volume: 26, Issue:12

    Topics: Collagen; Corneal Stroma; Corneal Ulcer; Cross-Linking Reagents; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fusarium; Humans; Keratoconus; Mycoses; Photosensitizing Agents; Pyrimidines; Riboflavin; Surgical Wound Infection; Tobramycin; Triazoles; Ultraviolet Rays; Voriconazole; Wound Healing; Young Adult

2010
Oral voriconazole dose in children: one size does not fit all.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Oct-01, Volume: 51, Issue:7

    Topics: Administration, Oral; Adolescent; Antifungal Agents; Child; Child, Preschool; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2010
Trichosporon surgical wound infection in a renal allograft recipient successfully treated with voriconazole.
    Transplantation, 2010, Sep-15, Volume: 90, Issue:5

    Topics: Adult; Antifungal Agents; Biopsy; Humans; Immunosuppressive Agents; Kidney Transplantation; Kidney Tubules; Male; Mycoses; Necrosis; Pyrimidines; Treatment Outcome; Triazoles; Trichosporon; Voriconazole

2010
Combined therapy against murine-disseminated infection by Fusarium verticillioides.
    Mycopathologia, 2011, Volume: 171, Issue:3

    Topics: Amphotericin B; Animals; Antifungal Agents; Drug Therapy, Combination; Fusarium; Mice; Mycoses; Pyrimidines; Survival Rate; Triazoles; Voriconazole

2011
Fatal invasive trichosporonosis due to Trichosporon loubieri in a patient with T-lymphoblastic lymphoma.
    Medical mycology, 2011, Volume: 49, Issue:3

    Topics: Antifungal Agents; DNA, Fungal; DNA, Ribosomal Spacer; Fatal Outcome; Female; Fungemia; Humans; Immunocompromised Host; Molecular Sequence Data; Mycoses; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sequence Analysis, DNA; Triazoles; Trichosporon; Voriconazole; Young Adult

2011
Severe Arthrographis kalrae keratomycosis in an immunocompetent patient.
    Cornea, 2011, Volume: 30, Issue:3

    Topics: Adult; Antifungal Agents; Candida albicans; Contact Lenses, Hydrophilic; Corneal Perforation; Corneal Ulcer; Eye Infections, Fungal; Female; Humans; Keratoplasty, Penetrating; Mitosporic Fungi; Mycoses; Pyrimidines; Reoperation; Triazoles; Voriconazole

2011
In vivo confocal microscopy and anterior segment optical coherence tomography in a case of alternaria keratitis.
    Cornea, 2011, Volume: 30, Issue:4

    Topics: Administration, Topical; Aged; Alternaria; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Humans; Male; Microscopy, Confocal; Mycoses; Pyrimidines; Tomography, Optical Coherence; Triazoles; Voriconazole

2011
A case of bovine valve endocarditis caused by Engyodontium album.
    Medical mycology, 2011, Volume: 49, Issue:4

    Topics: Adult; Antifungal Agents; Arthritis, Juvenile; Ascomycota; Beauveria; DNA, Fungal; Endocarditis; Heart Valve Prosthesis; Humans; Male; Mitral Valve; Mycoses; Prosthesis-Related Infections; Pyrimidines; Reoperation; Sequence Analysis, DNA; Triazoles; Voriconazole

2011
Impact of therapeutic drug monitoring of voriconazole in a pediatric population.
    The Pediatric infectious disease journal, 2011, Volume: 30, Issue:6

    Topics: Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Female; Humans; Infant; Male; Mycoses; Plasma; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2011
Resolution of recurrent fusarium arthritis after prolonged antifungal therapy.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2011, Volume: 17, Issue:1

    Topics: Ankle Joint; Antifungal Agents; Arthritis, Infectious; Drug Therapy, Combination; Fusarium; Humans; Immunocompromised Host; Mycoses; Pyrimidines; Recurrence; Toe Joint; Triazoles; Voriconazole

2011
Invasive fungal rhinitis caused by Paecilomyces lilacinus infection: Report of a case and a novel treatment.
    Ear, nose, & throat journal, 2010, Volume: 89, Issue:12

    Topics: Aged; Antifungal Agents; Combined Modality Therapy; Debridement; Female; Follow-Up Studies; Fungemia; Humans; Immunocompromised Host; Lung Transplantation; Mycoses; Paecilomyces; Pulmonary Fibrosis; Pyrimidines; Rhinitis; Severity of Illness Index; Treatment Outcome; Triazoles; Voriconazole

2010
Case collection study of the safety of AmBisome in association with voriconazole in the treatment of patients with invasive fungal infection.
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2010, Volume: 23, Issue:4

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Combinations; Female; Humans; Kidney Function Tests; Liver Function Tests; Male; Middle Aged; Mycoses; Pyrimidines; Survival Analysis; Triazoles; Voriconazole; Young Adult

2010
Recurrent Lecythophora mutabilis keratitis and endophthalmitis after deep anterior lamellar keratoplasty.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2011, Volume: 129, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Combined Modality Therapy; Corneal Transplantation; Corneal Ulcer; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Microscopy, Acoustic; Middle Aged; Mycoses; Phialophora; Pyrimidines; Recurrence; Triazoles; Voriconazole

2011
Effects of voriconazole co-administration on oxycodone-induced adverse events: a case in the retrospective survey.
    European journal of clinical pharmacology, 2011, Volume: 67, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Antifungal Agents; Aspergillosis; Burkitt Lymphoma; Chronic Pain; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Mycoses; Oxycodone; Pyrimidines; Receptors, Opioid, mu; Retrospective Studies; Triazoles; Voriconazole

2011
Voriconazole as secondary antifungal prophylaxis in stem cell transplant recipients.
    Haematologica, 2011, Volume: 96, Issue:2

    Topics: Antifungal Agents; Humans; Leukemia; Mycoses; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole

2011
Cerebral phaeohyphomycosis caused by Bipolaris spicifera after heart transplantation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2011, Volume: 13, Issue:4

    Topics: Antifungal Agents; Ascomycota; Brain Abscess; Cerebral Phaeohyphomycosis; Heart Transplantation; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Male; Middle Aged; Mycoses; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole

2011
A retrospective analysis of the effect of patient-specific factors on voriconazole concentrations in oncology patients.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2012, Volume: 18, Issue:1

    Topics: Adult; Age Factors; Aged; Alkaline Phosphatase; Antifungal Agents; Female; Humans; International Normalized Ratio; Linear Models; Male; Middle Aged; Multivariate Analysis; Mycoses; Neoplasms; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult

2012
Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Female; Hematology; Hospital Costs; Humans; Length of Stay; Lipopeptides; Male; Middle Aged; Models, Economic; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2011
Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus successfully treated by oral voriconazole and nystatin packing.
    Mycopathologia, 2011, Volume: 172, Issue:2

    Topics: Administration, Oral; Administration, Topical; Aged; Antifungal Agents; Dermatomycoses; Female; Humans; Liver Cirrhosis; Mycoses; Nystatin; Paecilomyces; Pyrimidines; Skin Ulcer; Treatment Outcome; Triazoles; Voriconazole

2011
The effects of intrastromal voriconazole injection and topical voriconazole in the treatment of recalcitrant Fusarium keratitis.
    Cornea, 2011, Volume: 30, Issue:8

    Topics: Administration, Topical; Adult; Antifungal Agents; Corneal Stroma; Corneal Ulcer; Eye Infections, Fungal; Fusarium; Humans; Injections, Intraocular; Male; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2011
Successful treatment of intra-abdominal Exophiala dermatitidis infection in a dog.
    The Veterinary record, 2011, Feb-26, Volume: 168, Issue:8

    Topics: Abdomen; Abdominal Abscess; Animals; Antifungal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Exophiala; Female; Itraconazole; Mycoses; Naphthalenes; Pyrimidines; Terbinafine; Treatment Outcome; Triazoles; Voriconazole

2011
Diagnosis and treatment of fungal infection after liver transplantation.
    Chinese medical journal, 2011, Volume: 124, Issue:7

    Topics: Adult; Amphotericin B; Antifungal Agents; Female; Fluconazole; Humans; Liver Transplantation; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole

2011
Fatal invasive infection with fungemia due to Microascus cirrosus after heart and lung transplantation in a patient with cystic fibrosis.
    Journal of clinical microbiology, 2011, Volume: 49, Issue:7

    Topics: Adult; Antifungal Agents; Ascomycota; Caspofungin; Cystic Fibrosis; DNA, Fungal; Echinocandins; Fatal Outcome; Fungemia; Heart Transplantation; Histocytochemistry; Humans; Immunocompromised Host; Lipopeptides; Lung Transplantation; Male; Microscopy; Molecular Sequence Data; Mycoses; Pleura; Pyrimidines; Radiography, Thoracic; Sequence Analysis, DNA; Tomography, X-Ray Computed; Triazoles; Voriconazole

2011
Invasive Myceliophthora thermophila infection mimicking invasive aspergillosis in a neutropenic patient: a new cause of cross-reactivity with the Aspergillus galactomannan serum antigen assay.
    Medical mycology, 2011, Volume: 49, Issue:8

    Topics: Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus; Base Sequence; Cross Reactions; Diagnosis, Differential; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Middle Aged; Molecular Sequence Data; Mycoses; Neutropenia; Pyrimidines; Sensitivity and Specificity; Sordariales; Spores, Fungal; Triazoles; Voriconazole

2011
Delayed recalcitrant fungal endophthalmitis secondary to Curvularia.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2011, Volume: 46, Issue:2

    Topics: Abscess; Aged; Amphotericin B; Ascomycota; Cataract Extraction; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Eye Enucleation; Eye Infections, Fungal; Female; Humans; Mycoses; Pyrimidines; Recurrence; Triazoles; Vitrectomy; Vitreous Body; Voriconazole

2011
The effect of enteral nutrition supplements on serum voriconazole levels.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2012, Volume: 18, Issue:1

    Topics: Adolescent; Antifungal Agents; Enteral Nutrition; Food-Drug Interactions; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Pyrimidines; Suspensions; Triazoles; Voriconazole

2012
Therapeutic drug monitoring of voriconazole after intravenous administration in infants and children with primary immunodeficiency.
    Therapeutic drug monitoring, 2011, Volume: 33, Issue:4

    Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Female; Humans; Immunologic Deficiency Syndromes; Infant; Injections, Intravenous; Male; Mycoses; Pyrimidines; Treatment Failure; Triazoles; Voriconazole

2011
Selection of resistant fungi in liver transplant recipients during use of newer antifungal agents -- a report of two cases.
    Annals of the Academy of Medicine, Singapore, 2011, Volume: 40, Issue:6

    Topics: Adult; Antifungal Agents; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fatal Outcome; Female; Fluconazole; Humans; Lipopeptides; Liver Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Trichosporonosis; Voriconazole; Young Adult

2011
Fatal post-operative Trichoderma longibrachiatum mediastinitis and peritonitis in a paediatric patient with complex congenital cardiac disease on peritoneal dialysis.
    Journal of medical microbiology, 2011, Volume: 60, Issue:Pt 12

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child, Preschool; Echinocandins; Fatal Outcome; Female; Heart Defects, Congenital; Humans; Immunocompromised Host; Lipopeptides; Mediastinitis; Mycoses; Peritoneal Dialysis; Peritonitis; Postoperative Complications; Pyrimidines; Spleen; Triazoles; Trichoderma; Voriconazole

2011
Dosing voriconazole in an obese patient.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Volume: 53, Issue:7

    Topics: Adult; Antifungal Agents; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Mycoses; Obesity; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole

2011
Tenosynovitis caused by a pseudallescheria boydii infection and symptoms of reflex sympathetic dystrophy after a dog bite.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2011, Volume: 17, Issue:7

    Topics: Animals; Antifungal Agents; Bites and Stings; Diagnosis, Differential; Dogs; Humans; Male; Middle Aged; Mycoses; Pseudallescheria; Pyrimidines; Reflex Sympathetic Dystrophy; Tenosynovitis; Triazoles; Voriconazole

2011
Post-traumatic Pseudallescheria apiosperma osteomyelitis: positive outcome of a young immunocompetent male patient due to surgical intervention and voriconazole therapy.
    Mycoses, 2011, Volume: 54 Suppl 3

    Topics: Adolescent; Antifungal Agents; Bone Transplantation; Fractures, Open; Humans; Immunocompetence; Male; Microbial Sensitivity Tests; Mycoses; Osteomyelitis; Pseudallescheria; Pyrimidines; Tibial Fractures; Transplantation, Autologous; Treatment Outcome; Triazoles; Voriconazole

2011
Penicillium marneffei infection presenting as vulv-ulcer in an HIV-infected woman.
    European journal of medical research, 2011, Sep-12, Volume: 16, Issue:9

    Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Diagnosis, Differential; Female; HIV; HIV Infections; Humans; Mycoses; Penicillium; Pyrimidines; Triazoles; Ulcer; Voriconazole; Vulvar Diseases; Young Adult

2011
Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period.
    Haematologica, 2012, Volume: 97, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Medication Adherence; Middle Aged; Mycoses; Myelodysplastic Syndromes; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2012
Voriconazole serum levels measured by high-performance liquid chromatography: a monocentric study in treated patients.
    Medical mycology, 2012, Volume: 50, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Child, Preschool; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Serum; Time Factors; Triazoles; Voriconazole; Young Adult

2012
Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:3

    Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Immunocompromised Host; Incidence; Infant; Male; Mycoses; Plasma; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2012
[Efficacy of voriconazole for treatment of invasive fungal infections in 87 cases with hematologic malignancies].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2011, Volume: 32, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2011
Administration of voriconazole in patients with renal dysfunction.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 54, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Creatinine; Female; Humans; Infusions, Intravenous; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Mycoses; Pyrimidines; Renal Insufficiency; Retrospective Studies; Triazoles; Voriconazole; Young Adult

2012
Purpureocillium lilacinum as a cause of cavitary pulmonary disease: a new clinical presentation and observations on atypical morphologic characteristics of the isolate.
    Journal of clinical microbiology, 2012, Volume: 50, Issue:5

    Topics: Aged, 80 and over; Antifungal Agents; DNA, Fungal; Female; Humans; Hypocreales; Lung Diseases, Fungal; Microscopy; Molecular Sequence Data; Mycoses; Pyrimidines; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole

2012
Prospective, observational study of voriconazole therapeutic drug monitoring among lung transplant recipients receiving prophylaxis: factors impacting levels of and associations between serum troughs, efficacy, and toxicity.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5

    Topics: Adult; Aged; Antifungal Agents; Central Nervous System; Chromatography, High Pressure Liquid; Cystic Fibrosis; Drug Monitoring; Female; Fungi; Humans; Liver; Lung; Lung Transplantation; Male; Middle Aged; Mycoses; Prospective Studies; Pulmonary Fibrosis; Pyrimidines; Treatment Outcome; Triazoles; United States; Voriconazole

2012
[Outcome analysis of caspofungin in combination with voriconazole for treatment of 12 hematologic malignancies cases with invasive fungal infection].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2011, Volume: 32, Issue:8

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2011
Scedosporium apiospermum keratomycosis in a dog.
    Veterinary ophthalmology, 2012, Volume: 15, Issue:6

    Topics: Animals; Antifungal Agents; Ascomycota; Dog Diseases; Dogs; Keratitis; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole

2012
Systemic mycosis in a California sea lion (Zalophus californianus) with detection of cystofilobasidiales DNA.
    Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2012, Volume: 43, Issue:1

    Topics: Animals; Antifungal Agents; Basidiomycota; DNA, Fungal; Fatal Outcome; Itraconazole; Male; Mycoses; Pyrimidines; Sea Lions; Triazoles; Voriconazole

2012
Idiosyncratic nature of voriconazole photosensitivity in children undergoing cancer therapy.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:7

    Topics: Antifungal Agents; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Mycoses; Neoplasms; Photosensitivity Disorders; Pyrimidines; Triazoles; Voriconazole

2012
High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2012, Volume: 31, Issue:7

    Topics: Adult; Antifungal Agents; Carcinoma, Squamous Cell; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Immunocompromised Host; Immunosuppression Therapy; Lung Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Risk Factors; Skin Neoplasms; Triazoles; Voriconazole

2012
Paecilomyces lilacinus endophthalmitis following cataract surgery: a therapeutic challenge.
    Klinische Monatsblatter fur Augenheilkunde, 2012, Volume: 229, Issue:4

    Topics: Aged; Antifungal Agents; Cataract Extraction; Endophthalmitis; Humans; Male; Mycoses; Paecilomyces; Pyrimidines; Surgical Wound Infection; Treatment Outcome; Triazoles; Voriconazole

2012
Voriconazole-induced phototoxicity in children.
    The Pediatric infectious disease journal, 2012, Volume: 31, Issue:7

    Topics: Chemoprevention; Child; Child, Preschool; Dermatitis, Phototoxic; Female; Humans; Immunocompromised Host; Incidence; Infant; Male; Mycoses; Neoplasms; Pyrimidines; Retrospective Studies; Risk Assessment; Triazoles; Voriconazole

2012
Duration of voriconazole exposure: an independent risk factor for skin cancer after lung transplantation.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2012, Volume: 38, Issue:8

    Topics: Antifungal Agents; Female; Humans; Immunocompromised Host; Lung Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Risk Factors; Skin Neoplasms; Triazoles; Voriconazole

2012
Editorial commentary: Antifungal therapeutic drug monitoring progress: getting it right the first time.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 55, Issue:3

    Topics: Antifungal Agents; Female; Humans; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole

2012
Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 55, Issue:3

    Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Drug Monitoring; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses; Plasma; Pyrimidines; Triazoles; Voriconazole

2012
Fungal malignant otitis externa: pitfalls, diagnosis, and treatment.
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2012, Volume: 33, Issue:5

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Female; Humans; Male; Mycoses; Otitis Externa; Pseudomonas aeruginosa; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2012
A retrospective analysis of voriconazole pharmacokinetics in Japanese pediatric and adolescent patients.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2013, Volume: 19, Issue:1

    Topics: Administration, Intravenous; Administration, Oral; Adolescent; Antifungal Agents; Aspergillosis; Candidemia; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Japan; Male; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2013
Multicenter study of voriconazole pharmacokinetics and therapeutic drug monitoring.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:9

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antifungal Agents; Australia; Drug Interactions; Drug Monitoring; Female; Glucocorticoids; Humans; Male; Middle Aged; Mitosporic Fungi; Mycoses; Nucleic Acid Synthesis Inhibitors; Phenytoin; Pyrimidines; Retrospective Studies; Rifampin; Treatment Outcome; Triazoles; Voltage-Gated Sodium Channel Blockers; Voriconazole

2012
Frequency of fungal isolation and antifungal susceptibility pattern of the fungal isolates from nasal polyps of chronic rhinosinusitis patients at a tertiary care centre in north India.
    Medical mycology, 2013, Volume: 51, Issue:2

    Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Female; Fungi; Humans; Immunoglobulin E; Incidence; India; Itraconazole; Male; Middle Aged; Mucins; Mycoses; Nasal Polyps; Pyrimidines; Retrospective Studies; Rhinitis, Allergic, Perennial; Sinusitis; Tertiary Healthcare; Tomography, X-Ray Computed; Triazoles; Voriconazole

2013
Management of recurrent Paecilomyces lilacinus keratitis.
    Clinical & experimental optometry, 2013, Volume: 96, Issue:3

    Topics: Aged; Humans; Keratitis; Male; Mycoses; Paecilomyces; Pyrimidines; Recurrence; Triazoles; Voriconazole

2013
[Early onset of paralytic ileus caused by simultaneous administration of bortezomib and azole antifungals in multiple myeloma patients].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2012, Volume: 53, Issue:8

    Topics: Aged; Antifungal Agents; Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Interactions; Drug Therapy, Combination; Humans; Intestinal Pseudo-Obstruction; Itraconazole; Middle Aged; Multiple Myeloma; Mycoses; Pyrazines; Pyrimidines; Triazoles; Voriconazole

2012
In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study.
    Journal of clinical microbiology, 2012, Volume: 50, Issue:12

    Topics: Antifungal Agents; China; Cross Infection; Drug Resistance, Fungal; Epidemiological Monitoring; Fluconazole; Humans; Mycoses; Prospective Studies; Pyrimidines; Triazoles; Voriconazole; Yeasts

2012
Penicillium marneffei chylous ascites in acquired immune deficiency syndrome: a case report.
    World journal of gastroenterology, 2012, Oct-07, Volume: 18, Issue:37

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Alkynes; Amphotericin B; Anti-Retroviral Agents; Antifungal Agents; Benzoxazines; Chylous Ascites; Cyclopropanes; Diagnosis, Differential; Humans; Male; Middle Aged; Mycoses; Penicillium; Pyrimidines; Sepsis; Triazoles; Voriconazole

2012
Successful treatment of a severe case of fusariomycosis in a beluga whale (Delphinapterus leucas leucas).
    Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2012, Volume: 43, Issue:3

    Topics: Animals; Animals, Zoo; Antifungal Agents; Drug Administration Schedule; Extremities; Fusarium; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole; Whales

2012
In vitro antifungal drug susceptibilities of Penicillium marneffei from China.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2013, Volume: 19, Issue:4

    Topics: Animals; Antifungal Agents; China; Humans; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Penicillium; Pyrimidines; Rats; Terbinafine; Triazoles; Voriconazole

2013
In vitro activity of colistin as single agent and in combination with antifungals against filamentous fungi occurring in patients with cystic fibrosis.
    Mycoses, 2013, Volume: 56, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Colistin; Cystic Fibrosis; Drug Evaluation, Preclinical; Drug Synergism; Echinocandins; Exophiala; Humans; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2013
An atypical, pigment-producing Metschnikowia strain from a leukaemia patient.
    Medical mycology, 2013, Volume: 51, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Base Sequence; DNA, Fungal; DNA, Ribosomal; Fluconazole; Humans; Italy; Leukemia; Male; Metschnikowia; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Phylogeny; Pigments, Biological; Pyrazines; Sequence Analysis, DNA; Sputum; Voriconazole

2013
Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:3

    Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Fluconazole; Hematologic Neoplasms; Humans; Hypokalemia; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Mycoses; Ofloxacin; Pyrimidines; Risk Factors; Torsades de Pointes; Triazoles; Ventricular Dysfunction, Left; Voriconazole

2013
Scedosporium apiospermum soft tissue infection as the initial presentation of acute myeloid leukemia: a case report.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Mar-01, Volume: 31, Issue:7

    Topics: Aged, 80 and over; Amputation, Surgical; Antifungal Agents; Antimetabolites, Antineoplastic; Azacitidine; Bone Marrow; Decitabine; Diagnosis, Differential; Disease Progression; Fatal Outcome; Female; Humans; Leg Ulcer; Leukemia, Myeloid, Acute; Mycoses; Pancytopenia; Pyrimidines; Scedosporium; Soft Tissue Infections; Triazoles; Voriconazole

2013
Evaluation of intravenous voriconazole in patients with compromised renal function.
    BMC infectious diseases, 2013, Jan-16, Volume: 13

    Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Creatinine; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; Mycoses; Pyrimidines; Renal Insufficiency; Triazoles; Voriconazole; Young Adult

2013
[Infectious diseases: progress in diagnosis and treatment. Topics: IV. Towards containing infectious diseases: 3. Development of new antifungal drugs].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2012, Nov-10, Volume: 101, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Micafungin; Mycoses; Pyrimidines; Triazoles; Voriconazole

2012
Invasive sino-orbital mycosis in an aplastic anemia patient caused by Neosartorya laciniosa.
    Journal of clinical microbiology, 2013, Volume: 51, Issue:4

    Topics: Aged; Anemia, Aplastic; Antifungal Agents; Debridement; DNA, Fungal; Echinocandins; Eye Enucleation; Fungal Proteins; Humans; Lipopeptides; Male; Micafungin; Molecular Sequence Data; Mycoses; Neosartorya; Orbital Diseases; Phylogeny; Pyrimidines; Sequence Analysis, DNA; Sequence Homology; Sinusitis; Triazoles; Voriconazole

2013
Reflections on the approach to treatment of a mycologic disaster.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Cladosporium; Humans; Mucormycosis; Mycoses; Pyrimidines; Rhizopus; Rhodotorula; Triazoles; Voriconazole

2013
Schizophyllum commune: a new organism in eye infection.
    Mycopathologia, 2013, Volume: 175, Issue:3-4

    Topics: Administration, Topical; Adult; Amphotericin B; Antifungal Agents; Cornea; Corneal Transplantation; DNA, Fungal; DNA, Ribosomal Spacer; Humans; Keratitis; Male; Molecular Sequence Data; Mycoses; Polymerase Chain Reaction; Pyrimidines; Schizophyllum; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole

2013
Voriconazole.
    The Medical letter on drugs and therapeutics, 2002, Jul-22, Volume: 44, Issue:1135

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Fusarium; Humans; Injections, Intravenous; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2002
Voriconazole treatment of disseminated paecilomyces infection in a patient with acquired immunodeficiency syndrome.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Oct-01, Volume: 35, Issue:7

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Humans; Male; Mycoses; Paecilomyces; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2002
New drugs, old drugs - dear drugs, cheap drugs.
    Swiss medical weekly, 2002, Jun-15, Volume: 132, Issue:23-24

    Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bone Marrow Transplantation; Caspofungin; Cyclosporine; Echinocandins; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Renal Insufficiency; Triazoles; Voriconazole

2002
Multidrug-resistant Trichosporon asahii isolates are susceptible to voriconazole.
    Journal of clinical microbiology, 2003, Volume: 41, Issue:2

    Topics: Antifungal Agents; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole

2003
Successful treatment of disseminated fusariosis.
    Bone marrow transplantation, 2003, Volume: 31, Issue:5

    Topics: Amphotericin B; Child, Preschool; Female; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2003
Comment: caspofungin acetate for treatment of invasive fungal infections.
    The Annals of pharmacotherapy, 2003, Volume: 37, Issue:4

    Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Drug Synergism; Echinocandins; Guinea Pigs; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2003
Improving the mouse model for studying the efficacy of voriconazole.
    The Journal of antimicrobial chemotherapy, 2003, Volume: 51, Issue:6

    Topics: Animals; Beverages; Citrus paradisi; Disease Models, Animal; Fusarium; Kidney; Mice; Mice, Inbred ICR; Mycoses; Pyrimidines; Spleen; Triazoles; Voriconazole

2003
Voriconazole in the treatment of invasive mold infections in transplant recipients.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2003, Volume: 22, Issue:7

    Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Fungi; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Organ Transplantation; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2003
Successsful voriconazole treatment of disseminated fusarium infection in an immunocompromised patient.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Jul-15, Volume: 37, Issue:2

    Topics: Aged; Amphotericin B; Antifungal Agents; Fusarium; Humans; Immunocompromised Host; Male; Mycoses; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2003
Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi.
    Journal of clinical microbiology, 2003, Volume: 41, Issue:8

    Topics: Amphotericin B; Anti-Bacterial Agents; Aspergillus; Caspofungin; Echinocandins; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Penicillium; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole

2003
Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Sep-01, Volume: 37, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Animals; Antifungal Agents; Brain; Brain Chemistry; Child; Child, Preschool; Drug Administration Schedule; Female; Guinea Pigs; Humans; Immunocompromised Host; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole

2003
Cerebral phaeohyphomycosis in an immunodeficient child treated medically with combination antifungal therapy.
    Medical mycology, 2003, Volume: 41, Issue:4

    Topics: Anti-Bacterial Agents; Antifungal Agents; Ascomycota; Brain Abscess; Brain Diseases; Caspofungin; Child; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Immunologic Deficiency Syndromes; Lipopeptides; Male; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2003
[Update on voriconazole].
    Deutsche medizinische Wochenschrift (1946), 2003, Aug-15, Volume: 128, Issue:33

    Topics: Adult; Age Factors; AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Candidiasis; Child; Humans; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2003
Voriconazole serum concentrations in an infant treated for Trichosporon beigelii infection.
    The Pediatric infectious disease journal, 2003, Volume: 22, Issue:11

    Topics: Antifungal Agents; Fatal Outcome; Humans; Infant; Mycoses; Neutropenia; Pyrimidines; Triazoles; Trichosporon; Voriconazole

2003
Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:12

    Topics: Animals; Antifungal Agents; Brain; Colony Count, Microbial; Kidney; Male; Mice; Mycoses; Neutropenia; Pyrimidines; Scedosporium; Spleen; Survival Analysis; Triazoles; Voriconazole

2003
Pharmacokinetic interaction between voriconazole and ciclosporin A following allogeneic bone marrow transplantation.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:1

    Topics: Adolescent; Antifungal Agents; Bone Marrow Transplantation; Cyclosporine; Drug Interactions; Female; Humans; Leukemia, Myeloid, Acute; Mycoses; Pyrimidines; Triazoles; Voriconazole

2004
Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy.
    Transplantation, 2003, Dec-15, Volume: 76, Issue:11

    Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Child; Drug Resistance, Fungal; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Middle Aged; Mycoses; Neoplasms; Pyrimidines; Salvage Therapy; Transplantation; Treatment Failure; Triazoles; Voriconazole

2003
[symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
    Drug and therapeutics bulletin, 2004, Volume: 42, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2004
Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants.
    The New England journal of medicine, 2004, Feb-26, Volume: 350, Issue:9

    Topics: Adult; Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole; Zygomycosis

2004
In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens.
    American journal of ophthalmology, 2004, Volume: 137, Issue:5

    Topics: Antifungal Agents; Cornea; Databases, Factual; Drug Resistance, Fungal; Endophthalmitis; Eye Infections, Fungal; Fungi; Humans; In Vitro Techniques; Keratitis; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2004
Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis.
    European journal of haematology, 2004, Volume: 73, Issue:1

    Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Child; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Geotrichosis; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Liposomes; Male; Mycoses; Myelodysplastic Syndromes; Peptides; Peptides, Cyclic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Survival Rate; Treatment Outcome; Triazoles; Voriconazole

2004
Fungal keratitis caused by Paecilomyces lilacinus associated with a retained intracorneal hair.
    Cornea, 2004, Volume: 23, Issue:5

    Topics: Anti-Bacterial Agents; Antifungal Agents; Corneal Stroma; Corneal Ulcer; Drug Therapy, Combination; Eye Foreign Bodies; Eye Infections, Fungal; Foreign-Body Migration; Hair; Humans; Male; Middle Aged; Mycoses; Naphthalenes; Paecilomyces; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2004
Fusarium dimerum infection in a stem cell transplant recipient treated successfully with voriconazole.
    Bone marrow transplantation, 2004, Volume: 34, Issue:9

    Topics: Adult; Anemia, Aplastic; Antifungal Agents; Female; Fusarium; Humans; Mycoses; Pyrimidines; Radiography, Thoracic; Stem Cell Transplantation; Tomography, X-Ray Computed; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole

2004
Antifungal therapy in patients with fever and neutropenia--more rational and less empirical?
    The New England journal of medicine, 2004, Sep-30, Volume: 351, Issue:14

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Lipopeptides; Liposomes; Mycoses; Neoplasms; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2004
Voriconazole-induced QT interval prolongation and ventricular tachycardia: a non-concentration-dependent adverse effect.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Sep-15, Volume: 39, Issue:6

    Topics: Adolescent; Antifungal Agents; Bradycardia; Female; Fusarium; Humans; Mycoses; Opportunistic Infections; Pyrimidines; Tachycardia, Ventricular; Torsades de Pointes; Triazoles; Voriconazole

2004
Design issues in a prospective randomized double-blinded trial of prophylaxis with fluconazole versus voriconazole after allogeneic hematopoietic cell transplantation.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Oct-15, Volume: 39 Suppl 4

    Topics: Antifungal Agents; Double-Blind Method; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Research Design; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Voriconazole

2004
Effect of voriconazole on a corneal abscess caused by fusarium.
    Acta ophthalmologica Scandinavica, 2004, Volume: 82, Issue:6

    Topics: Abscess; Antifungal Agents; Corneal Diseases; Eye Infections, Fungal; Fusarium; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole

2004
Voriconazole-induced musical hallucinations.
    Infection, 2004, Volume: 32, Issue:5

    Topics: Aged; Antifungal Agents; Hallucinations; Humans; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole

2004
Caspofungin versus liposomal amphotericin B for empirical therapy.
    The New England journal of medicine, 2005, Jan-27, Volume: 352, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Infusions, Intravenous; Lipopeptides; Liposomes; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2005
Caspofungin versus liposomal amphotericin B for empirical therapy.
    The New England journal of medicine, 2005, Jan-27, Volume: 352, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Lipopeptides; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Survival Rate; Triazoles; Voriconazole

2005
[Drugs used in prophylaxis and treatment of fungal infections in immunosuppressed children].
    Przeglad lekarski, 2004, Volume: 61 Suppl 2

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Drug Resistance, Fungal; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Mycoses; Neoplasms; Peptides, Cyclic; Pyrimidines; Risk Factors; Triazoles; Voriconazole

2004
Breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Apr-15, Volume: 40, Issue:8

    Topics: Adult; Antifungal Agents; Fusarium; Humans; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Failure; Triazoles; Voriconazole

2005
Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: clearance with voriconazole.
    Journal of pediatric hematology/oncology, 2005, Volume: 27, Issue:5

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Fungemia; Humans; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Outcome; Triazoles; Trichosporon; Voriconazole

2005
Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Jun-15, Volume: 40, Issue:12

    Topics: Adult; Amphotericin B; Antifungal Agents; Cornea; Corneal Transplantation; Fusarium; Humans; Itraconazole; Keratitis; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole

2005
[Disseminated cutaneous and visceral fusariosis in an aplastic patient: an unusual digestive entry].
    Annales de dermatologie et de venereologie, 2005, Volume: 132, Issue:3

    Topics: Adult; Amsacrine; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Diet; Fusarium; Humans; Immunocompromised Host; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole

2005
[Subcutaneous phaeohyphomycosis due to Exophiala spinifera in a renal transplant recipient].
    Annales de dermatologie et de venereologie, 2005, Volume: 132, Issue:3

    Topics: Antifungal Agents; Cyclosporine; Exophiala; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Leg; Middle Aged; Mycoses; Prednisone; Pyrimidines; Triazoles; Voriconazole

2005
[Disseminated fusarium infection in two neutropenic children].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2005, Volume: 12, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Child; Drug Combinations; Fatal Outcome; Female; Fusarium; Humans; Immunocompromised Host; Leukemia, Lymphoid; Leukemia, Myeloid; Male; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2005
Voriconazole in the treatment of invasive fungal infections.
    Intensive & critical care nursing, 2005, Volume: 21, Issue:6

    Topics: Administration, Oral; Antifungal Agents; Clinical Trials as Topic; Critical Care; Drug Interactions; Drug Monitoring; Humans; Immunocompromised Host; Infusions, Intravenous; Mycoses; Patient Selection; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2005
In vitro activities of new and established triazoles against opportunistic filamentous and dimorphic fungi.
    Medical mycology, 2005, Volume: 43, Issue:3

    Topics: Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Species Specificity; Thiazoles; Triazoles; Voriconazole

2005
Voriconazole activity against clinical yeast isolates: a multicentre Italian study.
    International journal of antimicrobial agents, 2005, Volume: 26, Issue:3

    Topics: Antifungal Agents; Candida; Cryptococcus neoformans; Drug Resistance, Fungal; Fungi; Geotrichum; Humans; Inpatients; Italy; Microbial Sensitivity Tests; Mycoses; Outpatients; Pyrimidines; Saccharomyces cerevisiae; Triazoles; Trichosporon; Voriconazole

2005
[In vitro susceptibility of fungal and yeast clinical isolates to itraconazole and voriconazole].
    Revista iberoamericana de micologia, 2005, Volume: 22, Issue:2

    Topics: Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Scedosporium; Sporothrix; Triazoles; Voriconazole; Yeasts

2005
[Treatment of invasive fungal infections with voriconazole. Evaluation of experience with compassionate use of voriconazole in Spain].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2005, Volume: 18, Issue:2

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Child, Preschool; Drug Resistance, Fungal; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Spain; Treatment Outcome; Triazoles; Voriconazole

2005
Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin.
    American journal of ophthalmology, 2005, Volume: 140, Issue:3

    Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Cataract Extraction; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Fusarium; Humans; Lens Implantation, Intraocular; Lipopeptides; Male; Middle Aged; Mycoses; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Triazoles; Vitrectomy; Voriconazole

2005
Voriconazole susceptibility of yeasts isolated from the mouths of patients with advanced cancer.
    Journal of medical microbiology, 2005, Volume: 54, Issue:Pt 10

    Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mouth Diseases; Mycoses; Neoplasms; Palliative Care; Pyrimidines; Triazoles; Voriconazole; Yeasts

2005
Fatal Trichosporon asahii septicemia in a Guatemalan farmer with acute lymphoblastic leukemia.
    Southern medical journal, 2005, Volume: 98, Issue:9

    Topics: Adult; Agriculture; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Catheterization, Peripheral; Emigration and Immigration; Fatal Outcome; Fever; Guatemala; Humans; Male; Mycoses; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sepsis; Triazoles; Trichosporon; United States; Urease; Voriconazole; Yeasts

2005
Advances in antifungal therapy.
    The Pediatric infectious disease journal, 2005, Volume: 24, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Animals; Antifungal Agents; Caspofungin; Child; Child, Preschool; Clinical Trials as Topic; Echinocandins; Fungal Proteins; Humans; Infant; Infant, Newborn; Lipopeptides; Lipoproteins; Micafungin; Middle Aged; Mycoses; Peptides, Cyclic; Pyrimidines; Thiazoles; Treatment Outcome; Triazoles; Voriconazole

2005
Endogenous Phialemonium curvatum endophthalmitis.
    American journal of ophthalmology, 2005, Volume: 140, Issue:4

    Topics: Aged; Antifungal Agents; Ascomycota; Cataract Extraction; Drug Contamination; Endocarditis; Endophthalmitis; Erectile Dysfunction; Eye Infections, Fungal; Fungemia; Humans; Male; Muscle, Smooth; Mycoses; Parasympatholytics; Pyrimidines; Triazoles; Ultrasonography; Vitrectomy; Vitreous Body; Voriconazole

2005
[Economic evaluation of the treatment of systemic fungal infections in immunocompromised patients: the role of itraconazole].
    Recenti progressi in medicina, 2005, Volume: 96, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Mycoses; Neutropenia; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2005
Breakthrough invasive infection due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a stem cell transplant patient receiving liposomal amphotericin B and caspofungin for suspected aspergillosis.
    Infection, 2005, Volume: 33, Issue:5-6

    Topics: Aged; Amphotericin B; Anemia, Aplastic; Ascomycota; Aspergillosis; Body Fluids; Caspofungin; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Mycoses; Peptides, Cyclic; Pyrimidines; Saccharomycetales; Shock, Septic; Triazoles; Voriconazole

2005
Voriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis.
    The Journal of infection, 2005, Volume: 51, Issue:4

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Resistance, Fungal; Fungemia; Humans; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Mycoses; Neutropenia; Paecilomyces; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole

2005
Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:1

    Topics: Animals; Antifungal Agents; Drug Synergism; Fungi; Lovastatin; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2006
Cyclomyces tabacinus as a cause of deep tissue infection: the first case report.
    Mycoses, 2006, Volume: 49, Issue:2

    Topics: Aged; Antifungal Agents; Arthritis, Infectious; Basidiomycota; Humans; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole

2006
Chronic endophthalmitis due to verticillium species after cataract surgery treated (or managed) with pars plana vitrectomy and oral and intravitreal voriconazole.
    Retina (Philadelphia, Pa.), 2006, Volume: 26, Issue:2

    Topics: Administration, Oral; Antifungal Agents; Chronic Disease; Combined Modality Therapy; Endophthalmitis; Eye Infections, Fungal; Humans; Injections; Lens Implantation, Intraocular; Male; Middle Aged; Mitosporic Fungi; Mycoses; Phacoemulsification; Postoperative Complications; Pyrimidines; Triazoles; Vitrectomy; Vitreous Body; Voriconazole

2006
Successful voriconazole therapy of disseminated Fusarium verticillioides infection in an immunocompromised patient receiving chemotherapy.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 57, Issue:4

    Topics: Antifungal Agents; Female; Fusarium; Humans; Immunocompromised Host; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2006
[Voriconazole at Saint Louis Hospital (Paris): Analysis of two-years of compassionate use].
    Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:2 Pt 1

    Topics: Acute Disease; Antifungal Agents; Aspergillosis; Candidiasis; Cohort Studies; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Mycoses; Pyrimidines; Retrospective Studies; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2006
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Spain; Triazoles; Voriconazole; Yeasts

2006
Rare lower extremity invasive fungal infection in an immunosuppressed patient: Exserohilum longirostratum.
    Plastic and reconstructive surgery, 2006, Volume: 117, Issue:3

    Topics: Aged; Antifungal Agents; Cellulitis; Comorbidity; Debridement; Disease Progression; Hepatitis C, Chronic; Humans; Immunocompromised Host; Leg Ulcer; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole

2006
Incidence of voriconazole hepatotoxicity during intravenous and oral treatment for invasive fungal infections.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 57, Issue:6

    Topics: Administration, Oral; Antifungal Agents; Hematologic Diseases; Humans; Injections, Intravenous; Liver; Liver Function Tests; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2006
Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B.
    The Journal of infection, 2006, Volume: 53, Issue:6

    Topics: Adult; Amphotericin B; Antifungal Agents; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole

2006
Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2006, Volume: 12, Issue:5

    Topics: Adult; Antifungal Agents; Cord Blood Stem Cell Transplantation; Creatinine; Dose-Response Relationship, Drug; Drug Evaluation; Drug Interactions; Female; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Leukemia; Lipids; Male; Middle Aged; Mycoses; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Pyrimidines; Retrospective Studies; Sirolimus; Transplantation, Homologous; Triazoles; Voriconazole

2006
Black fluid from a traumatic wound.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Jun-01, Volume: 42, Issue:11

    Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Fractures, Open; Humans; Male; Meropenem; Mycoses; Pyrimidines; Soft Tissue Infections; Thienamycins; Triazoles; Voriconazole; Wound Infection

2006
[Effect of new antifungals on the etiology of invasive fungal infections: emergence, resistance and breakthrough infection].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2006, Volume: 19, Issue:1

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Communicable Diseases, Emerging; Drug Resistance, Multiple, Fungal; Humans; Immunocompromised Host; Mycoses; Organ Transplantation; Postoperative Complications; Prosthesis-Related Infections; Pyrimidines; Recurrence; Triazoles; Voriconazole; Zygomycosis

2006
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Cryptococcosis; Cryptococcus; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2006
Efficacy of voriconazole in a guinea pig model of invasive trichosporonosis.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6

    Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Guinea Pigs; Humans; Kidney; Liver; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Spleen; Survival Analysis; Triazoles; Trichosporon; Voriconazole

2006
Fusarium oxysporum pneumonia in an immunocompetent host.
    Southern medical journal, 2006, Volume: 99, Issue:6

    Topics: Aged; Antifungal Agents; Bronchoscopy; Female; Fusarium; Humans; Immunocompetence; Mycoses; Pneumonia; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole

2006
Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Aug-15, Volume: 43, Issue:4

    Topics: Acute Disease; Antifungal Agents; Aspergillosis; Echinocandins; Fungemia; Humans; Leukemia, Myeloid; Lipopeptides; Lipoproteins; Male; Micafungin; Middle Aged; Mycoses; Peptides, Cyclic; Pyrimidines; Triazoles; Trichosporon; Voriconazole

2006
[Clinical cases in medical mycology. Case no. 21].
    Revista iberoamericana de micologia, 2006, Volume: 23, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Resistance, Fungal; Endophthalmitis; Exophiala; Female; Fungemia; Humans; Itraconazole; Middle Aged; Mycoses; Opportunistic Infections; Osteolysis; Pregnancy; Pregnancy Complications, Infectious; Pyrimidines; Recurrence; Th2 Cells; Triazoles; Voriconazole

2006
Antifungal therapy in patients with hematological malignancies: how to avoid overtreatment?
    European journal of haematology, 2006, Volume: 77, Issue:4

    Topics: Adult; Aged; Antifungal Agents; Caspofungin; Echinocandins; Female; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Peptides, Cyclic; Prospective Studies; Pyrimidines; Triazoles; Voriconazole

2006
AmBisome treatment of fungal sinusitis in severe immunocompromised patient with acute lymphoblastic leukemia relapsed after autologous peripheral blood transplantation.
    Acta bio-medica : Atenei Parmensis, 2006, Volume: 77 Suppl 2

    Topics: Adult; Amphotericin B; Anti-Infective Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Combined Modality Therapy; Cytarabine; Cytomegalovirus Infections; Enterococcus faecalis; Fatal Outcome; Humans; Idarubicin; Immunocompromised Host; Immunoglobulins, Intravenous; Liposomes; Male; Mycoses; Peripheral Blood Stem Cell Transplantation; Pneumonia; Postoperative Complications; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pseudomonas putida; Pulmonary Edema; Pyrimidines; Sinusitis; Staphylococcus epidermidis; Transplantation, Autologous; Triazoles; Voriconazole

2006
Severe osteomyelitis caused by Myceliophthora thermophila after a pitchfork injury.
    Annals of clinical microbiology and antimicrobials, 2006, Sep-08, Volume: 5

    Topics: Child, Preschool; Humans; Knee Injuries; Male; Mitosporic Fungi; Mycoses; Osteomyelitis; Pyrimidines; Triazoles; Voriconazole

2006
[Successful treatment with voriconazole for disseminated cutaneous and visceral infection by Fusarium solani in a patient with acute myeloid leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2006, Volume: 47, Issue:8

    Topics: Antifungal Agents; Dermatomycoses; Fusarium; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Opportunistic Infections; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2006
In vitro activity and synergism of amphotericin B, azoles and cationic antimicrobials against the emerging pathogen Trichoderma spp.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Antimicrobial Cationic Peptides; Azoles; Chlorhexidine; Communicable Diseases, Emerging; Drug Synergism; Fluconazole; Guanidines; Humans; Microbial Sensitivity Tests; Mycoses; Polymers; Pyrimidines; Triazoles; Trichoderma; Voriconazole

2006
[Keratomycosis due to Cylindrocarpon lichenicola].
    Mycoses, 2006, Volume: 49 Suppl 2

    Topics: Aged; Amphotericin B; Antifungal Agents; Clematis; Eye Infections, Fungal; Fusarium; Humans; Hypocreales; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole

2006
Intravitreal voriconazole for drug-resistant fungal endophthalmitis: case series.
    Retina (Philadelphia, Pa.), 2006, Volume: 26, Issue:8

    Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Humans; Injections; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Visual Acuity; Vitreous Body; Voriconazole

2006
Voriconazole prophylaxis in lung transplant recipients.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2006, Volume: 6, Issue:12

    Topics: Antifungal Agents; Aspergillosis; Chemoprevention; Female; Humans; Lung Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Probability; Pyrimidines; Retrospective Studies; Survival Analysis; Time Factors; Triazoles; Voriconazole

2006
Treatment of cutaneous infection by Alternaria alternata with voriconazole in a liver transplant patient.
    Transplantation proceedings, 2006, Volume: 38, Issue:8

    Topics: Alternaria; Antifungal Agents; Dermatomycoses; Fatal Outcome; Humans; Liver Transplantation; Middle Aged; Mycoses; Postoperative Complications; Pyrimidines; Skin; Triazoles; Voriconazole

2006
Penicillium piceum infection: diagnosis and successful treatment in chronic granulomatous disease.
    Medical mycology, 2006, Volume: 44, Issue:8

    Topics: Antifungal Agents; Biopsy, Fine-Needle; Blood Sedimentation; Child; DNA, Fungal; Genetic Diseases, X-Linked; Granulomatous Disease, Chronic; Humans; Male; Microscopy; Molecular Sequence Data; Mycoses; Osteomyelitis; Penicillium; Pyrimidines; Radiography, Thoracic; Sequence Analysis, DNA; Triazoles; Voriconazole

2006
Topical and oral voriconazole in the treatment of fungal keratitis.
    American journal of ophthalmology, 2007, Volume: 143, Issue:1

    Topics: Administration, Oral; Administration, Topical; Adult; Aged; Aged, 80 and over; Antifungal Agents; Eye Infections, Fungal; Female; Fungi; Humans; Keratitis; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2007
Unexplained increase in Paecilomyces variotii blood culture isolates in the UK.
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2006, Nov-16, Volume: 11, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Blood; Caspofungin; Diagnosis, Differential; Echinocandins; Equipment Contamination; False Positive Reactions; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Mycoses; Paecilomyces; Peptides, Cyclic; Pyrimidines; Species Specificity; Triazoles; United Kingdom; Voriconazole

2006
Voriconazole and fungal keratitis: a report of two treatment failures.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2006, Volume: 22, Issue:6

    Topics: Administration, Topical; Aged, 80 and over; Antifungal Agents; Colletotrichum; Fusarium; Humans; Keratitis; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Pyrimidines; Treatment Failure; Triazoles; Voriconazole

2006
Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients.
    Cancer, 2007, Apr-15, Volume: 109, Issue:8

    Topics: Antifungal Agents; Graft Rejection; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2007
Management of tunnel fungal infection with voriconazole.
    Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:5

    Topics: Administration, Oral; Administration, Topical; Aged; Antifungal Agents; Cataract Extraction; Corneal Ulcer; Eye Infections, Fungal; Female; Fusarium; Humans; Microsurgery; Mycoses; Pyrimidines; Surgical Wound Infection; Triazoles; Visual Acuity; Voriconazole

2007
Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report.
    BMC infectious diseases, 2007, May-10, Volume: 7

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child; Drug Therapy, Combination; Echinocandins; Female; Fusarium; Humans; Lipopeptides; Mycoses; Peptides, Cyclic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2007
Posaconazole prophylaxis in hematologic cancer.
    The New England journal of medicine, 2007, May-24, Volume: 356, Issue:21

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Humans; Mucositis; Mycoses; Opportunistic Infections; Oxidoreductases; Point Mutation; Pyrimidines; Sterol 14-Demethylase; Triazoles; Voriconazole

2007
[Treatment with voriconazole for invasive fungal infection during chemotherapy for leukemia: doses and plasma concentration of voriconazole in children].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2007, Volume: 48, Issue:5

    Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Drug Monitoring; Female; Humans; Immunocompromised Host; Infant; Leukemia; Male; Metabolic Clearance Rate; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2007
Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole.
    Bone marrow transplantation, 2007, Volume: 40, Issue:5

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Data Collection; Drug Evaluation; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Premedication; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole; Zygomycosis

2007
Basidiomycetous fungal Inonotus tropicalis sacral osteomyelitis in X-linked chronic granulomatous disease.
    The Pediatric infectious disease journal, 2007, Volume: 26, Issue:7

    Topics: Adult; Antifungal Agents; Basidiomycota; Caspofungin; Echinocandins; Granulomatous Disease, Chronic; HMGB1 Protein; Humans; Lipopeptides; Male; Mycoses; Osteomyelitis; Peptides, Cyclic; Pyrimidines; Sacrum; Triazoles; Voriconazole

2007
Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study.
    BMC infectious diseases, 2007, Jul-02, Volume: 7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Female; Fluconazole; Humans; Male; Middle Aged; Mycoses; Neutropenia; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2007
The fusarium keratitis outbreak: not done yet?
    Archives of ophthalmology (Chicago, Ill. : 1960), 2007, Volume: 125, Issue:7

    Topics: Adult; Amphotericin B; Antifungal Agents; Child; Combined Modality Therapy; Corneal Ulcer; Disease Outbreaks; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fusarium; Humans; Keratoplasty, Penetrating; Microbial Sensitivity Tests; Mycoses; Natamycin; Pyrimidines; Triazoles; Voriconazole

2007
Third-time lung transplant using extended criteria lungs.
    The Annals of thoracic surgery, 2007, Volume: 84, Issue:2

    Topics: Adult; Antifungal Agents; Brain Death; Humans; Lung Transplantation; Male; Mycoses; Patient Selection; Postoperative Complications; Pyrimidines; Reoperation; Tissue Donors; Treatment Outcome; Triazoles; Voriconazole

2007
Lecythophora mutabilis prosthetic valve endocarditis in a diabetic patient.
    Medical mycology, 2007, Volume: 45, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Aortic Valve; Ascomycota; Diabetes Complications; Drug Combinations; Endocarditis; Heart Valve Prosthesis; Humans; Male; Middle Aged; Molecular Sequence Data; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Prosthesis-Related Infections; Pyrimidines; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole

2007
Voriconazole as therapy for systemic Penicillium marneffei infections in AIDS patients.
    The American journal of tropical medicine and hygiene, 2007, Volume: 77, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Female; Humans; Male; Mycoses; Penicillium; Pyrimidines; Triazoles; Voriconazole

2007
Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2007, Volume: 26, Issue:11

    Topics: Aged; Amphotericin B; Antifungal Agents; Cross Infection; Drug Therapy, Combination; Humans; Leukemia, Myeloid, Acute; Male; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole

2007
Recalcitrant Beauveria bassiana keratitis: confocal microscopy findings and treatment with posaconazole (Noxafil).
    Cornea, 2007, Volume: 26, Issue:8

    Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Beauveria; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Microscopy, Confocal; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole

2007
Candida krusei arthritis in a patient with hematologic malignancy: successful treatment with voriconazole.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Oct-01, Volume: 45, Issue:7

    Topics: Antifungal Agents; Arthritis, Infectious; Candida; Humans; Knee Joint; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mycoses; Pyrimidines; Synovial Fluid; Triazoles; Voriconazole

2007
Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:5

    Topics: Acute Kidney Injury; Adult; Aged; Antifungal Agents; Area Under Curve; Critical Illness; Female; Half-Life; Hemodiafiltration; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole

2007
[Present and future of voriconazole in the treatment of invasive mycoses: the inseparable binomial diagnosis-treatment].
    Revista iberoamericana de micologia, 2007, Sep-30, Volume: 24, Issue:3

    Topics: Antifungal Agents; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2007
Antifungal efficacy of voriconazole, itraconazole and amphotericin b in experimental fusarium solani keratitis.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2008, Volume: 246, Issue:2

    Topics: Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Corneal Ulcer; Disease Models, Animal; Eye Infections, Fungal; Fusarium; Itraconazole; Mycoses; Pyrimidines; Rabbits; Treatment Outcome; Triazoles; Voriconazole

2008
Images in haematology. Cerebral fungal abscess in a patient with acute promyelocytic leukaemia.
    British journal of haematology, 2008, Volume: 140, Issue:3

    Topics: Antifungal Agents; Brain Abscess; Combined Modality Therapy; Female; Fusarium; Humans; Leukemia, Promyelocytic, Acute; Magnetic Resonance Imaging; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2008
In vitro efficacy of voriconazole against clinical isolates of Scytalidium spp. from clinical lesions.
    International journal of antimicrobial agents, 2008, Volume: 31, Issue:2

    Topics: Antifungal Agents; Humans; Mitosporic Fungi; Mycoses; Pyrimidines; Triazoles; Voriconazole

2008
In vitro activity (MIC and MFC) of voriconazole, amphotericin B, and itraconazole against 192 filamentous fungi: the GISIA-2 study.
    Journal of chemotherapy (Florence, Italy), 2007, Volume: 19, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fungi; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2007
Case report: allergic bronchopulmonary aspergillosis and allergic fungal sinusitis successfully treated with voriconazole.
    The Journal of asthma : official journal of the Association for the Care of Asthma, 2007, Volume: 44, Issue:10

    Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Humans; Hypersensitivity; Male; Middle Aged; Mycoses; Pyrimidines; Remission Induction; Sinusitis; Triazoles; Voriconazole

2007
Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia.
    Pharmacotherapy, 2008, Volume: 28, Issue:1

    Topics: Administration, Oral; Adult; Aged; Alanine Transaminase; Antifungal Agents; Aspartate Aminotransferases; Bilirubin; Creatinine; Exanthema; Female; Fever; Humans; Injections, Intravenous; Male; Middle Aged; Mycoses; Neutropenia; Pyrimidines; Retrospective Studies; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2008
Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Jan-15, Volume: 46, Issue:2

    Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2008
Virulence studies of Scedosporium and Fusarium species in Drosophila melanogaster.
    The Journal of infectious diseases, 2007, Dec-15, Volume: 196, Issue:12

    Topics: Animals; Drosophila melanogaster; Drosophila Proteins; Female; Fusarium; Humans; Mycetoma; Mycoses; Pyrimidines; Scedosporium; Spores, Fungal; Toll-Like Receptors; Triazoles; Virulence; Voriconazole

2007
Breakthrough cutaneous alternariosis in a patient with acute lymphoblastic leukemia: clinical features and diagnostic issues.
    Leukemia & lymphoma, 2008, Volume: 49, Issue:1

    Topics: Adult; Alternaria; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Skin Diseases; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole

2008
Cervical spondylodiscitis caused by Blastoschizomyces capitatus.
    Infection, 2009, Volume: 37, Issue:2

    Topics: Adult; Amphotericin B; Antifungal Agents; Cervical Vertebrae; Dipodascus; Discitis; Female; Humans; Leukemia, Myeloid, Acute; Mycoses; Neck; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Ultrasonography; Voriconazole

2009
Voriconazole-induced blistering in the setting of graft versus host disease: A report of 2 patients.
    Journal of the American Academy of Dermatology, 2008, Volume: 58, Issue:3

    Topics: Adult; Antifungal Agents; Blister; Bone Marrow Transplantation; Extremities; Female; Fusarium; Graft vs Host Disease; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole

2008
Treatment of invasive fungal infections in clinical practice: a multi-centre survey on customary dosing, treatment indications, efficacy and safety of voriconazole.
    International journal of hematology, 2008, Volume: 87, Issue:2

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2008
Primary prophylaxis with voriconazole in patients receiving induction chemotherapy on the MRC adult acute lymphoblastic leukaemia trial (UK-ALL XII) to avoid itraconazole-enhanced vinca neurotoxicity.
    International journal of laboratory hematology, 2008, Volume: 30, Issue:2

    Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Humans; Itraconazole; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole

2008
Recurrent Trichosporon asahii glossitis: a case report.
    The journal of contemporary dental practice, 2008, Mar-01, Volume: 9, Issue:3

    Topics: Administration, Inhalation; Adult; Antifungal Agents; Asthma; Bronchodilator Agents; Budesonide; Drug Resistance, Fungal; Glossitis; Humans; Immunocompromised Host; Male; Mycoses; Pyrimidines; Recurrence; Triazoles; Trichosporon; Voriconazole

2008
Successful treatment of subcutaneous Scytalidium hyalinum infection with voriconazole and topical terbinafine in a cardiac transplant patient.
    Transplantation, 2008, Mar-15, Volume: 85, Issue:5

    Topics: Administration, Topical; Antifungal Agents; Ascomycota; Erythema; Heart Transplantation; Humans; Male; Middle Aged; Mycoses; Naphthalenes; Postoperative Complications; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2008
[Usefulness of voriconazole in treatment of Phoma glomerata after penetrating injury].
    Journal francais d'ophtalmologie, 2008, Volume: 31, Issue:1

    Topics: Aged; Antifungal Agents; Ascomycota; Eye Injuries, Penetrating; Humans; Male; Mycoses; Pyrimidines; Retinal Detachment; Triazoles; Voriconazole

2008
Disseminated infection by Bipolaris spicifera in an immunocompetent subject.
    Medical mycology, 2008, Volume: 46, Issue:4

    Topics: Adult; Amphotericin B; Ascomycota; DNA, Fungal; DNA, Ribosomal; Humans; Immunocompetence; Itraconazole; Lymph Nodes; Male; Mycoses; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole

2008
Invasive pulmonary infection due to Trichoderma longibrachiatum mimicking invasive Aspergillosis in a neutropenic patient successfully treated with voriconazole combined with caspofungin.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, May-15, Volume: 46, Issue:10

    Topics: Adolescent; Antifungal Agents; Caspofungin; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Hematologic Neoplasms; Humans; Lipopeptides; Male; Mycoses; Neutropenia; Pneumonia; Pyrimidines; Radiography, Thoracic; Tomography, X-Ray Computed; Triazoles; Trichoderma; Voriconazole

2008
Combined therapy in treatment of murine infection by Fusarium solani.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:3

    Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Drug Therapy, Combination; Echinocandins; Fusarium; Immunocompromised Host; Kidney; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Mycoses; Pyrimidines; Spleen; Survival Analysis; Triazoles; Voriconazole

2008
In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:4

    Topics: Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

1997
[Antifungal drugs: the new frontier].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 1998, Volume: 11, Issue:3

    Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Vulvovaginal; Caspofungin; Drug Resistance, Microbial; Echinocandins; Female; Fungi; Humans; Lipopeptides; Male; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Research; Triazoles; Trypanocidal Agents; Voriconazole

1998
In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

1998
Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi.
    Medical mycology, 1998, Volume: 36, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

1998
Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species.
    Journal of clinical microbiology, 1999, Volume: 37, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

1999
Voriconazole. UK 109496.
    Drugs in R&D, 1999, Volume: 1, Issue:2

    Topics: Animals; Antifungal Agents; Aspergillosis; Drug Interactions; Drugs, Investigational; Fungi; Guinea Pigs; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

1999
Cutaneous infection caused by Paecilomyces lilacinus in a renal transplant patient: treatment with voriconazole.
    Scandinavian journal of infectious diseases, 2000, Volume: 32, Issue:3

    Topics: Antifungal Agents; Dermatomycoses; Humans; Immunocompromised Host; Kidney Transplantation; Male; Middle Aged; Mycoses; Opportunistic Infections; Paecilomyces; Pyrimidines; Triazoles; Voriconazole

2000
[Therapy of deep seated mycoses--Timing of administration and selection of antifungal agents].
    The Japanese journal of antibiotics, 2000, Volume: 53, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Mycoses; Nystatin; Pyrimidines; Triazoles; Voriconazole

2000
Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading.
    Diagnostic microbiology and infectious disease, 2000, Volume: 38, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Reference Standards; Time Factors; Triazoles; Trichosporon; Turkey; Voriconazole

2000
In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
    Journal of clinical microbiology, 2001, Volume: 39, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2001
Empirical antifungal therapy--new options, new tradeoffs.
    The New England journal of medicine, 2002, Jan-24, Volume: 346, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2002
Voriconazole versus liposomal amphotericin B in patients with neutropenia and persistent fever.
    The New England journal of medicine, 2002, Jan-24, Volume: 346, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Data Interpretation, Statistical; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Research Design; Treatment Outcome; Triazoles; Voriconazole

2002
Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Canada; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Quality Control; Thiazoles; Triazoles; United States; Voriconazole

2002
Decisions about voriconazole versus liposomal amphotericin B.
    The New England journal of medicine, 2002, May-09, Volume: 346, Issue:19

    Topics: Amphotericin B; Antifungal Agents; Clinical Protocols; Data Interpretation, Statistical; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Research Design; Triazoles; Voriconazole

2002
Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
    The New England journal of medicine, 2002, May-30, Volume: 346, Issue:22

    Topics: Amphotericin B; Antifungal Agents; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2002
Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
    The New England journal of medicine, 2002, May-30, Volume: 346, Issue:22

    Topics: Amphotericin B; Antifungal Agents; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2002